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ABSTRACT OF THE DISSERTATION
The impact of mRNA structure on tRNA selection and ribosome rescue
by
Erica N. Thomas
Doctor of Philosophy in Biology and Biomedical Sciences
Plant and Microbial Biosciences
Washington University in St. Louis, 2019
Professor Hani S. Zaher, Chair

The faithful and rapid translation of proteins from genetic information is an essential feature of
the ribosome. The general process of tRNA selection is governed by the ability of the ribosome
to select for the aminoacylated tRNA (aa-tRNA) that matches the codon in its A-site. The
efficiency and accuracy of this selection depends on the ability of nucleotides to form proper
hydrogen bonds. While much is known about how chemical alterations of tRNA and rRNA can
impact the fidelity of translation, less is known about how similar changes to mRNA affect
decoding. In this work, we describe several studies aimed at investigating the impact of mRNA
structural alterations on translation. We examine the impact of alkylative damage of mRNA both
in vitro and in vivo and show that the accumulation of these adducts increases ribosomal stalling
and subsequent rescue by the trans-translation pathway in bacteria. Additionally, we characterize
the base pairing preferences of the most common oxidative damage adduct of mRNA, 8oxoguanosine, on the ribosome. Finally, we show that the kink structure adopted by the
phosphodiester backbone of mRNA on the ribosome impacts translation under sub-optimal base

x

pairing conditions. Together, this works offers novel insight into the importance of mRNA
structure in maintaining the speed and fidelity of translation.
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Chapter 1

Alterations and disruption of tRNA selection in bacteria
Erica N. Thomas and Hani S. Zaher
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ABSTRACT
Translation is a fundamental step of the central dogma, during which the ribosome
decodes an mRNA transcript to produce protein. During the elongation phase, multiple
mechanisms work to ensure that the mRNA codon pairs with the proper aminoacyl-tRNA (aatRNA). The speed and accuracy of this process can be altered through various means, such as
addition of aminoglycoside antibiotics, introduction of ribosomal mutations, and alterations to
tRNA modifications. However, fewer studies have focused on how changes to mRNA structure
impact tRNA selection. Here, we discuss what is known about tRNA selection, how it could be
altered, and the consequences of ribosome stalling in bacteria.
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INTRODUCTION
The accuracy and efficiency of translation is vital to the production of functional proteins
in all living organisms. On average, translation proceeds with only one misincorporation per 103
to 104 events (1–3). The accuracy of this template-driven process depends on the ability of the
ribosome to properly select the aminoacyl-tRNA (aa-tRNA) that is the correct match for the
mRNA codon in the A site. Proper decoding relies on Watson-Crick hydrogen bonding between
nucleotides at all three positions of the codon, with the exception of some permissible wobble
hydrogen bonding in the third position (4). Interestingly, the energetics of the hydrogen bonding
alone cannot explain the observed accuracy of decoding (5, 6). During the process of tRNA
selection, the ribosome plays an active role in correctly recognizing the specific geometry of
Watson-Crick base pairs before proceeding with peptidyl transfer (7, 8). This intricate process
allows for the ribosome to discriminate between substrates with very small differences in the free
energy of binding (9).
The bacterial ribosome is composed of two main subunits: the small subunit, or the 30S,
and the large subunit, known as the 50S. These two subunits come together during initiation to
form the 70S ribosome. Throughout translation, the ribosome utilizes three different tRNA
binding sites: 1) the A site, or the aminoacyl-tRNA site, 2) the P site, or the peptidyl-tRNA site,
and 3) the E site, or the exit site. During elongation, a ternary complex composed of an aa-tRNA,
elongation factor-Tu (EF-Tu), and GTP is delivered to the A site. Several downstream reactions
occur, resulting ultimately in the reaction of the newly delivered amino acid with the peptidyltRNA in the P site. To complete the cycle, translocation occurs, which is a reaction catalyzed by
EF-G that uses the energy of GTP hydrolysis to promote the movement of peptidyl-tRNA into
the P site, and the deacylated tRNA into the E site. Translation termination in bacteria begins
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when stop codons enter the A site and are recognized by either release factor 1 or 2 (RF1 and
RF2) which hydrolyze the peptidyl-tRNA and release the peptide chain (10).

Translation Elongation and tRNA Selection
During tRNA selection, the ribosome must distinguish between the aa-tRNAs that match
the codon in the A site, known as cognate aa-tRNAs, and near-cognate aa-tRNAs, which have
one mismatch between the codon and anticodon. In order to select the cognate over the nearcognate aa-tRNA, the ribosome recognizes the small energetic differences between them
multiple times through mechanisms known as kinetic proofreading and induced fit (11, 12). This
repeated exploitation of free energy (∆∆G) separated by a functionally irreversible reaction
compounds the effects, resulting in the observed high accuracy of tRNA selection. Kinetic
proofreading during this process is possible because the aa-tRNA is delivered to the A site in a
complex with GTP and EF-Tu, and the hydrolysis of GTP by EF-Tu serves as the functionally
irreversible reaction that separates the two independent interactions between the aa-tRNA and
the ribosome. The first utilization of the ∆∆G of binding between the cognate and non-cognate
aa-tRNAs occurs during the initial encounter between the ribosome and the GTP form of the
ternary complex. The second utilization of the ∆∆G of binding occurs during the association of
the ribosome with either the GDP state of the ternary complex or free form the of tRNA after
dissociation of EF-Tu. These independent steps of evaluation between the aa-tRNA and the
ribosome can lead to greater discrimination, particularly if equilibrium is rapidly attained during
the steps before the relatively slow steps of GTPase activation and accommodation (9).
The initial step of tRNA selection is a codon-independent interaction between the
ribosome and the ternary complex (Figure 1). This interaction is governed by rate constants k1
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and k -1, and these rates are similar between cognate (no mismatch), near-cognate (one
mismatch), and non-cognate (greater than one mismatch) aa-tRNAs (13, 14). The rate of binding
between the ribosome and ternary complex is high and has been shown to be dependent on EFTu. It is hypothesized that the positive charge and the large size of the L7/L12 stalk of the
ribosome interacts with EF-Tu, thus explaining the fast rate of binding between the two (15). The
next step is codon recognition (k2), which is similar for cognate and near-cognates, but is very
slow for non-cognates (14). The first step that distinguishes between cognates and near-cognates
is dissociation during initial codon recognition (k -2) (16). On average, the rate of dissociation for
near-cognates compared to cognates is about one thousand-fold faster under high-fidelity
conditions, which is a larger difference than is expected when only considering the free energy
differences of tRNA-mRNA binding between cognates and near-cognates (16). This observation
suggests that the ribosome plays an active role in stabilizing the cognate interaction through
induced fit.
The next steps of tRNA selection are dependent on the GTPase activity of EF-Tu. During
GTPase activation (k3), which is the rate-limiting step of GTP hydrolysis (kGTP), the active site of
EF-Tu undergoes a conformational change (17). The forward rate of GTPase activation depends
on the properties of the decoding helix, i.e. the pairing interaction between the codon and the
anticodon. Therefore, the rate of GTPase activation is faster for cognate aa-tRNAs than for nearcognate aa-tRNAs (16, 18, 19). The inorganic phosphate is released (kpi) after GTP hydrolysis,
and EF-Tu is rearranged to its GDP-bound state before dissociating from the aa-tRNA (k6) (19).
This irreversible reaction is followed by a kinetic partitioning that occurs during the second
encounter between the ribosome and the aa-tRNA. During this stage, which is known as
proofreading, the aa-tRNA either moves completely into the A site during accommodation (k5)
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or dissociates from the ribosome during rejection (k7). The rate of accommodation is accelerated
for cognate aa-tRNAs, while the rate of rejection is accelerated for near-cognate aa-tRNAs in
order to maintain the accuracy of translation. If the aa-tRNA is accommodated, it will proceed
with peptidyl transfer (kpep) in the large ribosomal subunit where it gets incorporated into the
growing peptide chain. (19–21).

Figure 1.1: Schematic of tRNA selection (10). Green arrows indicate reactions that are
accelerated for cognate aa-tRNAs, while red arrows indicate reactions that are accelerated for
near-cognate aa-tRNAs. Selection begins with codon-independent initial binding of the ternary
complex to the ribosome, governed by k1 and k-1. Codon recognition is codon dependent and is
governed by k2 and k-2. GTPase activation follows, during which EF-Tu undergoes a
conformational change governed by k3 and k-3. The next step is the irreversible hydrolysis of
GTP (kGTP). The dissociation of EF-Tu leads into the proofreading stage, where the kinetic
partitioning between accommodation (k5) and rejection (k7) occurs. Peptidyl transfer (kpep)
follows accommodation.
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Peptide Release
Termination of translation occurs when one of the nearly universal stop codons, including
UAA, UAG, and UGA, enters the A site. Unlike tRNA selection, which depends on RNA-RNA
interactions, peptide release is dependent on protein-RNA interactions. In bacteria, stop codons
are recognized by protein factors known as class I release factors (RFs) that subsequently trigger
the release of the elongating peptide. RF1 decodes UAG while RF2 decodes UGA, and both of
the factors decode UAA (22). Bacteria also depend on RF3, which is a GTPase class II release
factor that helps to complete termination. This likely occurs via downstream reactions through
coupling the energy of GTP hydrolysis to the removal of the class I RF after peptide release (23).
The RFs cannot utilize Watson-Crick base pairing, so they rely on RNA-protein interactions to
achieve their low error-frequency of approximately 1 in 105 events (24).
Class I release factors share several functional similarities to aa-tRNAs. Both class I RFs
and aa-tRNAs have a domain for recognizing the appropriate codons with high specificity in the
small subunit of the ribosome. For aa-tRNAs and RFs, these regions are the anticodon and
domain 2, respectively. Additionally, they each have another domain involved in promoting
catalysis in the peptidyl transfer center (PTC) of the large subunit. For aa-tRNAs and RFs, these
regions are the acceptor stem and domain 3, respectively (10). Although these bifunctional
species share similarities, they work through fundamentally different mechanisms. For one,
instead of Watson-Crick RNA-RNA base pairs, RNA-protein interactions are utilized during
peptide release. “Tripeptide anticodons” were identified as the region of RFs that are critical for
stop codon recognition (25). These motifs are proline-any amino acid-threonine (PxT) for RF1
and serine-proline-phenylalanine (SPF) for RF2. Several structural studies provide clear
evidence that these regions occupy the decoding center near the mRNA in the A site (26–31).
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RFs also work through different mechanisms than aa-tRNAs to achieve their specificity. Because
RF3 cannot provide the irreversible step necessary for kinetic proofreading, class I RFs derive
specificity from relatively large apparent binding (Km) contribution for stop codons over sense
codons (32). This indicates that all sense codons trigger decreased class I RF binding.
Contributions to specificity are also derived from kcat effects that range from 2- to 1000-fold
depending on the sense codon and RF, suggesting that class I RFs bind in a qualitatively
different fashion to stop and sense codons (32). These binding strategies may be exploited for
specificity by RFs because of the inherently larger differences in ∆∆G of binding available for
protein-RNA interactions relative to RNA-RNA interactions or because proofreading
mechanisms do not exist for RFs (10).

Structural Determinants of tRNA Selection
Several ribosomal proteins and nucleotides have been shown to play vital roles in
monitoring the interaction between the anticodon and codon in the decoding center, which
encompasses functionally important residues of the 16S rRNA, including nucleotides 1400-1500
of helix 44, 1050-1200 of helix 43, and the 530 loop of helix 18 (33, 34). The specific residues
that are critical for tRNA binding to the A-site include G529, G530, A1492, and A1493 (35, 36).
Residues A1492 and A1493 monitor the geometry of the codon-anticodon helix in the first two
positions, while C518, G530, and portions of ribosomal protein S12 monitor the second and third
positions (4, 37). The Watson-Crick geometries of the first two positions are more strictly
monitored than the third position, which allows for certain wobble base pair geometries (Figure
2).
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In the apo-structure of the ribosome, A1492, A1493, and G530 exist in a conformation
where their hydrogen bonding interfaces are facing out of the A-site. Upon binding of the aatRNA to the codon, A1492 and A1493 move from an intrahelical position in helix 44 to an
extrahelical position while G530 flips from a syn to an anti-conformation. These nucleotides
congregate together to inspect the minor groove of the decoding helix and increase the specificity
for Watson-Crick base pairs (4). This active monitoring of the codon-anticodon helix by the
ribosome explains the level of tRNA selection accuracy that cannot be achieved by hydrogen
bonding between codons and anticodons alone. Once the proper codon-anticodon interaction is
detected by the ribosome, downstream signals trigger large conformational changes of the
ribosome in a process known as domain closure (38). These movements include the rotation of
the head towards the shoulder domain of the 30S subunit as well as the rotation of the shoulder
domain towards the inter-subunit space. This brings the shoulder domain close to EF-Tu, which
in turn positions the catalytically important His84 of EF-Tu for GTP hydrolysis so tRNA
selection can continue into the proofreading phase (39).
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Figure 1.2: Active monitoring of tRNA-mRNA interactions by rRNA residues. A) Firstposition monitoring of the codon-anticodon interaction by A1493. B) Second-position
monitoring by G530 and A1492. C) Third-position monitoring by G530. Note that this figure
depicts accurate hydrogen bonds, but the exact stereochemistry of the nucleotides is not
represented here (40).
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Altering the Accuracy of tRNA Selection
Aminoglycoside Antibiotics
Several mechanisms exist to either restrict or relax the accuracy of tRNA selection. A
particular class of antibiotics, known as the aminoglycosides, relax tRNA selection conditions
and increase the rate of ribosomal miscoding (41). This class encompasses a large range of
molecules including paromomycin, streptomycin, neomycin, kanamycin, and gentamycin that
can induce a wide array of miscoding events by working through distinct mechanisms.
Paromomycin and streptomycin have been particularly instrumental in helping to elucidate
structural changes that occur during tRNA selection (10). Paromomycin accelerates both of the
forward reaction rates in tRNA selection, GTPase activation (k3) and accommodation (k5), while
reducing the rate of near-cognate tRNA dissociation from the A site during codon recognition (k2)

and rejection (k7) (42, 43). Specifically, paromomycin pushes A1492 and A1493 into an

intermediate position where they are able to engage the minor groove of the codon-anticodon
helix (44). This conformation looks very similar to the one that is assumed when a cognate aatRNA is bound to the A-site codon (45). In this way, it switches the ribosome into a highly
activated state regardless of the codon-anticodon interaction in the A site and kpep increases for
both near-cognate and cognate aa-tRNAs (43, 46).
Streptomycin also increases miscoding on the ribosome, but through a mechanism
independent of paromomycin. The antibiotic has been shown to substantially reduce the forward
rates of GTPase activation (k3) for cognate tRNAs while only slightly stimulating these values
for near-cognate tRNAs (47). Structural studies show that streptomycin generates these kinetic
changes by inducing a lateral shift of helix 44 (h44), which contains A1492 and A1493. This
lateral shift appears to be sufficient to stabilize near-cognate tRNAs. Additionally, this shift
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increases the energetic barriers associated with domain closure for cognate tRNAs, resulting in
an overall increase in miscoding (48).

Ribosomal Mutations
Several ribosomal mutants in E. coli cause tRNA selection to become either more
restrictive or promiscuous. The mutations that cause tRNA selection to be more restrictive were
discovered in auxotrophic mutants that displayed a dependency on streptomycin (7). Several of
these mutations mapped to the gene encoding the small ribosomal protein S12 (rpsL),
specifically at the contact points between S12 and the 16S RNA helix 44 and helix 27 that are
important for domain closure (49, 50). The mutations disrupt these interactions, thereby
destabilizing the closed conformation and increasing accuracy during tRNA selection.
Ribosomal ambiguity (ram) mutants are those that increase ribosomal promiscuity and
miscoding (51). These mutations frequently alter the small ribosomal subunit proteins S4 (rpsD)
and S5 (rpsE). The two proteins form an interface that is disrupted during domain closure. The
mutations reduce the number of bonds that must be broken, thereby lowering the energetic
barrier necessary for this disruption to occur and increasing ribosomal miscoding (52, 53).

tRNA Modifications
The energetics of hydrogen bonding as well as the active monitoring of the codonanticodon helix by the ribosome cannot still not fully explain the ability of the ribosome to
discriminate between closely related codons. In these cases, accurate decoding relies on the
chemical modifications of anticodons to fine-tune their base-pairing properties (54, 55).
Modifications can either expand or restrict the decoding capacity of anticodons, and the
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expression levels of hundreds of proteins can be altered by variations in these modifications.
Specifically, base modifications are common at positions 34 and 37 of the tRNA (56). Position
34 of the tRNA base pairs with the third position wobble base of the codon and allows for it to
have an expanded decoding capacity (57, 58). For example, to avoid mispairing with the AUG
Met codon, the AUA Ile tRNA utilizes a C that is modified to lysidine (k2C) in position 34 of the
anticodon. In this way, the Ile tRNA avoids a U•G wobble with the AUG Met codon at the third
position and instead forms a k2C•A base pair with the AUA codon (59). Position 37 of the
anticodon is adjacent to the 3’ site of the anticodon and modifications at this site play a critical
role in the stabilization of the first base pair of the codon-anticodon helix. For example, modified
m1G37 in the anticodons of bacteria prevents frameshifting, whereby the mRNA slips during
translation by one or more base pairs in either the 5’ (-1) or 3’ (+1) direction (60). In this way,
modifications of tRNA are critical for accurate decoding.

mRNA Modifications and Structure
While much is known about how tRNA modifications modulate tRNA selection, less is
known about how modifications and structural alterations to mRNA can impact translation. More
than 100 distinct chemical modifications of RNA are known; however, it remains unclear which
chemical modifications are intentional, and which are the result of nucleic acid damage (61).
Nucleic acids are susceptible to multiple types of chemical damage, including alkylation,
deamination, oxidation, and depurination. Sources of damage include reactive oxygen species,
UV radiation, ionizing radiation, alkylating agents, and possibly even the aberrant activity of
tRNA modifying enzymes. If these damage-induced adducts interfere with the ability of the
nucleotide to form proper base pairs, they can have a negative impact on the speed and accuracy
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of translation. Intentional modifications can also be the result of alkylating enzymes; therefore, it
is difficult to distinguish between alkylative damage and intentional modifications (62, 63).
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Figure 1.3: Structures of modified nucleobases discussed in this thesis. Altered residues are
indicated in red. Damaged nucleobases are those that are generated from exogenous and
endogenous chemical damage, while modified nucleotides are intentional regulatory marks
introduced by the cell. Resonance structures are indicated for m1A and m3C.
15

Nucleobase Modifications and Adducts
There are several indications that certain mRNA modifications are intentional and
dynamic regulatory marks. One indication is that the modification has specific proteins serving
as its readers, writers, and erasers that can act on mRNA. For example, N6-methyladenosine
(m6A), which is the most abundant internal modification in eukaryotic mRNA and is also found
in bacterial mRNA, is a reversible modification (64). It has dedicated methyltransferases,
including methyltransferase-like 3 and 14 (METTL3 and METTL14) as well as Wilms tumor 1associated protein (WTAP) (65–69). Importantly, it also has dedicated demethylases, including
fat mass and obesity associated protein (FTO) and AlkB homologue 5 (ALKBH5) to remove the
modification (70, 71). Through these writers and erasers, the levels of m6A on mRNA can be
modulated. Additionally, m6A possess multiple readers including YTHDF1, YTHDF2,
YTHDF3, and YTHDC1 that can recognize this modification and perform downstream functions
(72–74). Another indication that a modification is intentional is its specific enrichment in certain
regions of mRNA. For example, m6A is found in over 25% of human transcripts with enrichment
in long exons, 3’UTRs, and near stop codons (73). This targeted enrichment suggests that the
modification could be serving a function in some aspect of mRNA metabolism (64).
While m6A serves as an intriguing candidate for an intentional mRNA modification to
regulate translation elongation, previous work has shown that it does not significantly interfere
with the tRNA selection process (75, 76). This is expected, as the methylated nitrogen still
retains one hydrogen to participate in proper base pairing; therefore, it is not likely to be
intentionally utilized to modulate the speed or accuracy of tRNA selection. Previous studies have
instead suggested that m6A in mRNA may play a role in a wide variety of processes related to
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mRNA metabolism, including the enhancement of nuclear processing and export, the promotion
of translation, and mRNA maturation (64).
There are many more mRNA adducts that are the result of nucleotide damage compared
to those that serve as intentional modifications (63). These adducts can directly impact the WC
interface between nucleotides, generate new hydrogen bonding interfaces, or cause internal
rearrangements of atoms such that the original WC interface is altered. Two of the most common
types of nucleotide damage that impact base pairing are oxidative and alkylative damage.
Oxidative damage is generated from both endogenous and exogenous processes. For example,
cellular respiration produces superoxide radical O2- during electron transport through the
reduction of molecular oxygen by components of the electron transport chain (77, 78).
Additionally, O2- is intentionally produced to kill invading microbes by immune cells using the
enzyme NADPH oxidase (79). In order to control cellular levels of O2-, superoxide dismutase
catalyzes the metal-dependent dismutation of superoxide into O2 and H2O2 (80). Because H2O2
can react with intracellular iron through Fenton and Haber-Weiss chemistry to form highly
reactive hydroxyl radicals, it is enzymatically reduced to water and molecular oxygen (81).
Additionally, several exogenous sources of oxidative damage include ionizing and UV radiation,
as well as toxic compounds (82). Less is known about the accumulation of alkylative damage;
however, it is known that several chemotherapeutic agents are alkylating agents that may rely on
RNA damage for their efficacy (83). Additionally, several known sources of endogenous
alkylative damage are the aberrant activity of the universal methyl donor S-adenosyl methionine
(SAM) and nitrosated bile adducts (84).
Oxidative damage can cause myriad damage adducts, but one of the most abundant
oxidative damage adducts of mRNA is 8-oxoguanosine (8-oxoG). Under normal conditions, 8-
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oxoG is present at approximately 1 in 105 residues in total RNA and can increase as much as 10fold under oxidative stress conditions (85, 86). Previous work has shown that when 8-oxoG is
present in mRNA, it decreases the rate of peptidyl transfer in the presence of 8-oxoG•C base
pairs while increasing the rate of miscoding in the presence of 8-oxoG•A base pairs (87). From
structural studies performed using the DNA modification 8-oxodG, it was shown that the
introduction of the O8 to the guanosine causes a steric clash of the nucleobase with the
phosphate backbone of the nucleotide. As a result, the nucleobase changes conformation from its
normal anti conformation to a syn conformation to relieve this steric hindrance. This opens a new
hydrogen bonding interface and allows for 8-oxoG to mispair with adenosine (88).
Due to the susceptibility of oxygen and nitrogen to alkylative damage, there exists an
extensive list of possible alkylative modifications to nucleotides. Several of the modifications
can directly interfere with the WC interface between nucleotides, resulting in a decrease in the
rate of decoding and in some cases even miscoding. For example, the introduction of a methyl
group to the O6 of guanosine causes an internal rearrangement of electrons such that N1 is no
longer covalently bound to the hydrogen used to base pair at the WC interface. This results in a
significant reduction in the rate of peptidyl transfer in the presence of an O6-methylguanosine
(m6G)•C base pair (75). Additionally, the alteration of N1 from a hydrogen bond donor to a
hydrogen acceptor allows for m6G to base pair in the Watson-Crick conformation with uridine,
resulting in an increase in the rate of miscoding in the presence of an m6G•U base pair (75, 76).
Another alkylative damage adduct of interest in N1-methyladenosine (m1A). In theory,
this adduct should be disruptive to template-driven processes, as it directly interferes with the
ability of N1 to form hydrogen bonds as well as introduces a resonance structure with a positive
charge. Indeed, one study shows that the introduction of m1A into an mRNA increases ribosome
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stalling at this lesion (76). Interestingly, several reports have implicated that m1A may serve as
an intentional regulatory modification in mRNA (89). The modification is enriched around the
start site of transcripts, upstream of the first splice site on highly translated transcripts (90, 91).
The observation that m1A may serve as an intentional modification to promote translation (90) is
difficult to reconcile if m1A does indeed increase ribosome stalling. Additionally, m1A lacks
several of the characteristics of an intentional modification. For example, no readers, writers, or
erasers specific to m1A in mRNA have been identified (89). Controversy also exists around the
abundance of m1A in human cells, as several reports identified hundreds of sites in the
transcriptome (90, 91) while another identified only nine (92). More evidence is needed to
conclusively state that m1A serves as an intentional modification of mRNA.

Sugar and Backbone Structure and Modifications
In contrast to the nucleobase, the other two components of an RNA nucleotide, including
the ribose sugar and phosphate backbone, have fewer potential modifications and damage
adducts. The only common modification of the 2’hydroxyl ribose moiety of all four nucleotides
is 2’-O-methylation (2’OMe) (93, 94). While its function remains unclear, it can inhibit
adenosine to inosine RNA editing in vitro as well as drastically increase ribosome stalling in a
position-dependent manner (95, 96). The importance of the 2’OH of the ribose sugar in decoding
has also been investigated. The ribosomal RNA residues that monitor the interaction between the
codon and anticodon in the A site not only interact with the O2 of the purine base and the N4 of
the pyrimidine base, but they also hydrogen bond with the 2’OH of the ribose (4). Interestingly,
substitutions of this moiety with deoxy or fluoro groups had minimal impact on tRNA selection
but showed that it is required for the remodeling of mRNA during translocation (97).
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Even less is known about the structural importance of the phosphate backbone during
decoding. In the ribosome, mRNA displays a kink-like structure that is stabilized by electrostatic
interactions and it is speculated that this structure prevents slippage and is therefore critical for
frame maintenance (98, 99). No information was previously known about if and how this
structure of the phosphate backbone contributed to tRNA selection.

Ribosomal Rescue in Bacteria: Trans-Translation
When translation elongation is disrupted, eukaryotes have three main cytoplasmic
mRNA-surveillance processes that are utilized: 1) nonsense-mediated decay, 2) no-go decay, and
3) non-stop decay (100). The pathway that is utilized to rescue ribosomes and degrade the faulty
mRNA and incomplete peptide depends on the context of the disruption. For example, nonsensemediated decay recognizes premature stop codons (101) and non-stop decay is utilized when
transcripts do not contain stop codons (102). No-go decay functions to rescue ribosomes stalled
by physical blocks, including chemical damage and structural impediments such as pseudoknots
and hairpins (103). Bacteria, on the other hand, utilize at least one quality control pathway,
known as trans-translation, that can rescue ribosomes that have stalled at the 3’ end of a
truncated transcript (104). In theory, the trans-translation pathway can rescue ribosomes under
almost any circumstance, as truncated mRNAs are produced through a variety of processes,
including endonucleolytic cleavage, ribosome stalling, chemical insults, and premature
transcriptional termination (100). However, it has not been explicitly shown that that this
pathway rescues ribosomes stalled by damaged transcripts.
Through the process of trans-translation, one molecule known as transfer-messenger
RNA (tmRNA), which is encoded by the highly conserved ssrA gene, acts as both a tRNA and
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mRNA to ensure that stalled ribosomes complete the translation cycle and are recycled (105).
Though some details of the process remain to be elucidated, we do know that tmRNA, which is
aminoacylated by alanine (106), binds to the A site of the stalled ribosome (107). At this point,
the nascent peptide is then transferred to tmRNA (108), and translation then switches from the 3’
end of the defective mRNA to the portion of tmRNA that contains an ssrA-coding sequence
(105, 109), which resembles the degradation signal utilized by bacterial proteases (110). This
sequence tags the C-terminus of the incomplete protein and signals for its degradation. Like aatRNAs, tmRNA binds EF-Tu (111, 112) while also requiring another protein partner known as
SmpB (113). The tmRNA molecule binds the A site in a quaternary complex with EF-Tu, SmpB,
and GTP.

Figure 1.4: Schematic depicting trans-translation. A) The ribosome reaches the 3’ end of a
transcript lacking a stop codon. B) The tmRNA-SmpB-EF-Tu-GTP complex recognizes the
stalled ribosome. C) The nascent peptide is transferred to tmRNA. Translation then resumes of
the open reading frame (ORF) of ssrA which tags the incomplete peptide at its 3’ end. The
mRNA is then released and degraded. D) Termination occurs when a release factor recognizes
the stop codon in the ssrA ORF. E) The ribosome dissociates and the incomplete peptide is
degraded (100).
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One of the main questions with regards to trans-translation is how the selectivity of this
process is governed. As is previously discussed, the specificity of peptidyl transfer is achieved by
cognate codon-anticodon interactions between mRNA and tRNA during translation elongation,
and these interactions are required to initiate conformational changes in the decoding center (10).
Interestingly, tmRNA lacks an anticodon stem loop; therefore, it cannot form the same type of
interactions as aa-tRNAs (114). However, crystal structures of the tRNA-like domain of tmRNA
in complex with SmpB shows that the protein occupies the decoding center and that the complex
adopts a structure which is similar to tRNA, with the N-terminal domain of the protein in place
of the anticodon stem loop (115). These structural as well as biochemical studies suggest that
SmpB is likely to interact with A1492, A1493, and G530 residues of the decoding center (116,
117); however, the A-minor interactions that these residues have with aa-tRNA and mRNA
cannot occur with the protein. Additionally, mutating any of the decoding center residues has no
impact on tmRNA activity in a reconstituted system (118). One recent crystal structure of a T.
thermophilus tmRNA-SmpB-EF-Tu complex shows that the decoding center adopts a
conformation that is similar, but not identical to, that observed with normal elongation
complexes (119). This supports the idea that SmpB induces rearrangement of A1492 and A1493,
but their identities are not critical to the stabilization of the induced state of the ribosome.
Another question with regards to the selectivity of trans-translation is how the process
avoids targeting actively translating ribosomes. One common feature of tmRNA targets is that
there is little-to-no mRNA downstream of the P site. In vitro studies have shown that complexes
with greater than six nucleotides downstream of the P site are poorly recognized by tmRNA
(120, 121). In solution, the C-terminal domain of SmpB is unstructured (122, 123), but in
complex with the ribosome it forms a helical structure (119). This structure extends from the A
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site towards the mRNA-entry tunnel where it makes contacts with the 16S rRNA, and early
mutational analysis revealed that the ability of this region to form this structure is critical for
ssrA tagging (118, 124). Overall, SmpB cannot bind the ribosome unless it has reached the 3’end of the mRNA because the C-terminus of the protein occupies the site that is normally
occupied by the mRNA during translation elongation. This structural clash between SmpB and
the mRNA ensures that the tmRNA does not bind the A site of the actively translating ribosome,
and hence avoids prematurely terminating protein synthesis.
While much is known about how the initial steps of trans-translation occur, more is yet to
be uncovered about the process. For example, after the first peptidyl transfer reaction,
translocation must occur to bring the tmRNA open reading frame (ORF) into the A site of the
ribosome. The new ORF has to occupy the mRNA entry tunnel where SmpB initially binds; as a
result, SmpB is predicted to change conformation to allow for template switching (125). This
process, by which the resume codon of the tmRNA is positioned into the A-site, is still not well
understood, but appears to be dependent on key interactions between SmpB and sequence
elements upstream of the ORF (126).
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CONCLUSION
While much is known about how changes to the ribosome and tRNA can impact tRNA
selection, less is known about how structural changes to mRNA can alter this process. Studies
have been performed to investigate the impact of several nucleobase adducts that impact
hydrogen bonding, as well as those that serve as intentional modifications; however, several
open questions remain. For example, it is known from previous studies in DNA that the
frequency at which 8-oxodG base pairs with A or C depends on the fidelity of the polymerase
decoding the lesion (127–130). Previous work from our group shows that 8-oxoG in mRNA
stalls the ribosome, but the conformation of 8-oxoG within the ribosome remained unclear (87).
Additionally, previous work has shown that several alkylative damage adducts can increase
ribosomal stalling, bypass, and/or miscoding (75, 76). The molecular pathways in eukaryotes to
rescue stalled ribosomes is well characterized (100). In contrast, the bacterial system used to
rescue stalled ribosomes from damaged transcripts was still unknown. Finally, the importance of
the kink structure in the phosphate backbone of mRNA in the context of the ribosome remained
uninvestigated. Addressing these and other questions will help to elucidate the importance of
mRNA structure in translation.

QUESTIONS ADDRESSED BY THIS THESIS WORK
Although our understanding of how mRNA structure can impact translation has greatly
increased in the last decade, there still exist significant gaps in knowledge of how the ribosome
deals with alterations in mRNA structure. Broadly, my thesis work has focused on understanding
how modifications to mRNA impact tRNA selection. My research focused around four
questions:
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•

Does 8-oxoG in mRNA prefer to base pair in the syn or anti conformation in the
context of the A-site of the ribosome?

•

Does the presence of m1A in mRNA cause ribosome stalling and/or specific
miscoding events?

•

How do bacteria rescue ribosomes stalled by alkylative damage?

•

Is the kink-structure of the mRNA phosphate backbone in the ribosome important for
tRNA selection?
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Alkylative damage of mRNA leads to ribosome stalling and rescue by trans-translation in
bacteria
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ABSTRACT
The highly efficient and accurate process of translation can be disrupted by damage to nucleic
acids. Several endogenous and exogenous damaging agents can cause the accumulation of
alkylative adducts, which can disrupt the normal hydrogen bonding between nucleotides.
Multiple alkylative adducts of nucleotides have been shown to impact the speed and/or accuracy
of the decoding process in vitro, and several adducts are able to stall the ribosome. However,
little is known about the cellular response to ribosome stalling by alkylative damage in vivo. In
order to investigate the impact of alkylative damage of RNA on ribosome rescue, we treat E. coli
with two common alkylating agents, methyl methanesulfonate (MMS) and
methylnitronitrosoguanidine (MNNG), and observe the accumulation of several disruptive
adducts, including N(1)-methyladenosine (m1A). Using a well-defined bacterial translation
system, we confirm that m1A stalls ribosomes in vitro. In bacteria, ribosomal stalling is primarily
relieved by trans-translation, which utilizes transfer-messenger RNA (tmRNA) to release the
ribosome and tag the incomplete peptide for degradation. To assess if ribosomes use transtranslation to rescue ribosomes stalled by alkylative damage in vivo, we utilize a previously
generated mutant transfer-messenger RNA (tmRNA) that encodes a His6 tag in place of its
peptide degradation signal. When E. coli expressing tmRNA- His6 are treated with alkylating
agents, we observe an increase in tmRNA activity. These data demonstrate that alkylative
damage to RNA in bacteria leads to ribosome stalling and rescue by the trans-translation
pathway.
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INTRODUCTION
Nucleic acids are consistently experiencing damage from numerous endogenous and
exogenous insults, including reactive oxygen species, ultraviolet radiation, and alkylating agents
(1, 2). In particular, the oxygen and nitrogen atoms of nucleobases are readily modified by
alkylating agents. RNA is more susceptible to chemical insults than DNA, likely due to its exposed
Watson-Crick (WC) hydrogen bonding interface (3, 4). Alkylation of the WC interface of mRNA
is particularly disruptive during the process of decoding on the ribosome (5). The initial stage of
tRNA selection, known as codon recognition, depends on the ability of the mRNA codon and the
anticodon of the amino acyl tRNA (aa-tRNA) to form proper hydrogen bonds (6, 7). WatsonCrick-base-pair conformations are accepted at all three positions of the codon-anticodon, while
certain wobble conformations are also tolerated at the third position (8, 9). The introduction of
alkylative damage to this interface is known to disrupt hydrogen bonding interactions and as a
result, is highly likely to reduce translational speed and fidelity (10).
Several alkylative damage adducts of mRNA have either been predicted or shown to be
detrimental to the decoding process. For example, O6-methylguanosine (m6G), N1methylguanosine (m1G), 3-methylcytidine (m3C), and N1-methyladenosine (m1A) are of interest
due to their potential to interfere with normal WC interfaces (10). Prior work has shown the
presence of m6G in mRNA interferes with the speed and accuracy of decoding (11, 12). The
introduction of a methyl group to the O6 of guanosine causes an internal rearrangement of
electrons such that N1 is no longer covalently bound to the hydrogen used to base pair at the WC
interface. This results in a significant reduction in the rate of peptidyl transfer in the presence of
an m6G•C base pair (11). Additionally, the alteration of N1 from a hydrogen bond donor to a
hydrogen acceptor allows for m6G to base pair in the Watson-Crick conformation with uridine,
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resulting in an increase in the rate of miscoding in the presence of an m6G•U base pair (11). Due
to the difficulty of incorporating the adduct into a synthesized transcript, the impact of m 3C on
decoding fidelity has remained elusive. However, we predict that this lesion causes ribosomal
stalling, as it disrupts the N3 position that is directly involved in hydrogen bonding with guanosine.
Recently, N1-methyladenosine has been the focus of several studies due to its potential
role as a regulatory modification on mRNA (13). Depending on the m1A-seq technique used, N1methyladenosine abundance has been found on human transcripts ranging from 20% of the
transcriptome (14, 15) to only nine sites in mRNA (16). The adduct has been shown to be enriched
around the start codon of transcripts, upstream of the 1st splice site. Over half of the identified m1A
adducts have been mapped to the coding region of transcripts (14, 15). A specific regulatory role
of this modification has not been identified; on the contrary, studies generally support the
hypothesis that m1A exists primarily as a damage adduct. For example, one study using crude E.
coli translation extracts showed that m1A significantly increased ribosome stalling when it was
present at any of the three positions in the codon (12). This effect on translation is anticipated,
considering that m1A is particularly disruptive to the hydrogen bonding interface, as it interferes
with the ability of the N1 to hydrogen bond and introduces a resonance structure with a positive
charge to the nucleotide (Figure 2A). Additionally, m1A can lead to local duplex melting in RNA
which could impede the codon-anticodon helix (17).
We hypothesize that an increase in the abundance of chemical damage that disrupts the
hydrogen boding interface between mRNA and tRNA, such as alkylation, will result in increased
ribosomal stalling in vivo. Eukaryotes have several mRNA-surveillance pathways to rescue stalled
ribosomes from a variety of scenarios, including premature stop codons (nonsense-mediated
decay) (18), transcripts lacking stop codons (non-stop decay) (19), and physical blocks (no-go
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decay) (20). Bacteria, on the other hand, utilize at least one quality-control pathway, known as
trans-translation, to rescue ribosomes stalled at the 3’ end of a truncated transcript (21, 22). During
this process, one molecule known as transfer-messenger RNA (tmRNA), which is encoded by the
highly conserved ssrA gene, acts as both a tRNA and mRNA to rescue stalled ribosomes and
ensure that the incomplete peptide is tagged for degradation (22). The tmRNA molecule, in
complex with EF-Tu and another protein partner known as SmpB, recognizes the stalled ribosome
and binds to the A site (23), at which point the nascent peptide is transferred to tmRNA (24).
Translation is then switched from the 3’ end of the defective mRNA to the portion of tmRNA that
contains the ssrA-coding sequence (22, 25). This sequence codes for a tag that resembles the
degradation signal utilized by bacterial proteases (26), and signals for the incomplete peptide to be
degraded. The ssrA sequence also contains a stop codon which is recognized by release factors so
the ribosome can complete the translation cycle and be recycled. Additionally, there is evidence
to suggest that the tmRNA-SmpB complex recruits RNase R to degrade the damaged mRNA (27,
28).
In theory, the trans-translation pathway can rescue ribosomes stalled from a variety of
obstacles, as truncated mRNAs are produced during several processes, including endonucleolytic
cleavage, ribosome stalling, chemical insults, and premature transcriptional termination (1).
However, trans-translation has not been specifically shown to rescue ribosomes stalled from
chemically damaged transcripts. Here, we introduce alkylative damage to E. coli RNA and
subsequently observe the activity of trans-translation. We first demonstrate that treating E. coli
with common alkylating agents increases the levels of several disruptive alkylative adducts,
including m1A. As previous data was generated using crude extracts to demonstrate that m1A
resulted in ribosome stalling (12), we utilized our well-characterized reconstituted in vitro
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translation system to obtain quantitative data with regards to the effect of m1A on peptidyl-transfer
(29). Additionally, when we treat E. coli with alkylating agents, we observe increased levels of
tmRNA activity, suggesting that trans-translation is responsible for rescuing ribosomes from
damaged transcripts in bacteria. Furthermore, when we treat E. coli lacking functional tmRNA
with alkylating agents, they exhibit delayed recovery compared to wild-type (WT) cells,
supporting the hypothesis that alkylative damage results in defects in translation.
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RESULTS
Treatment of E. coli with MMS or MNNG causes significant increases in alkylative damage
of RNA
In order to investigate the impact of alkylative damage on ribosomal rescue in bacteria, we
first established a method to introduce alkylative damage to RNA in E coli. We chose to treat cells
with either methyl methanesulfonate (MMS) or methylnitronitrosoguanidine (MNNG), two agents
that work through different nucleophilic substitution mechanisms to alkylate nucleotides. MMS
alkylates its target through an SN2-type mechanism, while MNNG reacts through an SN1-type
one (4); therefore, we expected to observe differences in the types and levels of adduct that each
agent generated. After treatment with the alkylating agents, RNA was extracted, digested with P1
nuclease into individual nucleotides, and subsequently treated with calf-intestinal phosphatase
(CIP) to generate nucleosides which were analyzed by liquid chromatography – mass spectrometry
(LC-MS). We generated standard curves for each of the unmodified nucleosides, as well as for
N1-methyladenosine (m1A), N6-methyladenosine (m6A), N1-methylguanosine (m1G), O6methylguanosine (m6G), and N3-methylcytidine (m3C) in order to directly quantify the modified
nucleosides within each condition (Supplemental Figure S1).
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Supplementary Figure 2.S1: LC-MS calibration curves for modified and unmodified
nucleosides
A) The integrated peak area for absorbance at 260 nm was recorded for known micromolar
concentrations of unmodified nucleoside standards. Peak area versus concentration was plotted
and fit to a linear equation, which was used to calculate sample concentrations. B) The integrated
peak area for cps intensity was recorded for known picomolar concentrations of modified
nucleoside standards. Peak area versus concentration was plotted and fit to a linear equation,
which was used to calculate sample concentrations.
One previous study measured endogenous m6A/A levels of 0.3% in E. coli (30). In
agreement with these experiments, we observe approximately 0.6% m6A/A in untreated RNA
(Figure 1A). We did not measure an increase in m6A levels after treatment with either alkylating
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agent (Figure 1A). This result was expected, as neither MMS nor MNNG alkylate the N6 position
of adenosine (4). Additionally, MMS and MNNG have been shown to cause low levels of m1G
accumulation in DNA (4); however, we do not measure significant increases in the levels of this
modification (Figure 1B). This is likely because m1G is an intentional modification of E. coli tRNA
and rRNA (31), so when the cells are treated with MMS and MNNG we do not detect substantial
accumulation of this adduct over background. Indeed, the base level of m1G was at least 200-fold
higher than m1A (Figure 1).
Contrary to m6A and m1G levels, we measure 10 to 200-fold increases in m3C and m1A
when we treat cells with MMS or MNNG (Figures 1C and 1D), and at least a 12-fold increase in
m6G in those treated with MNNG (Figure 1E). This is consistent with previous studies which show
that the O6 position of guanosine is primarily targeted by MNNG but not MMS, and that m3C and
m1A are minor alkylative adducts in double-stranded DNA (32) but are substantially more reactive
as nucleophiles in the absence of hydrogen bonding (33). This same increase in reactivity for m1G
in single-stranded RNA is not observed because it is a secondary amine with an adjacent carbonyl
group which is less reactive than m1A and m3C, both of which have the higher reactivity profiles
of amidine groups (4).
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Figure 2.1: Treatment of E. coli with MMS and MNNG results in significant accumulation
of detrimental alkylative damage adducts in RNA
A-E) Quantification of the integrated peak area of modified nucleosides in picomolar
concentrations normalized to the integrated peak areas of absorbance at 260nm for their
corresponding unmodified nucleosides in micromolar concentrations. Nucleosides were
quantified from untreated cells (white), MMS-treated cells (black), and MNNG-treated cells
(gray). The quantified nucleoside for each plot is indicted above.

N1-methyladenosine stalls ribosomes and behaves as a non-cognate codon in vitro
Having established a method of increasing the levels of alkylative adducts in E. coli
mRNA, we next used our well-defined reconstituted bacterial translation system to quantify
changes in peptidyl-transfer introduced by the presence of m1A in mRNA (29). Using this system,
incorporation efficiency of any single amino acid can be measured. We generated ribosomal
initiation complexes carrying f-[35S]-Met-tRNAfMet in the P site and displaying either an intact
GAA codon, or an m1A adduct at the second position (Gm1AA) in the A site (Figure 2B). The intact
GAA codon is normally decoded by Glu-tRNAGlu. Since m1A inhibits the ability of the N3 on
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adenosine to form hydrogen bonds as well as introduces a positive charge in the hydrogen bonding
interface, normal Watson-Crick interactions would be disrupted, and we predicted that this would
lead to a reduction in the rate of translation and potentially miscoding events (Figure 2A).
We reacted the intact and m1A-containing initiation complexes with cognate Glu-tRNAGlu
ternary complexes at multiple timepoints and visualized the dipeptide products using an
electrophoretic thin-layer chromatography (TLC) system. The points were fitted to a first-order
rate equation, and the rate of each reaction was calculated. We found that the presence of m1A
resulted in a 250-fold decrease in the rate of translation, as well as an almost 90% decrease in the
endpoint (Figure 2C). These results demonstrate that m1A is highly detrimental to the decoding
process in the presence of cognate tRNAs and is likely disruptive enough to result in ribosomal
stalling.
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Figure 2.2: N(1)-methyladenosine (m1A) in mRNA significantly decreases the rate and
endpoint of translation in vitro
A) Chemical structure of m1A. The N1-methyl group is highlighted in red, and the resonance
structure of the molecule is represented. B) Schematic representation of adenosine and m1A
initiation complexes encoding for the dipeptide Met-Glu. Both complexes contain the initiator
fMet-tRNAfMet in the P site; the A complex displays a GAA codon, while the m1A complex
displays a Gm1AA codon in the A site. C) Represented time-courses of duplicate peptide-bond
formation reactions between initiation complexes either containing (red) or lacking (blue) m1A
and Glu-tRNAGlu cognate ternary complexes.
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Having established that m1A disrupts the ability of the codon to form a cognate
interaction, we next tested if the presence of m1A causes the codon to behave as a near-cognate
codon, which harbors a single mismatch. When a cognate tRNA pairs with a corresponding
undamaged codon, a series of local conformational changes occur so that specific residues of the
ribosome make contacts with the codon-anticodon complex. These local rearrangements lead to
global changes, resulting in the shift of the ribosome from an open to a closed conformation, a
process known as ‘domain closure’, thus allowing the complex to proceed through the remainder
of tRNA selection (34). This process is altered by the addition of the aminoglycoside antibiotic
paromomycin, which forces the ribosomal residues involved in the conformational changes into
an intermediate position between the open and closed conformations. This reduces the energic
barriers necessary for the ribosome to undergo domain closure in the presence of near-cognate
amino acyl-tRNAs (aa-tRNAs), thus resulting in an increase in the rate of miscoding (35, 36). If
m1A causes the codon to behave like a near-cognate instead of a cognate codon in the presence
of the cognate ternary complex, we expect that the addition of paromomycin to this reaction
would increase the rate of peptide bond formation.
We reacted the m1A -containing initiation complex described earlier with cognate GlutRNAGlu ternary complexes in the presence and absence of paromomycin. We observed no
significant difference between these reactions, demonstrating that paromomycin does not rescue
the effect of m1A on peptide-bond formation (Figure 3). Since near-cognate interactions are
rescued in the presence of antibiotics, this suggests that m1A disrupts the ability of the codon to
form base-pairing interactions with the cognate anticodon so drastically it acts as a non-cognate.
From these results, we predict that m1A is not only disrupting the ability of the A to form a
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hydrogen bond, but also distorting the codon-anticodon helix significantly enough to disrupt the
hydrogen bonds of its neighboring nucleotides.

Figure 2.3: Paromomycin does not rescue the impact of m1A on peptide bond formation
Representative time-course of duplicate peptide-bond formation reactions between initiation
complexes containing m1A and Glu-tRNAGlu cognate ternary complexes. Reactions were
performed either in the presence (red) or absence (blue) of the aminoglycoside antibiotic
paromomycin.
To provide further evidence to support the observation that m1A causes the codon to
behave as a non-cognate, we investigated if m1A altered miscoding in the presence of near- and
non-cognate tRNAs. We performed a tRNA survey, in which we reacted the previously
described m1A-containing and lacking initiation complexes with all possible ternary complexes
for two minutes, which is sufficient time to reach the endpoint of significant reactions (Figure 4).
As anticipated for the codon containing the unmodified adenosine, we observed no significant
dipeptide accumulation except for the reaction in the presence of the cognate ternary complex
(Figure 4). For the codon containing m1A, no significant dipeptide accumulation occurred in the
presence of any aa-tRNA, supporting the hypothesis that m1A causes the codon to behave as a
non-cognate.
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Figure 2.4: Specific miscoding events are not observed for a codon containing m1A
Phosphorimager scan of electrophoretic TLCs used to follow dipeptide-formation reactions (twominute incubation time). TCs are indicated above and within each set, the reaction on the left
was performed using an IC displaying an unmodified GAA codon while the reaction on the right
was performed using an IC displaying a modified Gm1AA codon.

N1-methyladenosine does not interfere with trans-translation in vitro
The results thus far show that m1A is highly disruptive to peptidyl transfer in vitro. From
this data, we hypothesized that alkylative damage to E. coli would cause ribosomal stalling in
vivo. We predicted that the main ribosomal rescue system in bacteria, the trans-translation
pathway, would be responsible for releasing stalled ribosomes from these damaged transcripts
(21). However, if the presence of m1A in the A site disrupts the interaction between the codon
and the anticodon of the ternary complex, it is possible that it interferes with the ability of
tmRNA or SmpB to bind the A site and begin trans-translation. In this case, the ribosome would
be unable to be rescued by trans-translation from transcripts damaged by m1A in vivo.
To test if m1A in the A site interferes with the binding of tmRNA or SmpB, we
performed in vitro peptidyl transfer reactions in the presence of either a codon containing m1A or
a codon with an unmodified A, and an in vitro reconstituted quaternary complex containing
SmpB, tmRNA, EF-Tu, and GTP. Similar to tmRNA in vivo, the tmRNA used in this experiment
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was amino-acylated with alanine (37). We utilized the same mRNA constructs that were used in
the in vitro peptidyl transfer assays, as we had shown that the transcript containing m1A
significantly interfered with peptidyl transfer. These transcripts are not ideal substrates for transtranslation, as they contain twelve nucleotides downstream of the P site instead of seven, which
has previously been shown to be the maximum number of downstream nucleotides for sufficient
activation of trans-translation (38, 39). Even using sub-optimal substrates, we observe similar
rates and endpoints of peptidyl transfer for codons containing either A or m1A (Figures 5A and
5B). This data suggests that m1A does not significantly interfere with the binding of SmpB or
tmRNA to the A site; therefore, the possibility remains that m1A leads to ribosomal stalling in
vivo that is subsequently rescued by trans-translation.
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Figure 2.5: m1A does not significantly interfere with the recognition of initiation complexes
by trans-translation in vitro
A) Phosphorimager scan of an electrophoretic TLC used to follow dipeptide-formation reactions.
The timecourse on the left was performed using ICs displaying an unmodified GAA codon and
trans-translation quaternary complexes. The timecourse on the right was performed using ICs
displaying a modified Gm1AA codon and trans-translation quaternary complexes. B)
Quantification of the timecourses performed in A.

Alkylative damage of RNA increases tmRNA activity in vivo
Having established a method to introduce alkylative damage adducts to E. coli RNA
through treatment with MMS or MNNG, we took advantage of a previously generated tmRNA
construct which contains an altered native degradation peptide tag sequence; specifically, the six
C-terminal residues are substituted for an HHHHHH (His6) tag (tmRNA-H6), in order to assess
the activity of tmRNA (40). Using this system, if ribosomes stall in vivo and tmRNA is activated,
His6 tagging of incomplete peptides will increase.
We treated E. coli expressing tmRNA-H6 with either 0.1% MMS or 5 μg/mL MNNG and
performed a western blot to analyze the resulting total protein. As predicted, we observed
approximately 2 to 3-fold increases in His6-tagging levels (Figures 6A and 6B). To show that the
treatments were causing significant alkylative damage, we also probed for the activation of Ada,
which is an enzyme that is involved in the adaptive response (41). Ada is normally present at
very low levels in the cell, and it induces its own expression as well as the expression of other
proteins involved in the adaptive response upon alkylative damage (42, 43). Indeed, we observe
significant increases in Ada activation when we treat with MMS or MNNG, and along with the
LC-MS data, demonstrates that we are introducing significant alkylative damage.
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Figure 2.6: Alkylative damage of RNA in E. coli induces ribosome rescue through the transtranslation pathway
A) Western blot displaying total protein collected from E. coli expressing tmRNA-His6. Cells
were either untreated or treated with MMS, MNNG, or ciprofloxacin. Additionally, cells either
received (+) or did not receive (-) a pre-treatment with rifampicin before treatment with the
indicated damaging agent. Blots were probed with α His, α Ada, α RecA, and α RF2. B)
Quantification of the increase in His6 levels for each no rifampicin pre-treatment condition. His6
samples were first normalized to their corresponding RF2 loading control, and then foldincreases in His6 levels were calculated by dividing the treated samples by the untreated samples.
Quantification was performed in triplicate ± SD. C) Quantification of the fold-decrease of His6
levels upon pre-treatment with rifampicin. His6 samples were first normalized to their
corresponding RF2 loading control. Fold-decreases in His6 levels were calculated by dividing the
rif pre-treatment condition for each sample with its corresponding no-rif pre-treatment condition
and subtracting this value from 1. Quantification was performed in triplicate ± SD.

In order to show that the increase in tmRNA activity was due to alkylative damage rather
than other potential effects from cell death, we treated E. coli with 0.1% MMS and performed a
spot assay with the treated cells and do not observe significant death at this concentration
(Supplemental Figure S2A and S2B). Additionally, a previous report has shown that when the
ClpAP, ClpXP, and Lon proteases are inactive, the levels of his-tagging by the tmRNA system
increase, as the incomplete peptide products are able to further accumulate (40). When E. coli
with null alleles of clpP, clpX, and lon genes are treated with the alkylating agents, we observe
even more extensive his-tagging as the incomplete peptides generated from alkylative damage
accumulate (Supplemental Figure S3).
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Supplementary Figure 2.S2: WT and ∆ssrA E. coli exhibit similar survival phenotypes after
treatment with MMS
A) Spot assay of WT and ∆ssrA cells either after no treatment or treatment with 0.1% MMS for
the indicated amount of time. B) Quantification of colony forming units in (A) performed in at
least duplicates. C) Spot assay of WT and ∆ssrA cells either after no treatment or treatment with
0.5% MMS for the indicated amount of time. D) Quantification of colony forming units in (C)
performed in at least duplicates.
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Supplementary Figure 2.S3: Deletion of ClpAP, ClpXP, and Lon proteases results in
further accumulation of His6 after alkylative damage
Western blot displaying total protein collected from either WT E. coli, strains expressing
tmRNA-His6, or strains expressing tmRNA-His6 with null alleles of clpP, clpX, and lon genes.
Cells were either untreated or treated with MMS or MNNG. The blot was probed with α His, α
Ada, and α RF2.

As has been noted in a previous study, the his-tagging patterns between each of the
samples appear almost identical (40). This was a surprising observation, as we expected the
alkylative damage to be randomly located throughout the transcriptome, thereby causing a more
uniform streak of his-tagging or banding patterns that varied from sample to sample. In order to
investigate if this consistent banding pattern was an artifact of the His antibody we were using,
we probed a western blot with His antibodies from three different manufacturers. Each antibody
had a distinct His-tagging pattern (Supplemental Figure S4). This data suggests that the
consistent His-tagging pattern is likely more due to an artifact of the His antibodies than a
particular pattern of proteins that are preferentially His-tagged.
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Supplementary Figure 2.S4: Different His antibodies display unique banding patterns on
western blots
Western blots displaying total protein collected from E. coli expressing tmRNA-His6. Cells were
either untreated or treated with MNNG. Each treatment set contains a dilution series (1.0, 0.5,
and 0.25) of total protein. Western blots were probed with three His antibodies from different
manufacturers, including Santa Cruz Biotechnology, Abcam, or GenScript. α RF2 was used as a
loading control.
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The accumulation of His-tagged peptide products suggests that alkylative damage of
RNA is stalling ribosomes in vivo and activating tmRNA. However, the alkylative damage from
MMS and MNNG damages DNA as well as RNA (4). This is supported by the increase in RecA,
which is a protein that is essential for the maintenance and repair of DNA (44), that we observe
increasing via western blot when we treat with these alkylating agents (Figure 6A). Therefore, it
was also possible that the resulting increase in His-tagging was primarily due to the production
of truncated transcripts from damaged DNA. These truncated transcripts lack a stop codon;
therefore, ribosomes will stall at the 3’ end of the transcript with an empty A site and this has
been previously shown to activate the response of tmRNA (22). To ensure that the observed His
-tagging was due to RNA damage rather than truncated RNA produced from damaged DNA, we
pre-treated the cells with a rifampicin (Rif) approximately forty seconds before treating with
damaging agents. Rif is an inhibitor of RNA polymerase initiation; therefore, the pretreatment
with rif halts transcriptional initiation and allows us to separate the effects of DNA damage from
RNA damage (45). In addition to MMS and MNNG, we also treated the cells with ciprofloxacin
(cip) and mitomycin C (MMC). Cip is an antibiotic that inhibits the ligation activity of DNA
gyrase and topoisomerase IV but not the cleavage activity, thereby causing the topoisomerases to
create double stranded breaks in DNA (46). MMC causes intra- and inter-strand DNA crosslinks
that can block the activities of DNA polymerase and RNA polymerase (47). We predict that
these two agents, which specifically cause DNA damage, will produce truncated transcripts and
cause His-tagging by tmRNA. We also expect to observe a decrease in His-tagging generated by
DNA damaging agents, but not for the alkylating agents, after pre-treatment with rif if the
tmRNA activity is due primarily to alkylative damage of RNA rather than truncated transcripts.
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When we pre-treat E. coli expressing tmRNA-H6 with rif and then with MMS, we
observe a slight (10%) decrease in His-tagging levels compared to the no pre-treatment
condition, suggesting that the His-tagging in this condition is primarily due to RNA damage
(Figure 6C). When we treat the cells with MNNG, we do observe a slightly higher decrease
(20%) in the amount of His-tagging for the rif pre-treatment condition compared to no pretreatment (Figure 6C). This suggests that a portion of the His-tagging is due to truncated
transcripts produced from DNA damage; however, the levels of His-tagging in the rif pretreatment condition are still significantly higher than the samples with no alkylative damage.
When we treat cells with cip, we observe significant His-tagging in the no rif pre-treatment
condition, approximately the same fold-increase as MNNG and MMS (Figure 6B). This
observation supports our initial hypothesis that DNA damage generates truncated transcripts that
cause ribosomal stalling and activate tmRNA. However, when we pre-treat the cells with rif and
then with cip, we observe a 40% decrease in His-tagging (Figure 6C). When we treated cells
with MMC, we did observe increases in RecA activation but no significant increases in levels of
His-tagging, demonstrating that the DNA crosslinking damage induced by MMC does not
activate the tmRNA system (Supplemental Figure S4). While little is known about how RNA
polymerase stalling is resolved from double-stranded breaks, from this data we predict that
double-stranded breaks produce more truncated mRNA transcripts than crosslinking. Overall, we
conclude that while truncated transcripts produced from damaged DNA do activate tmRNA, the
predominate source of tmRNA activation in MMS- and MNNG- treated samples is the alkylative
damage of RNA.
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Supplementary Figure 2.S5: Ciprofloxacin, but not mitomycin C, increases His6 levels
Western blot displaying total protein collected from E. coli expressing tmRNA-His6. Cells were
either untreated or treated with ciprofloxacin (cip) or mitomycin C (MMC). Additionally, cells
either received (+) or did not receive (-) a pre-treatment with rifampicin before treatment with
the indicated damaging agent. The blot was probed with α His, α RecA, and α RF2.

The ability to rescue stalled ribosomes is important for cellular recovery after alkylative
damage
Even though the ssrA gene that encodes tmRNA is highly conserved in bacteria, previous
studies have shown that ∆ssrA E. coli show no appreciable growth phenotype under standard
laboratory conditions but do exhibit delayed growth under certain stress conditions (37, 48).
Since we observed that tmRNA is utilized to rescue ribosomes stalled due to damaged RNA, we
hypothesized that the ability for cells to rescue stalled ribosomes is important for cellular
recovery upon treatment with alkylating agents. To test this, we treated ∆ssrA and WT cells with
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either 0.5% MMS or 20 μg/mL MNNG, washed the cells to remove the alkylating agent, and
allowed them to recover while monitoring growth. If trans-translation is responsible for rescuing
ribosomes stalled by alkylative damage, we expect to observe a lag in the recovery time for
∆ssrA cells compared to WT after treatment with alkylating agents.
As expected, in the absence of any pretreatment, ∆ssrA and WT cells recover at
approximately the same rate. However, after treatment with MMS or MNNG, ∆ssrA cells have
an approximately 1.5-hour lag in their recovery compared to WT cells (Figure 7). This data
demonstrates that cells lacking tmRNA are more sensitive to alkylative damage. To rule out
cellular death as a cause for the observed lag, we treated both ∆ssrA and WT cells with 0.5%
MMS for 20, 40, and 60 minutes, washed the cells to remove the alkylating agents, and
performed spot assays to quantify cell death. We observe similar rates of cell death for ∆ssrA and
WT cells, suggesting that the previously observed lag in recovery time is not due to a difference
in the number of cells killed, but rather the ability of the cells to quickly recover after treatment
with alkylating agents (Supplementary Figure S2C and S2D). This data suggests that the ability
for cells to efficiently recover post-alkylative damage depends on their ability to rescue stalled
ribosomes from damage RNA using tmRNA.
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Figure 2.7: Ribosome rescue by tmRNA is important for cellular recovery after treatment
with alkylating agents
Average of three replicate growth assays plotting the recovery of E. coli post-alkylative damage.
WT (blue) and ∆ssrA (red) cells either received no treatment or treatment with MMS or MNNG.
The alkylating agents were washed from the samples and the OD600 of the cells was recorded
during the recovery period.
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DISCUSSION
Several recent reports have shown that mRNA can be intentionally modified to control its
function (49). For example, m6A is a reversible modification of mRNA that appears to play a
role in the regulation of gene expression (50). Additionally, mRNA containing pseudouridine
(Ψ) has been shown to produce significantly higher levels of functional protein than its
unmodified counterpart (51). Although much has been revealed about the role that intentional
modifications serve in regulating various aspects of mRNA metabolism, most chemical
modifications of mRNA are disruptive damage adducts (10). Previous work had shown that
several alkylative damage adducts, including m1A and m6G, drastically slow translation and
cause increases in miscoding events in vitro (11, 12). However, little was known about how
alkylative damage of mRNA elicits cellular responses in vivo. Additionally, the quantitative
effects of m1A on the speed and accuracy of translation remained unknown. Here, we introduce
alkylative damage to bacterial RNA and monitored cellular responses to translation. A priori, we
hypothesized that the main ribosome rescue system in bacteria, the trans-translation pathway,
works to release stalled ribosomes from transcripts containing alkylative damage. Indeed, we
find that upon treatment of E. coli with alkylating agents, trans-translation activity significantly
increased (Figure 5). Furthermore, we show that when cells lack functional trans-translation,
they do not recover as efficiently after treatment with alkylating agents (Figure 6).
In order to assess the cellular response of bacteria to alkylative damage, we first
established a method to reliably introduce alkylative damage adducts to E. coli in vivo. We chose
two common alkylating agents, MMS and MNNG, which work through an SN2- and SN1-type
nucleophilic substitution mechanism, respectively (4). We measured the levels of several
modifications via LC-MS with and without treatment, and each of the observed changes is
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supported by existing literature (4). As a negative control, we chose to measure changes in m6A
levels, as exocyclic amino groups of guanine, cytosine, and adenine are known to be poor
nucleophiles in methylation reactions. Indeed, we do not observe significant changes in m6A
levels upon treatment with the agents (Figure 1A). We do observe increases in levels of m1A and
m3C which are known targets of MMS and MNNG in single-stranded DNA and RNA (Figures
1C and 1D) (4, 32). Additionally, we observe increases in m6G levels only in MNNG-treated
samples (Figure 1E). This is consistent with studies showing that MNNG produces a greater
percentage of O-methyl adducts (4).
Our group had previously utilized an in vitro reconstituted bacterial translation system to
investigate the impact of m6G on decoding (11); however, we had not analyzed the effects of
m1A. We hypothesized that the positively charged resonance structure of m1A would not only
disrupt its ability to base pair but would also distort the codon-anticodon helix significantly
enough to disrupt the ability of its neighboring nucleotides to base pair. Structural studies of the
A site show that the first and second position of the codon-anticodon helix are strictly monitored
by rRNA residues as well as ribosomal proteins to ensure that only Watson-Crick base pairs are
recognized as acceptable interactions (34, 52, 53). We chose to analyze m1A in the second
position of the codon rather than the first because if our hypothesis held true, first position m1A
may interfere with the ability of the nucleotide immediately 5’ of the transcript to base pair. In
this experimental setup, the upstream codon is the start codon, so in theory this could reduce the
efficiency of translation initiation, which was not the focus of this study.
The rate and endpoint of peptide-bond formation in the presence of m1A was
substantially less than those measured for the unmodified control (Figure 2C). This is supported
by a previous study showing that m1A in mRNA increases ribosome stalling in crude extracts
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(Figure 2C) (12). Furthermore, the addition of paromomycin to this reaction does not suppress
the effect of m1A on peptide-bond formation (Figure 3) and the tRNA survey between the m1Acontainin codon and all potential near- and non-cognate aa-tRNAs shows no substantial
reactivity (Figure 4), suggesting that the adduct causes the codon to behave like a non-cognate.
Overall, the disruptive nature of m1A in the coding region does not support the idea that it is an
intentional modification that promotes translation (14), but rather that it is a highly detrimental
adduct of mRNA.
Having confirmed that m1A is a disruptive adduct of mRNA in vitro, we then sought to
investigate the cellular response to alkylative damage in vivo. We first demonstrated in vitro that
m1A does not significantly interfere with the recognition of the IC by the trans-translation
quaternary complex (Figure 5), suggesting that translating ribosomes stalled by alkylative lesions
such as m1A can be targeted by trans-translation. Using a tmRNA modified to His-tag
incomplete peptides from stalled translation complexes (40), we observe increased transtranslation activity upon cellular treatment with alkylating agents (Figure 6A). This suggests that
alkylative damage of RNA causes ribosomal stalling that is severe enough to elicit responses
from ribosome rescue pathways. Because bacterial mRNAs do not contain poly-A tails like
eukaryotic transcripts, it is difficult to purify bacterial mRNA from rRNA and tRNA; therefore,
we cannot be certain that the observed effects on translation are due to mRNA damage
exclusively. However, there exist several compelling reasons to support the hypothesis that the
tmRNA response is primarily due to mRNA damage. For one, the complex folding of rRNA as
well as its association with ribosomal proteins is thought to make it a poor target for alkylative
damage (10). Specifically, the rRNA residues responsible for monitoring the base pairing in the
decoding center are not exposed to the cytoplasm in translating ribosomes; therefore, it is
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unlikely that they are damaged by the agents (54). Additionally, tRNA are susceptible to
alkylative damage, but only 3 out of an average of 76 nucleotides directly participate in base
pairing with the codon. This reduces the probability that damaged nucleotides in tRNA cause the
observed ribosomal stalling. The secondary structure of tRNA does not protect it from damage,
as it has been shown that tRNA accumulate damage to the same extent when they are folded as
when they are denatured (55). However, the CCA enzyme in E. coli, which attaches the
conserved CCA sequence at the 3’ end of all mature tRNAs, has been shown to have an innate
ability to discriminate against tRNA backbone damage (56). Because the CCA sequence serves
as the site of amino acid attachment for tRNAs, this suggests that damaged tRNAs would not be
aminoacylated, thereby also reducing the probability that damaged tRNAs are utilized during
translation.
We also confirm that the majority of tmRNA activity is due to RNA damage rather than
truncated transcripts produced by damaged DNA. One intriguing observation from these
experiments is that ciprofloxacin, but not MMC, increases tmRNA activity in the no-rifampicin
pre-treatment condition (Supplementary Figure S5). These DNA damaging agents work through
independent mechanisms – ciprofloxacin produces double-strand breaks (46) while MMC
generates crosslinks (47). When RNA polymerase encounters a DNA crosslink, it can change
conformation and backtrack on the DNA which extrudes the 3’ end of the mRNA (57, 58). These
backtracked polymerases are arrested, and their active sites no longer align with the 3’ hydroxyl
end of the mRNA (58). They then can become targets for several pathways which work to
restore transcription and repair the DNA (59, 60). The RNA and stalled RNA polymerase are
only released after multiple attempts at restoring transcription (61). This repair of DNA and
restoration of transcription in the presence of crosslinks could explain why we do not observe
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significant tmRNA activity, as the production of a truncated transcript from this scenario could
be rare. Contrary to stalling on a crosslink, little is known about the fate of bacterial RNA
polymerase when it encounters a double-stranded break. Based on our observation that
ciprofloxacin significantly increases tmRNA activity, we hypothesize that double-stranded
breaks are more likely to result in the production of truncated transcripts than DNA crosslinks.
Several studies have shown that bacteria lacking a functional trans-translation pathway
do not recover as efficiency after cellular stress, including nutrient and oxidative stress (37, 48).
We observe that alkylative stress also causes a delayed recovery period in cells lacking tmRNA,
likely because they are unable to efficiency rescue stalled ribosomes and resume growth (Figure
7). The ∆ssrA cells are likely still able to eventually resume growth after alkylative damage
because of the existence of several alternative ribosome-rescue factors. One factor, known as
alternative ribosome-rescue factor A (ArfA) works by recruiting RF2 to hydrolyze the peptidyltRNA and release the ribosome (62, 63). This factor acts as a backup for trans-translation, as its
expression increases when tmRNA activity is limited (64, 65). Additionally, it is not as ideal of a
system as trans-translation, as it does not tag the incomplete peptide for degradation. Another
factor that can release stalled ribosomes is ArfB, although it does not appear to function solely as
a backup for tmRNA and its physiological function remains to be elucidated (66, 67).
Regardless, these alternative ribosome rescue factors in E. coli are likely responsible for the
eventual recovery we observe.
Our hypothesis that alkylative damage is detrimental enough to decoding to cause
ribosomal stalling and rescue in vivo is also supported by the observation that bacteria contain at
least one protein that can repair alkylative lesions of mRNA. For example, AlkB is an alphaketoglutarate-dependent hydroxylase in E. coli that has been shown to repair alkylative lesions of
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single-stranded DNA and RNA, including m1A, m3C, and m1G (68). We also predict that the
targeting of stalled ribosomes by trans-translation results in the degradation of alkylated
transcripts, as previous studies have suggested that tmRNA recruits RNaseR to degrade non-stop
mRNA (27). Although the accumulation of alkylative damage under physiological conditions or
disease states has not been the focus of many studies, our work supports the idea that it is
important for cellular viability to rescue and prevent ribosomes from stalling on alkylated
transcripts and that trans-translation is the main pathway through which bacteria alleviate this
disruption to decoding.
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EXPERIMENTAL PROCEDURES
Strains
Strains were either derivatives of E. coli MG1655 (F- lambda- ilvG- rfb-50 rph-1) or X90
(ara∆(lac-pro) nalA argE(Am) rif thi-1/F’ lacIq lac+ pro+) (69). We received the following
strains from the lab of Dr. Sean Moore: SM694 (X90, ssrA::his6 - kan), SM876 (X90, ssrA::his6 kan, clpPX-lon::cam), and SM20 (X90, ∆ssrA, cam) (40). We received the SKEC4 (MG1655,
∆ssrA, ∆smpB, kan) strain from Dr. Allen Buskirk. P1 transduction was used to introduce kanR linked tmRNA-H6 into MG1655.
Western Analysis
To prepare total protein for Western blot analysis, E. coli were precipitated, washed with LB,
and resuspended in 2xSDS loading dye. The resuspension volume was adjusted to normalize for
OD600 of the culture at the time of collection. Total protein was separated by SDS-PAGE and
transferred to PVDF membrane in 1x Transfer buffer (25 mM Tris, 192 mM glycine, 20%
Methanol) in a wet apparatus. After transfer, the membrane was shaken for one hour in PBST
(3.2 mM Na2HPO4, 0.5 mM KH2PO4, 1.3 mM KCl, 135 mM NaCl, 0.05% Tween 20, pH 7.4.)
with 5% w/v powdered milk. The membrane was then washed with PBST and incubated with
primary antibody overnight at 4°C. The following dilutions of primary antibodies were used:
1:2500 anti-His (Abcam unless otherwise specified), 1:500 anti-Ada (Santa Cruz
Biotechnologies), 1:10,000 anti-RecA (Abcam), and 1:1,000 anti-RF2 (purified as described in
Zaher and Green Cell paper). The blot was then washed three times for 5 minutes, and then
incubated with the corresponding HRP-conjugated secondary antibody (1:10,000) in PBST for
one hour. After washing three times for 5 minutes, the membrane was treated with an HRP-
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reactive chemiluminescent reagent (Pierce ELC Western Blotting Substrate). Quantity One
software was utilized to quantify Western blots.
Treatment of E. coli with Damaging Agents
For all Western blot analyses, E. coli were treated with the following concentrations of damaging
agents: 0.1% MMS (Sigma-Aldrich), 5 μg/mL MNNG (TCI Products), 50 μg/mL ciprofloxacin
(Sigma-Aldrich), or 6 μg/mL MMC (Sigma-Aldrich). To determine the treatment time that
generated significant tmRNA activity and Ada activation, MG1655 cells containing tmRNA-His6
were grown from OD 0.05 to mid-log phase (OD 0.3-0.4) and treated with MMS for several
timepoints. The resulting total protein was analyzed via western blot (Supplemental Figure S6).
We observed significant tmRNA activity and Ada activation after a 20-minute treatment, which
is the treatment time we utilized for the remaining samples analyzed via Western blot.
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Supplementary Figure 2.S6: Optimal His6, Ada, and RecA levels are achieved after 20
minutes of MMS treatment
Western blot displaying total protein collected from E. coli expressing tmRNA-His6. Cells were
either untreated or treated with MMS for various lengths of time. The blot was probed with α
His, α Ada, α RecA, and α RF2.

To determine the optimal length of time for rifampicin pre-treatments, we treated MG1655 cells
containing tmRNA-His6 with 6 ug/mL rifampicin for several timepoints followed by 20 min
treatments with either MMS or ciprofloxacin. The resulting protein was analyzed via western
blot (Supplemental Figure S7). We observed significant decreases in Ada activation in the MMStreated samples and significant decreases in tmRNA activity and RecA activation in the
ciprofloxacin-treated samples after 10 seconds of rifampicin pre-treatment. We utilized a 10 to
45-second rifampicin pre-treatment time for the remaining samples analyzed via western blot.

Supplementary Figure 2.S7: Significant transcriptional runoff is achieved after 10 seconds
of rifampicin treatment
Western blots displaying total protein collected from E. coli expressing tmRNA-His6. A) Cells
were either untreated, treated with only ciprofloxacin, or pre-treated with rifampicin for various
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amounts of time before ciprofloxacin treatment. The blot was probed with α His, α RecA, and α
RF2. B) Cells were either untreated, treated with only MMS, or pre-treated with rifampicin for
various amounts of time before MMS treatment. The blot was probed with α His, α Ada, and α
RF2.
Quantification of Nucleosides via Liquid Chromatography – Mass Spectrometry
Overnight cultures of MG1655 E. coli were diluted to OD 0.05 in LB and grown to an OD of
0.3-0.4 at 37°C before 20 min treatment with either 0.1% MMS or 5 μg/mL MNNG. RNA was
isolated using a hot phenol method as previously described (70). 10 μg of total RNA was
digested by P1 nuclease (10 Units) at 50°C overnight. A final concentration of100mM Tris pH
7.5 and 1:100 v/v dilution of calf intestinal phosphatase (CIP) were added to the samples, and the
reaction was incubated for 1 hour at 37°C to convert 5’-monophosphates to nucleosides. The
samples were diluted to 150 μL and filtered (0.22 μm pore size) before injecting 10 μL into an
Agilent 1290 Infinity II UHPLC connected to an Agilent 6470 Triple Quadrupole mass
spectrometer. Nucleosides were separated on a Zorbax Eclipse Plus C18 column (2.1 x 50 mm x
1.8 micron) and then analyzed using multiple-reaction monitoring in positive-ion mode.
Calibration curves were generated with known concentrations of standards. Unmodified
nucleosides were monitored by absorbance at 260 nm. Modified nucleosides were monitored by
MRM. The retention times and mass transitions of each nucleoside are listed in Supplemental
Table S1. Free unmodified A, G, and C standards were purchased from Acros Organics and U
was purchased from TCI Products. Free modified nucleosides m7G, m1G, and m3C were
purchased from Carbosynth, m6G and m6A were purchased from Berry’s Associates, and m1A
was purchased from Cayman Chemical Company. Data was analyzed using Agilent qualitative
analysis, Excel, and Graphpad Prism software.
precursor product
mass
ion
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retention collision
time
energy

A
C
G
U
m1A
m6A
m3C
m7G
m1G
m6G

268.1
244.1
284.2
245.2
282.2
282
258.2
298.2
298
298

136
112
152
152.1
150.1
150
126
166
166
166

1.92
0.48
2.4
1
0.9
4.08
0.8
1.5
4.623
4.84

18
14
16
14
16
16
8
10
4.143
4.84

Supplementary Table 2.S1: Mass transitions, retention times, and collision energies for
nucleoside standards

Charging of Aminoacyl-tRNA
[35S]-fMet-tRNAfMet was prepared as previously described (71). The tRNAs were aminoacylated
by incubating total tRNA mix (Roche) at 150 μM with the appropriate amino acid (0.4 mM),
tRNA synthetase (~5 μM) and ATP (2 mM) in charging buffer composed of 100 mM K-HEPES
(pH 7.6), 20 mM MgCl2, 10 mM KCl, 1 mM DTT. After a 30-minute incubation at 37°C, the aatRNAs were purified by phenol/chloroform extraction, ethanol precipitated, and resuspended in
20 mM KOAc (pH 5.2) and 1 mM DTT.
Formation of Ribosomal Initiation Complexes
Protocols were performed as previously described (72). All initiation complex (IC) formation
and peptidyl transfer reactions were performed in 1x polymix buffer (46 in 8oxoG paper),
composed of 95 mM KCl, 5 mM NH4Cl, 5 mM Mg(OAc)2, 0.5 mM CaCl2, 8 mM putrescine, 1
mM spermidine, 10 mM K2HPO4 (pH 7.5), 1 mM DTT. In order to generate ICs, 70S ribosomes
(2µM), IF1, IF2, IF3, [35S]-fMet-tRNAfMet (3µM each), mRNA (6µM), and GTP (2 mM) in 1 ×
polymix buffer were incubated at 37°C for 30 min. The initiation complexes were purified from
free tRNAs and initiation factors over a 500 µL sucrose cushion composed of 1.1 M sucrose, 20
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mM Tris-HCl pH 7.5, 500 mM NH4Cl, 0.5 mM EDTA, and 10 mM MgCl2. The mixture was
spun for 2 hours at 287,000 × g at 4°C, and the pellet was resuspended in 1 × polymix buffer
and stored at -80°C. The fractional radioactivity that pelleted was used to determine the
concentration of IC.
Modified mRNAs containing m1A used in the IC formation reaction were purchased from The
Midland Certified Reagent Company, and its sequence is as follows: C AGA GGA GGU AAA
AAA AUG G(1-methyl-A)A UUG UAC AAA. The unmodified control mRNA was transcribed
from a dsDNA template using T7 polymerase and purified via denaturing PAGE (74).
Kinetics of Peptidyl Transfer
In order to exchange bound GDP for GTP, EF-Tu (30 µM final) was initially incubated with
GTP (2 mM final) in 1x polymix buffer for 15 mins at 37°C. The mixture was then incubated
with aminacyl-tRNAs (~6 µM) for 15 mins at 37°C to form ternary complexes (TC). For
reactions performed in the presence of paromomycin, 10 µg/mL final of the antibiotic were
added to this mixture. Kinetics assays were also performed using trans-translation quaternary
complexes (QCs), which were formed by incubating Ala-tRNAAla with SmpB, EF-Tu, and GTP
in 1x polymix for 15 mins at 37°C. The TC or QC mixture was then combined with an
equivalent volume of IC at 37°C either using RQF-3 quench-flow instrument or by hand. KOH
to a final concentration of 500 mM was used to stop reactions at different time points. Dipeptide
products and free fMet were separated using cellulose TLC plates that were electrophoresed in
pyridine-acetate at pH 2.8 (50 in 8oxog paper). TLC plates were then exposed to a phosphor
screen overnight, after which they were imaged using a Personal Molecular Imager (PMI)
system. The images were quantified, and the fraction of dipeptide fMet at each time point was
used to determine the rate of peptide bond formation using GraphPad Prism software.
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Alkylative Damage Recovery Assays
Overnight cultures of MG1655 and ∆ssrA MG1655 cells were diluted to OD600 0.05 and grown
to 0.3 – 0.4 at 37°C before treating with either 0.5% MMS or 20 μg/mL MNNG for 20 mins. The
OD600 of the cells was recorded at the time of collection, and the samples were washed twice
with LB and resuspended in an adjusted volume of LB. Cells were diluted to an OD600 of 0.005
at 100 μL final volume in a 96-well plate. Plates were shaken at 37°C for 20 hours in a BioTek
Eon microtiter plate reader which measured the OD600 of each well every 10 mins. OD600 data
over time was fit to an exponential function in Graphpad Prism to plot the growth curve.
Spot Assays for Viability Analysis
X90 and SM20 E. coli were grown from OD 0.5 to OD 0.3 at 37°C before treating with either
0.1% or 0.5% MMS. At each time point, an aliquot of the culture was removed, washed with LB,
and then serially diluted 1:10 eight times. 4 μL of each dilution were spotted on an LB plate. The
plates were imaged and colonies were counted using the Colony Counter plugin on ImageJ.
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Chapter 3
Insights into the base-pairing preferences of 8-oxoguanosine on the ribosome
This chapter is currently published in Nucleic Acids Research as Erica N. Thomas, Carrie L.
Simms, Hannah E. Keedy, and Hani S. Zaher (2019). Insights into the base-pairing preferences
of 8-oxoguanosine on the ribosome.
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ABSTRACT
Of the four bases, guanine is the most susceptible to oxidation, which results in the formation of
8-oxoguanine (8-oxoGua). In protein-free DNA, 8-oxodG adopts the syn conformation more
frequently than the anti one. In the syn conformation, 8-oxodG base pairs with dA. The equilibrium
between the anti and syn conformations of the adduct are known to be altered by the enzyme
recognizing 8-oxodG. We previously showed that 8-oxoG in mRNA severely disrupts tRNA
selection, but the underlying mechanism for these effects was not addressed. Here, we use
miscoding antibiotics and ribosome mutants to probe how 8-oxoG interacts with the tRNA
anticodon in the decoding center. Addition of antibiotics and introduction of error-inducing
mutations partially suppressed the effects of 8-oxoG. Under these conditions, rates and/or
endpoints of peptide-bond formation for the cognate (8-oxoG•C) and near-cognate (8-oxoG•A)
aminoacyl-tRNAs increased. In contrast, the antibiotics had little effect on other mismatches,
suggesting that the lesion restricts the nucleotide from forming other interactions. Our findings
suggest that 8-oxoG predominantly adopts the syn conformation in the A site. However, its ability
to base pair with adenosine in this conformation is not sufficient to promote the necessary
structural changes for tRNA selection to proceed.

KEYWORDS
Ribosome, translation, tRNA selection, 8-oxoguanosine, oxidative damage
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INTRODUCTION
Decoding of the genetic information is a remarkably accurate process that ensures the
maintenance of faithful protein production. In all domains of life, the ribosome carries out this
crucial task by utilizing multiple strategies to select for the aminoacyl-tRNA (aa-tRNA) that
corresponds to mRNA in the A site (1, 2). This process of tRNA selection is divided into two
phases: initial phase and proofreading, which are separated by the irreversible step of GTP
hydrolysis by EF-Tu (3). During the initial selection phase, aa-tRNA binds the A site of the
ribosome in a ternary complex with EF-Tu and GTP. During this stage, near-cognate aa-tRNAs,
which harbor a single mismatch, are discriminated against due to their inability to fully base pair
with the A-site codon. This results in the accelerated dissociation of the ternary complex. After
this initial codon-recognition step, EF-Tu undergoes a conformational change before GTP is
hydrolyzed (4). This step of GTPase activation is significantly accelerated for cognate aa-tRNAs,
thereby contributing to the overall accuracy of the tRNA selection process. After GTP hydrolysis,
GDP-bound EF-Tu undergoes additional conformational changes before dissociating from the
ribosome (5, 6). During the subsequent proofreading stage, the selection process is partitioned into
accommodation and rejection (7, 8). Cognate aa-tRNAs rapidly accommodate to then participate
in peptidyl transfer (PT), whereas near-cognate aa-tRNAs are more likely to be rejected (9–11).
This multi-step process of tRNA selection results in an overall misincorporation rate of 10-4 – 103

per PT event (12–15)
X-ray crystallography and cryo-EM reconstitution studies of various ribosome complexes

have provided some important molecular rationale for the process of tRNA selection, especially
during the initial selection stage (16–18). The EF-Tu-bound aa-tRNA binds the A site in a bent
state, referred to as the A/T state, where its anticodon can sample the codon (19). Once base pairing
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between the codon and the anticodon occurs, the conserved A1492, A1493, and G530 residues of
the decoding center change conformation and interact with the minor groove of the codonanticodon helix in a recently-identified stepwise manner (17). These interactions are only possible
if strict Watson-Crick base pairing is maintained at the first two positions of the codon. Additional
contacts are made by other ribosomal RNA (rRNA) residues as well as ribosomal protein S12 (20).
These local rearrangements in the decoding center trigger a global change in the small ribosomal
subunit (30S) (21). This so-called “domain closure” moves the shoulder of the 30S as well as EFTu closer to the large subunit (50S). As a result, the GTPase domain of EF-Tu binds the sarcinricin loop (SRL), activating the factor for GTP hydrolysis through interactions with the catalytic
histidine (22). It has been suggested that if the anticodon of the aa-tRNA is tightly bound in the
decoding center following EF-Tu dissociation, accommodation ensues. On the other hand, if the
tRNA is loosely bound then it is more likely to dissociate and be rejected (7, 23).
Several antibiotics are known to affect the overall selection process by altering the
interactions between the tRNA-mRNA complex and the decoding center. The most studied and
well-understood group is the aminoglycoside class of antibiotics. Nearly all bind in the decoding
center and reduce the energetics of “domain closure” by driving an “ON”-state of the decoding
center nucleotides. For instance, paromomycin binds in a rRNA pocket close to A1492 and A1493
and induces them to adopt a structure similar to that assumed in the presence of cognate tRNAs.
This, in turn, reduces the energetic cost associated with “domain closure” of the 30S subunit and
as a result, makes the process of tRNA selection more favorable in the presence of near-cognate
aa-tRNAs (24, 25). In comparison, streptomycin, which decreases GTPase activation for cognate
aa-tRNA and increases it for near-cognate aa-tRNAs, does not induce “domain closure”. Instead,
the antibiotic induces a lateral shift of helix 44 (h44), which contains A1492 and A1493; this
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rearrangement is distinct than that triggered by the addition of paromomycin. This lateral shift
appears to be sufficient to stabilize near-cognate tRNAs, whereas the prevention of “domain
closure” destabilizes cognate tRNAs, which results in an overall increase in miscoding (26, 27).
These largely structure-based models for tRNA selection, whereby local changes in the
decoding center drive global rearrangements in the small subunit, are also supported by genetic
studies. In particular, mutations in the 30S subunit that destabilize interactions that are important
for the transition from the “open” to “closed” state result in a hyperaccurate phenotype. These
mutations are typically found on the ribosomal protein S12, specifically at its interface with
h27/h44 of the 16S rRNA near the decoding center (28, 29). In contrast to the hyperaccurate
mutants, error-prone (often referred to as ribosomal ambiguity (ram)) mutants reduce the
energetics for transitioning to the “closed” state of the 30S by disrupting interactions important for
maintaining the “open” state (30). Mutations of this class are associated with changes to the
interfaces between ribosomal proteins S4 and S5 that are held together through electrostatic
interactions in the “open” state. Therefore, disruption of these interactions eases the transition to
the “closed” state, even in the presence of near-cognate tRNAs (31, 32).
Under typical circumstances, the ribosome only encounters mRNA composed of the four
canonical nucleobases. In contrast, the tRNA anticodon is often modified, and these modifications
impact how the anticodon base pairs with the codon. Similarly, mRNA appears to be modified,
albeit to a lesser extent than tRNAs. The most abundant of these mRNA modifications include N6methyladenosine (m6A), 5-methylcytosine (m5C), and pseudouridine (Ψ) (33). Although these
modifications do not change the Watson-Crick-base-pairing capabilities of the nucleotides, they
affect the decoding process. For example, m6A reduces the overall rate of peptide-bond formation
by almost an order of magnitude (34, 35). In contrast, the introduction of Ψ to mRNA has little
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effect on the speed of decoding but reduces accuracy on stop codons in vitro (36, 37). Regardless
of their effect on decoding, the biological implications of these modifications are currently not
fully understood, namely due to their low stoichiometries on mRNAs.
In contrast to these potentially intentional modifications, chemical damage to the mRNA
nucleobase is largely detrimental to the decoding process. Most damage adducts occur as a result
of reactivity between the mRNA and endogenous or exogenous agents (38). Some of the most
common nucleotide-damaging agents include ultraviolet light, alkylating agents, and reactive
oxygen species (ROS). In particular, ROS are produced endogenously as byproducts of metabolic
reactions and increase under stress conditions (39). Of the many potential ROS adducts, 8oxoguanosine (8-oxoG) is noteworthy due to its high abundance relative to other oxidized
nucleotides and its association with neurodegenerative disease (40, 41). Furthermore, 8-oxoG
significantly reduces the rate of peptide-bond formation to a point that it stalls protein synthesis
and is likely to activate the process of no-go decay (NGD). Indeed, our group has shown that the
introduction of 8-oxoG to the mRNA, independent of its position within the codon, slows down
PT by three to four orders of magnitude (42). While the overall kinetic consequences of 8-oxoG
on tRNA selection were recognized, the mechanistic details through which 8-oxoG interferes with
translation remained unknown. Specifically, we were interested in understanding how 8-oxoG
disrupted interactions with the anticodon within the decoding center of the ribosome.
Previous data from studies of the oxidative damage of DNA show that 8-oxodG can alter
the base pairing preferences of dG by changing the conformation of the nucleotide (43). When 8oxodG adopts the typical anti-conformation, the oxygen at carbon 8 is in steric clash with the
phosphate backbone (Figure 1). In order to relieve this steric clash, the base can rotate around its
glycosidic bond to the syn conformation, where it reveals a new hydrogen-bonding interface which
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it uses to form a Hoogsteen base pair with dA (43). Different DNA polymerases read 8-oxodG as
either a dG or dT at varying efficiencies, resulting in either accurate polymerization or a
transversion. The efficiency of incorporating dCMP versus dAMP across 8-oxodG depends on the
fidelity of the DNA polymerase. The steric constraints for base pairs in the active sites of high
fidelity polymerases increase the frequency at which 8oxodG base pairs with dA, as this base pair
is nearly identical in terms of its geometry to a normal Watson-Crick base pair than 8oxodG•C
(44, 45). While much is known about the base pairing preferences of 8-oxodG during replication,
the preference for the syn vs anti conformation of the base on the ribosome is not understood at
all.

Figure 3.1: 8-oxoG alters the base-pairing properties of the nucleotide
A) Structure depicting the Watson-Crick base pair of unmodified guanosine and cytidine. B)
Structure of 8-oxoG in the anti conformation forming a Watson-Crick base pair with cytidine, and
C) in the syn conformation forming a Hoogsteen base pair with adenosine.
In this study, we take advantage of a well-defined in vitro translation system to examine
the mechanism through which 8-oxoG in mRNA interferes with translation (46). We find that 8oxoG significantly impacts the initial phase of tRNA selection, suggesting that 8-oxoG is
interfering with the ability of the A-site codon to form a proper interaction with its corresponding
anticodon. To address how 8-oxoG is disrupting this interaction in the context of the A site, we
explored its base-pairing preferences by relaxing tRNA-selection conditions and reacting it with
its cognate tRNA and all possible near-cognate tRNAs. Under these relaxed tRNA selection
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conditions, we observed that 8-oxoG base pairs with either cytidine or adenosine independent of
its location in either the first or second position of the codon. Our analysis also shows that 8-oxoG
has a preference for base pairing with adenosine over cytidine under error-prone conditions,
suggesting that it more frequently exists in the syn conformation than the anti one on the ribosome.
Additionally, 8-oxoG disrupts the ability of the nucleotide to form base pairs with the remaining
near-cognates (8oxoG•U and 8oxoG•G). Our results contribute to the mechanistic understanding
of how 8-oxoG in mRNA disrupts translation.
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MATERIALS AND METHODS
Materials
All reactions were performed in 1x polymix buffer (47), composed of 95 mM KCl, 5 mM
NH4Cl, 5 mM Mg(OAc)2, 0.5 mM CaCl2, 8 mM putrescine, 1 mM spermidine, 10 mM K2HPO4
(pH 7.5), 1 mM DTT.
70S ribosomes were purified from MRE600 E. coli via a double pelleting technique (32).
Translation factors were overexpressed and purified from E. coli (46).
Modified mRNAs containing 8-oxoG were purchased from either IDT, Dharmacon, or The
Midland Certified Reagent Company. Unmodified control mRNAs were transcribed from a
dsDNA template using T7 RNA polymerase and purified via denaturing PAGE (48). The
sequence for the first position 8-oxoG mRNA was as follows: CAGAGGAGGUAAAAAA AUG
(8-oxo-rG)UU UUG UAC AAA. The sequence for the second position 8-oxoG-Arg mRNA was
as follows: CAGAGGAGGUAAAAAA AUG C(8-oxo-rG)C UUGUACAAA. The sequence for
the second position 8-oxo-Gly mRNA was as follows: CAGAGGAGGUAAAAAA AUG G(8oxo-rG)C UUG UAC AAA.
Charging of Aminoacyl-tRNA
[35S]-fMet-tRNAfMet was prepared as described (49). Pure tRNAs (tRNAVal, tRNAArg, or
tRNAMet from ChemBlock) were aminoacylated by incubating them at 10 μM with the
appropriate amino acid (0.4 mM), tRNA synthetase (~5 μM) and ATP (2 mM) in charging buffer
composed of 100 mM K-HEPES (pH 7.6), 20 mM MgCl2, 10 mM KCl, 1 mM DTT. After
incubation at 37°C for 30 minutes, the aa-tRNAs were purified by phenol/chloroform extraction
and ethanol precipitated. The aa-tRNAs were resuspended in in 20 mM KOAc (pH 5.2) and 1
mM DTT. Other tRNAs were aminoacylated by incubating total tRNA mix (Roche) at 150 μM
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in the presence of the corresponding amino acid and tRNA synthetase as above. The incubation
and purification were conducted as that done for the pure tRNAs.

Formation of Ribosomal Initiation Complexes
Protocols were performed as described (50). Briefly, to generate initiation complexes (IC), the
following components were incubated at 37°C for 30 min: 70S ribosomes (2µM), IF1, IF2, IF3,
[35S]-fMet-tRNAfMet (3µM each), mRNA (6µM) in 1 × polymix buffer in the presence of 2 mM
GTP. The complexes were then purified away from free tRNAs and initiation factors over a 500
µL sucrose cushion composed of 1.1 M sucrose, 20 mM Tris-HCl pH 7.5, 500 mM NH4Cl, 0.5
mM EDTA, and 10 mM MgCl2. The mixture was spun at 287,000 × g at 4°C for 2 hrs, and the
resulting pellet was resuspended in 1 × polymix buffer and stored at -80°C. In order to determine
the concentration of IC, the fractional radioactivity that pelleted was measured.

GTP Hydrolysis Assay
To assemble the ternary complexes, the following components were combined and incubated at
37°C for 15 minutes: 5 mCi/mL of [γ-32P]-GTP, 20 μM EF-Tu, and 5 μM of unlabeled GTP. An
equal volume of 30 μM aa-tRNA was then added to the reaction and allowed to incubate again at
37°C for 15 minutes. In order to purify away unbound GTP and aa-tRNA from the assembled
ternary complexes, samples were passed twice over P-30 spin columns (Biorad). The ternary
complex was then diluted to 1 μM in polymix buffer (0.5 μM in the final reaction) and mixed with
an equal volume of 2 μM IC (1 μM in the final reaction) at 20°C in a quench-flow instrument
(RQF-3, KinTek Corporation). The reactions were quenched through the addition of 40% formic
acid. The inorganic phosphate product was separated from unreacted GTP using Polyethylenimine
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(PEI) cellulose thin-layer chromatography (TLC) (Sigma) with 0.5 M potassium phosphate buffer
pH 3.5 as a mobile phase. Fractional radioactivity corresponding to inorganic phosphate at each
time-point was quantified using phosphorimaging and used to determine the observed rates of GTP
hydrolysis.

Kinetics of Peptidyl Transfer
EF-Tu (30 µM final) was initially incubated with GTP (2 mM final) in polymix buffer for 15 mins
at 37°C to exchange the bound GDP for GTP. To form the ternary complex, the mixture was
incubated with aminoacyl-tRNAs (~6 µM) for 15 mins at 37°C. For reactions performed in the
presence of antibiotics, streptomycin (100 µM final) or paromomycin (10 µg/mL final) were added
to this mixture. The ternary complex mixture was then combined with an equivalent volume of IC
at 37°C either by hand or using RQF-3 quench-flow instrument. The reaction was stopped at
different time points using KOH to a final concentration of 500 mM. Dipeptide products were
separated from free fMet using cellulose TLC plates that were electrophoresed in pyridine-acetate
at pH 2.8 (51). The TLC plates were exposed to a phosphor screen overnight, and the screens were
imaged using a Personal Molecular Imager (PMI) system. These images were quantified, and the
fraction of dipeptide fMet at each time point was used to determine the rate of peptide bond
formation using GraphPad Prism.
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RESULTS
8-oxoG interferes with the initial phase of tRNA selection
Previous work from our group showed that the presence of 8-oxoG within the A-site codon,
regardless of its position, has a drastic effect on the speed of translation and slight effect on
accuracy. The modification reduced the PT rate by almost three orders of magnitude for cognate
aa-tRNA, and slightly increased it for the near-cognate tRNAs interacting through 8-oxoG•A base
pairs with the codon (42). We hypothesized that the adduct inhibits base pairing, and as a result,
is likely to inhibit early stages of tRNA selection, particularly the codon-recognition step. For
technical reasons, we could not directly measure the kinetics of this step. Instead, in order to
address the potential effect of the modification on the initial phase of tRNA selection, we opted to
measure the rate of GTP hydrolysis as it reports on the overall selectivity of initial selection (11).
To accomplish this, we utilized a pre-steady-state-kinetics strategy in combination with our
reconstituted in vitro bacterial translation system. This system allows us to monitor individual and
specific amino-acid incorporation. Briefly, ternary complexes were generated by incubating EFTu with a specific aa-tRNA in the presence of radio-labeled [γ-32P]-GTP. Purified ternary
complexes were then incubated with initiation complexes programmed with intact mRNAs or 8oxoG-containing ones, and rates of GTP hydrolysis were determined by stopping the reaction at
various points.
In total, we analyzed 8 different complexes harboring 8-oxoG at different positions of the
A-site codon and their corresponding unmodified mRNAs. In particular, we measured the rates of
GTP hydrolysis for the following complexes: 8oxoGUU, C8oxoGC, G8oxoGC and GA8oxoG, and the
corresponding intact ones; these complexes code for Val, Arg, Gly and Glu, respectively. As
predicted, we measured rates of GTP hydrolysis that were significantly lower for the oxidized
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mRNAs relative to the corresponding unmodified ones (> three orders of magnitude for three of
the four complexes) More specifically, we measure rates of 42 s -1, 24 s-1, 47 s-1, and 86 s-1,
respectively, whereas the same rates for the unmodified ones were <0.0001 s-1, 0.064 s-1, 0.033 s1

, and 0.015 s-1, respectively (Figure 2). Interestingly, this change in rates of GTP hydrolysis

mirrors what we documented for PT, suggesting that most of the effects of the adduct on tRNA
selection are due to alteration to the initial phase of the selection process.

8-oxoG impairs decoding in a manner similar to a mismatch with subtle but important
distinctions
Thus far, our data has shown that the presence of 8-oxoG affects early stages of tRNA
selection by potentially interfering with the codon-anticodon interaction. More specifically, we
expect the modification to inhibit base pairing, resembling a mismatch. This would result in PT
reactions with oxidized complexes behaving in a manner analogous to reactions involving nearcognate aa-tRNAs. To probe this prediction, we increased ribosomal promiscuity through the
addition of aminoglycoside antibiotics to our in vitro PT reactions. This results in relaxed tRNAselection parameters, which increases the incorporation of near-cognate aa-tRNAs; and based on
our model, aa-tRNA reactivities should also increase with the oxidized complexes in the presence
of these antibiotics.
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Figure 3.2: 8-oxoG inhibits GTP hydrolysis by EF-Tu
A-D) Representative time courses of GTP hydrolysis reactions between the indicated initiation
and ternary complex (codon is shown at the bottom, while the anticodon is shown at the top). For
each codon, time courses were performed in the presence of G (blue) or 8-oxoG (red) and the
position of 8-oxoG within the codon is indicated in red. E) Bar graph showing the observed rate
of GTP hydrolysis (kGTP) for initiation complexes programmed with the indicated codon in the A
site. 8-oxoG was introduced at the position depicted in red. Blue bars represent observed rates with
unmodified complexes; red bars represent rates with 8-oxoG complexes. Plotted is the average of
three independent experiments and the error bars represent the standard error of the mean.
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We reacted the intact (CGC) complex and its oxidized counterpart (C8oxoGC) with its
cognate Arg-tRNAArg ternary complex and every possible second-position-near-cognate ternary
complex in the absence and presence of streptomycin or paromomycin. As expected, after 5
seconds of incubation, significant dipeptide formation was observed only in the presence of the
cognate ternary complex for the intact CGC complex (Figure 3). Additionally, as we had reported
earlier, the presence of 8-oxoG severely inhibited the formation of the cognate fMet-Arg dipeptide
while increasing the incorporation of Leu-tRNALeu, for which the second position A of the
anticodon base pairs with the 8-oxoG. The addition of antibiotics had no effect on the cognate
reaction in the presence of intact mRNA. However, and as anticipated, the antibiotic significantly
increased the formation of only the near-cognate fMet-His dipeptide. This is rationalized by the
fact that tRNAHis harbors U at the second position of its anticodon, which allows it to form a less
deleterious wobble-base pair with the G of the mRNA’s codon (52). Consistent with our model
that 8-oxoG changes the decoding process in a manner resembling that of a near-cognate, the
addition of antibiotics to the C8oxoGC complex increased the formation of fMet-Arg dipeptide and
that of fMet-Leu. Interestingly, the antibiotics appear to have little to no effect on the reactivity of
the C8oxoGC complex with His-tRNAHis. Together, these observations suggest that the effects of
8-oxoG on translation can be suppressed by antibiotics, but in a manner slightly distinct from a
mismatch.
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Figure 3.3: 8-oxoG in the second position of the codon changes the base pairing properties
of guanosine on the ribosome
A) Phosphorimager scan of electrophoretic TLCs used to follow dipeptide-formation reactions (5second incubation time) in the presence of the indicated initiation and ternary complexes in the
absence and presence of the indicated antibiotics. B) Quantification of the dipeptide yield as
performed in (A). Plotted is the average of three independent experiments and the error bars
represent the standard deviations around the means.
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To add more quantitative support for these differential reactivity profiles, we conducted
full-time courses of the PT reactions in the absence and presence of streptomycin or paromomycin.
Performing full-time courses allowed for us to measure the observed rate of peptide-bond
formation (kpep) which reports on the combined rates of aa-tRNA accommodation (k5) and rejection
(k7), as well as the end point of each reaction (Fp), which reports on the effectiveness of
proofreading (k5 relative to kpep) (9). In agreement with our end-point analysis, the antibiotics had
little effect on the endpoints and the rate of the reactions between the native initiation complex and
the cognate aa-tRNA (Figure 4A). This is in slight disagreement with previous reports showing
that streptomycin reduces the rate of peptide bond formation for cognate reactions by
approximately twofold (26, 53), whereas in our assays, streptomycin only slightly decreased these
rates. We note that these earlier experiments utilized different buffer systems, for which the
observed rate of peptide-bond formation in the presence of streptomycin is limited by GTP
hydrolysis.
Interestingly, the addition of the antibiotics to the same reaction with the 8-oxoGcontaining complex caused the observed rate of PT to increase twofold – we measured average
rates of 0.0097 s-1, 0.022 s-1, and 0.049 s-1in the absence of antibiotic and in the presence of
streptomycin or paromomycin, respectively (Figure 4B). Additionally, the endpoint of the
reactions increased by approximately an order of magnitude in the presence of the antibiotics, with
measured Fp values of 0.027, 0.37, and 0.52 for no antibiotic, streptomycin, and paromomycin,
respectively. Next, we performed reactions in the presence of the near-cognate aa-tRNAs. We
started with the G•A mismatch reaction involving the Leu-tRNALeu ternary complex. As our
reactivity-survey assay indicated, the addition of antibiotics did not increase the rate or endpoint
of PT with the intact complex but caused both to significantly increase for the oxidized complexes
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(Figures 4C and 4D). For the G•G and 8-oxoG•G mismatches involving Pro-tRNAPro ternary
complex, the addition of streptomycin had a barely detectable effect on the PT rate (Figures 4G
and 4H). In contrast, the antibiotics increased the observed PT rate for the His-tRNAHis, which
forms a wobble G•U mismatch with the mRNA, by more than an order of magnitude. Additionally,
the Fp value for the same reaction increased by more than twofold as a result of antibiotic addition
(Figure 4E). In contrast to the unmodified complex, His-tRNAHis failed to react with the 8-oxoG
complex (Figure 4F). These observations suggest that the modification does not allow the mRNA
to form a wobble base pair with U. Altogether, our findings suggest that oxidation of G changes
the base-pairing preference for the modified nucleotides on the ribosome, likely due to its chemical
nature as well as the geometry of the decoding center.
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Figure 3.4: The addition of antibiotics increases the kpep and Fp for cognate and a subset of
near-cognate tRNAs in the presence of 8-oxoG at the second position of the codon
A-H) Representative time courses of peptide-bond-formation reactions between the indicated
initiation and ternary complexes in the absence and presence of the indicated antibiotics. The time
courses shown on the right panel were carried out with the unmodified complex, whereas ones
shown on the left panel were carried out with the modified complex (8-oxoG drawn in red). Time
courses were conducted at least in duplicates. We note that the observed rates varied from
experiment to experiment due to differences in different preparation of aa-tRNA in the tRNA mix;
the fold difference as a result of antibiotic addition, however, was reproducible.

To provide further support for our model that antibiotics can suppress the effect of 8-oxoG
on decoding, we tested another set of complexes that displayed a different codon in the A site. In
particular, we programmed ribosomes with the oxidized G8oxoGC codon and tested their reactivity
with the cognate Gly-tRNAGly and near-cognate Val-tRNAVal ternary complexes. Similar to what
we observed for the G8oxoGC complex, both streptomycin increased the rate of peptide-bond
formation significantly (Supplementary Figure S1). These observations suggest that
aminoglycosides suppress the effect of the modification independent of the codon identity.

Supplementary Figure 3.S1: Streptomycin and paromomycin suppress the effects of 8-oxoG
on kpep for a complex displaying the G8oxoGC codon in the A site
A-B) Time courses of peptide-bond formation between the indicated initiation and ternary
complexes either in the absence of antibiotics or in the presence of paromomycin or streptomycin.
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The base-pairing preferences of 8-oxoG at the first position of the codon are slightly different
from those observed at the second position

Our data thus far shows that when 8-oxoG is in the second position of a codon, it changes
the base-pairing preferences of G on the ribosome. In order to investigate if the base-pairing
preferences of 8-oxoG that we observed were specific to the second position, we performed the
same peptidyl-transfer experiments with a codon containing 8-oxoG at the first position. We
reacted the complex containing intact codon (GUU) and the complex containing the 8-oxoG codon
(8-oxoGUU) with the cognate Val-tRNAVal, as well as all possible first-position-near-cognate aatRNAs in the presence of paromomycin or streptomycin. Once again, after 5 seconds of incubation
with no antibiotic, significant amount of dipeptide was formed exclusively in the presence of the
cognate ternary complex for the GUU codon, and the presence of 8-oxoG substantially decreased
the formation of the cognate dipeptide (Figure 5). However, at this position and after 5 seconds of
incubation, 8-oxoG did not result in any observable increase in the reactivity of the initiation
complex with Phe-tRNAPhe, which has an A at the third position of the anticodon (Figure 5). This
is contrary to what we observed in the second position, where dipeptide is formed in the presence
of the 8-oxoG•A base pair without the addition of antibiotics (Figure 3). We note that our source
of the tRNA mix often contained low levels of charged tRNAs, even after extensive attempts at
deacylation. Therefore, we observed some residual reactivity with the cognate Val-tRNAVal in
reactions containing the near-cognate tRNAs such as Phe-tRNAPhe, but that did not affect our
quantification since the two peptides migrate differently on our TLCs, allowing us to distinguish
them.
Upon addition of antibiotics, we observed significant increases in dipeptide formation for
the intact codon with two of the three near-cognate aa-tRNAs, namely Phe-tRNAPhe and Ile100

tRNAIle, for which the third position of the anticodon is an A and a U, respectively. This differs
from what we observed for the second-position mismatches, for which the addition of antibiotics
increased the dipeptide formation only for the near-cognate tRNA with the G•U base pair. When
we add the antibiotics to the reactions containing the 8-oxoG codon, we observe an increase in the
incorporation of Val-tRNAVal and Phe-tRNAPhe, for which the first position of the anticodon is a
C and A, respectively. This is similar to what we observe for 8-oxoG in the second position of the
codon. In both the first and second position of the codon, our data shows that 8-oxoG base pairs
with adenosine as well as cytidine when tRNA selection is relaxed, suggesting that it is able to
adopt both the syn or anti conformation on the ribosome.
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Figure 3.5: Antibiotics suppress the effects of 8-oxoG in the first position of the codon
A) Phosphorimager scan of electrophoretic TLCs used to follow dipeptide-formation reactions (5second incubation time) in the presence of the indicated initiation and ternary complexes in the
absence and presence of the indicated antibiotics. B) Quantification of the dipeptide yield as
performed in (A). Plotted is the average of three independent experiments and the error bars
represent the standard deviations around the means.
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Again, to provide additional quantitative support for our reactivity profiles, we performed
full-time courses of the PT reactions in the absence and presence of the aminoglycoside antibiotics.
As expected, the addition of the antibiotics had no significant effect on the reaction of the intact
GUU codon with the cognate Val-tRNAVal (Figure 6A). We measured rates of 31 s-1, 21 s-1, and
25 s-1 and Fp values of 0.69, 0.72, and 0.73 for the no treatment, streptomycin, and paromomycin
conditions, respectively. For the reactions between near-cognate Phe-tRNAPhe and Ile-tRNAIle
with the intact complex (G•A and G•U mismatches, respectively), the addition of antibiotics was
found to result in an increase in the endpoint, but not the rate (Figures 6C and 6E). This is in direct
contrast to what we observed for mismatches at the second position, for which the addition of the
antibiotics substantially increased the rate and endpoint of PT for the G•U base pair only and no
other mismatches (Figures 4E and 4C), consistent with the observations that decoding at the second
position appears to be more stringent relative to that at the first one (34).
For the 8-oxoG-containing codon, we measured a rate and endpoint with Val-tRNAVal (8oxoG•C base pair) of 0.044 s-1 and 0.308, respectively. Both of these values are much higher than
those measured for Phe-tRNAPhe (8-oxoG•A mismatch); kpep of 0.018 s-1 and Fp of 0.11 (Figures
6B, 6D). This differs from what we observed with 8-oxoG in the second position, where the rate
and endpoint were higher for the reaction involving an 8oxoG•A interaction relative to the 8oxoG•C (Figures 4B and 4D). These observations could be explained by at least two scenarios: 1)
the frequency of rotation of 8-oxoG around its glycosidic bond might be different depending on
its position within the codon; 2) the rate of dissociation of Phe-tRNAPhe from the 8-oxoGUU
complex is slow, when 8-oxoG is in the syn conformation, allowing the tRNA to sample the anti
conformation to form a Watson-Crick base pair and proceed with tRNA selection. Interestingly,
the 8-oxoG•A Phe-tRNAPhe reaction was found to benefit much more from the addition of
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antibiotics relative to the 8-oxoG•C Val-tRNAVal reaction. For the Val-tRNAVal reaction (8oxoG•C base pair), the observed rate and endpoint increased by a mere twofold to fourfold in the
presence of streptomycin and paromomycin (Figure 4B). In contrast, in the presence of PhetRNAPhe (8-oxoG•A base pair), the observed rate increased by more than an order of magnitude
and the endpoint increased by approximately sixfold (Figure 4D). These observations are
consistent with the second scenario, whereby 8-oxoG prefers the syn conformation in the decoding
center, but the addition of antibiotics stabilizes the tRNA long enough to allow it to sample the
anti conformation. If the tRNA harbors a C at that position, the selection process can proceed.
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Figure 3.6: Antibiotics drastically increase kpep and Fp for reactions between the 8oxoGUU
complex with Phe-tRNAPhe (8-oxoG•A base pair), and only slightly for reactions with ValtRNAVal (8-oxoG•C)
A-H) Representative time courses of peptide-bond-formation reactions between the indicated
initiation and ternary complexes (codon is shown at the bottom, while the anticodon is shown at
the top) in the absence and presence of the indicated antibiotics. The time courses shown on the
right panel were carried out with the unmodified complex, whereas ones shown on the left panel
were carried out with the modified complex (8-oxoG drawn in red). Time courses were conducted
at least in duplicates; the fold difference as a result of antibiotic addition was reproducible.

Error-prone and hyperaccurate ribosomes suppress and exaggerate the effects of 8-oxoG on
decoding, respectively
To provide further support for our model that altering tRNA selection parameters changes
the effect of 8-oxoG on decoding independent of drug addition, we utilized error-prone as well as
hyperaccurate ribosome mutants and assessed their effect on PT in the presence of 8-oxoG. We
chose the well-studied rpsD12 and rpsL141 mutants as representatives for the error-prone and
hyperaccurate types, respectively (54). As expected, the mutations had no effect on the observed
PT rate or endpoints for the intact complex in the presence of the cognate aa-tRNA (Figure 7A).
In contrast, and in agreement with our model, in the presence of 8-oxoG the error-prone mutation
increased the observed rate of formation of fMet-Arg dipeptide by sevenfold, whereas the
hyperaccurate decreased it by approximately fourfold (Figure 7B). Similarly, and consistent with
their effect on decoding, the error-prone mutation slightly increased the observed PT rate for the
near-cognate (G•A base pair), whereas the hyperaccurate one slightly decreased the rate (Figure
7C). In the presence of 8-oxoG, the hyperaccurate mutation suppressed the modification-induced
misincorporation of Leu-tRNALeu (8-oxoG•A base pair), for which we observe an almost ninefold
decrease in the observed PT rate, while the error-prone mutation increased the misincorporation
by fivefold (Figure 7D). These effects of ribosome mutations on peptide-bond formation in the
presence of 8-oxoG appear not to depend on the identity of the codon. We measure similar effects
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on complex programmed with the G8oxoGC codon (Supplementary Figure S2). Interestingly, for
both the no antibiotic and antibiotic treatments, the endpoints for PT reactions involving the
8oxoG•A interactions were at least twofold relative to those measured for ones involving the
8oxoG•C base pairs (Figure 7B and 7D). Collectively our data utilizing drug- as well as mutationinduced alteration of the tRNA-selection process support our model that 8-oxoG can base pair in
either the syn or anti conformation in the context of the A site, with a preference for the syn
conformation. Additionally, our data shows that 8-oxoG disrupts the ability of guanosine to
mispair with uridine, suggesting that the lesion modifies the conformation in which guanosine can
miscode.

Figure 3.7: Hyperaccurate and error-prone ribosomes suppress and amplify the effects of 8oxoG, respectively
A-D) Representative time courses of peptide-bond formation between the indicated initiation and
ternary complexes with the depicted ribosome mutant. The time courses shown on the right panel
were carried out with the unmodified complex, whereas ones shown on the left panel were carried
out with the modified complex (8-oxoG drawn in red). Time courses were conducted at least in
duplicates for constructs containing 8-oxoG; the fold difference was reproducible.
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DISCUSSION
Recent reports from a number of groups have shown that modification of the mRNA occurs
at levels that could potentially affect its function (33). Emerging from these studies are the
observations that ribosomal function as well as the decoding process could be significantly altered
as a consequence of these modifications. For some adducts, such as m6A which are deliberately
modified by cellular enzymes, the modifications appear to play roles in regulating gene expression
(55). In contrast, for most unintended adducts, like those that result from chemical damage, the
modifications are a burden to the translation machinery and pose challenges to the speed and
accuracy of the ribosome. We previously chose to study the effects of the oxidized base 8-oxoG
due to its high prevalence, especially under certain conditions, as well as its unique chemical
properties (40–43). Introducing the adduct to the mRNA, regardless of its position within the Asite codon, slowed down PT significantly. Previous studies regarding the impact of 8-oxoG on
DNA replication show that the modification can increase C to A transversions by preferentially
mispairing with A (56). Interestingly, 8-oxoG was found to only slightly increase misincorporation
of near-cognate aa-tRNAs during translation. These findings suggested that 8-oxoG interfered with
tRNA selection. Here, we expanded on these studies by characterizing the mechanism by which
8-oxoG affects the decoding process. A priori, we hypothesized that base-pairing interaction with
the modified nucleotide resembles a mismatch. As a result, 8-oxoG fails to trigger the required
conformational changes in the decoding center to proceed through the tRNA selection process.
Consistent with this proposal, we find the modification to severely inhibit GTP hydrolysis by EFTu, suggesting that it affects the initial phase of the selection process (Figure 2). Furthermore, the
introduction of miscoding antibiotics or ribosomes with error-prone mutations was found to
partially rescue the effect of the modification, as would be expected if 8-oxoG•C and 8-oxoG•A
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base pairs were to resemble mismatches. Indeed, when we add the antibiotics to the reactions of
intact codons and near-cognate aa-tRNAs, we see similar increases in kpep and/or Fp.
While the 8-oxoG•C and 8-oxoG•A base pairs resemble mismatches in both the first and
second position of the codon, we observe that 8-oxoG has distinct base pairing preferences based
on its position within the codon. In the absence of antibiotics, 8-oxoG in the second position prefers
to base pair with A, while 8-oxoG in the first position prefers to base pair with C (Figures 4 and
6). Structural studies of the A site show that the interactions between the second position codon
and its corresponding anticodon are monitored by the universally conserved A-minor interactions
of A1492, as well as G530 of the 16S rRNA and S50 of the ribosomal protein S12. Meanwhile,
the interactions between the first position codon and its corresponding anticodon are only
monitored by the A-minor interactions of A1493. Monitoring at both positions work to ensure that
only Watson-Crick base pairs are recognized as acceptable interactions (20, 21, 57). We speculate
that the bulky conformation of the anti-8-oxoG•C base pair is not recognized as an acceptable
interaction in the highly-monitored second position, thus explaining why we observe a preference
for the syn-8oxoG•A. Alternatively, the anti conformation of the modified base might be very short
lived that during codon recognition tRNAs harboring a C at the second position dissociate before
they can sample it. In the less stringently monitored first position, we observed a preference for
the anti-8-oxoG•C base pair in the absence of antibiotics, which could be explained by decreased
dissociation rates for near-cognate tRNAs at this position (58).
Upon addition of antibiotics, the average kpep and Fp for the 8oxoG•A in the first position
exceeded that of 8-oxoG•C, more closely resembling the trends we observe in the second position
of the codon (Figures 4 and 6). Additionally, we observe higher kpep and/or Fp values for 8oxoG•A
than 8-oxoG•C in the presence of error-prone ribosomes. Previous studies have shown that 8-oxoG
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prefers to exist in the syn conformation because of steric repulsion between the 8-oxo and the
phosphate backbone (43). This is consistent with our model that 8-oxoG primarily exists in the syn
conformation on the ribosome, and under normal conditions, is recognized as a mismatch when it
base pairs with A and is rejected during codon recognition. When error-prone conditions, which
suppress the effect of mismatches, are introduced in this case, the 8oxoG(syn)•A base pair can
move through codon recognition and into proofreading, and its Fp values are almost restored to
those observed in the presence of a G•U base pair (Figure 7). We speculate that 8-oxoG does not
exist in the anti conformation as frequently, but upon addition of antibiotics, the codon-anticodon
interaction is stabilized long enough to allow for the 8-oxoG to change from the syn to the anti
conformation and proceed with codon recognition.
The hypothesis that 8-oxoG primarily exists in the syn conformation on the ribosome is
also supported by its ability to disrupt base pairing with U. We observe significant reductions in
kpep and/or Fp values in the presence of an 8-oxoG•U base pair in error-prone conditions compared
to G•U, regardless of its position within the codon (Figures 4E, 4F, 6E, and 6F). This was a
surprising observation because the G•U wobble conformation should not be disrupted by the
introduction of the oxygen at carbon 8; therefore, we expected to see an increase in 8-oxoG•U
mispairing in the presence of antibiotics. In order to form a wobble base pair with U, 8-oxoG needs
to be in the anti conformation (52). We speculate that the inability of the antibiotics to increase
miscoding in the presence of 8-oxoG•U is due to 8-oxoG primarily existing in the syn conformation
on the ribosome. Additionally, we cannot exclude the possibility that the 8-oxoG•U wobble base
pair is structurally unfavorable in the A site; however, further studies would need to be performed
to test this hypothesis.
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Interestingly, circular dichroism (CD) analysis of RNA duplexes suggest that 8-oxoG
modification has little to no effect on the geometry of the A helix adopted by the RNA (59).
Similarly, X-ray and NMR analysis of DNA duplexes harboring 8-oxodG•dA or 8-oxodG•dC
revealed little to no distortion of the helical structure of the molecule (60–62). However, thermal
stability analysis of short modified RNAs shows that the lesion decreases the melting temperature
of the 8-oxoG•C duplex by as much as 10°C relative to G•C suggesting that there are energetic
penalties associated with this base pair (63). The 8-oxoG•A base pair, in contrast, is significantly
stabilized relative to the G•A base pair. Even with this increased stability, the Tm of duplexes
containing the 8-oxoG•A base pairs is on average 5°C lower than that of the canonical G•C base
pair. These observations suggest that even though the geometry of the 8-oxoG•A base pair is not
likely to change the overall structure of the codon-anticodon helix, the energetics of the interaction
between the mRNA and tRNA is not as favorable as would be expected for a cognate one.
In comparison to the ribosome, DNA polymerases display varying efficiencies for
incorporating dCMP or dAMP opposite to 8-oxodG dependent on the type of the polymerase. For
example, replicative polymerases incorporate dCMP across 8-oxodG with frequencies ranging
from 1:14 to 90:1 relative to dAMP incorporation (44). In addition, these polymerases are more
efficient at extending beyond the lesion when 8-oxodG is base paired with dA relative to dC,
suggesting that the polymerases tolerate the mispair presumably due to its similarity to WatsonCrick base pairs. Indeed, structural analysis of DNA polymerases bound with modified primertemplate complexes rationalized some of these observed effects on the accuracy of DNA
replication as well as the variation in the efficiencies of misincorporation rates (64–66). These
studies revealed that both base pairs are accommodated in the active site of the polymerases, but
their conformations as well as their interactions with the side chains of the proteins are dependent
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on the identity of the protein. For instance, in the case of T7 DNA polymerase, the 8-oxodG•A
base pair adopts a geometry nearly identical to that of a Watson-Crick base pair, rationalizing the
ability of the mispair to escape the proofreading function of the enzyme (67). In contrast to
replicative polymerases, translesion enzymes, like those used to replicate over thymine dimers,
tend to be relatively more accurate (68). At a structural level, this can be explained by the slightly
larger active site employed by these enzymes to allow access for large adduct, which in turn allows
for the formation of the 8-oxodG•C base pair. Although we lack equivalent structural data of the
ribosome bound to 8-oxoG-containing mRNA, our data suggests that either base pair can form
under normal conditions with a preference for 8-oxoG to base pair with A. However, the geometry
of the base pair is slightly distorted such that it fails to trigger the required conformational changes,
even in the presence of miscoding antibiotics. Furthermore, we hypothesize that the anti
conformation of 8-oxoG, which is required for base pairing with C, rapidly rotates to the preferred
syn conformation before EF-Tu is activated. In the presence of the antibiotic, the cognate tRNA is
stabilized long enough for the adduct to adopt the canonical anti conformation, activating EF-Tu,
and in doing so, suppressing the effect of the modification on tRNA selection.
The ability of ribosomes to bypass oxidative lesions, such as 8oxoG, may serve as an
advantage under oxidative stress conditions. Previous data from our group showed that the
presence of 8-oxoG can cause ribosomal stalling and activation of No-Go Decay pathways (42).
This stalling generates incomplete peptides that are recognized as such and degraded through
proteolysis. In the presence of error-prone ribosomes, we observe increased decoding of the 8oxoG adduct as either a G or U. Previous work has shown that the ability of error-prone ribosomes
to generate mistranslated proteins rather than stall may serve as a signal for the activation of stress
response pathways in vivo (69). Indeed, E. coli that expressed error-prone ribosomes were better
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able to survive hydrogen peroxide treatment than those expressing wild-type ribosomes.
Interestingly, natural E. coli vary over 10-fold in their mistranslation rates, suggesting that
miscoding is either tolerated or selected for in certain environments (70). The tendency towards
error-prone translation in the presence of oxidative damage, such as 8-oxoG, may serve as an
important adaptive mechanism through which cells tolerate high-stress environments.
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Chapter 4
Decoding on the ribosome depends on the structure of the mRNA phosphodiester backbone
This chapter is currently published in the Proclamations of the National Academy of Sciences as
Hannah E. Keedy*, Erica N. Thomas*, and Hani S. Zaher (2018) Decoding on the ribosome
depends on the structure of the mRNA phosphodiester backbone. *Authors contributed equally
to this manuscript.
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ABSTRACT
During translation, the ribosome plays an active role in ensuring that mRNA is decoded
accurately and rapidly. Recently, biochemical studies have also implicated certain accessory
factors in maintaining decoding accuracy. However, it is currently unclear whether the mRNA
itself plays an active role in the process beyond its ability to base pair with the tRNA. Structural
studies revealed that the mRNA kinks at the interface of the P and A sites. A magnesium ion
appears to stabilize this structure through electrostatic interactions with the phosphodiester
backbone of the mRNA. Here we examined the role of the kink structure on decoding using a welldefined in vitro translation system. Disruption of the kink structure through site-specific
phosphorothioate modification resulted in an acute hyperaccurate phenotype. We measure rates of
peptidyl transfer for near-cognate tRNAs that are severely diminished and in some instances are
almost one 100-fold slower than unmodified mRNAs. In contrast to peptidyl transfer, the
modifications had little effects on GTP hydrolysis by elongation factor thermal unstable (EF-Tu),
suggesting that only the proofreading phase of the tRNA selection process depends critically on
the kink structure. Although the modifications appear to have no effect on typical cognate
interactions, peptidyl transfer for a tRNA that uses atypical base pairing is compromised. These
observations suggest that the kink structure is important for decoding in the absence of WatsonCrick or G-U Wobble base pairing at the third position. Our findings provide evidence for a
previously unappreciated role for the mRNA backbone in ensuring uniform decoding of the genetic
code.

Keywords: Ribosome, Decoding, mRNA Structure, tRNA Selection, Phosphorothioate
Substitution
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SIGNIFICANCE STATEMENT
Reading of the genetic code is an intricate process in which the ribosome plays an active role in
ensuring that translation proceeds rapidly and accurately. Studies have revealed that the mRNA
adopts an unusual structure between the P and A sites of the small ribosomal subunit, where it is
signiﬁcantly kinked. In this work we probed the role of the kink structure in decoding.
Substitutions that disrupt this structure were found to increase the accuracy
of decoding. Conversely, peptide bond formation on difficult-to-decode codons was severely
reduced when this kink structure was perturbed. Our data suggests that the rigid nature of the
mRNA backbone is important for ensuring efﬁcient codon-anticodon interactions under
suboptimal conditions.
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INTRODUCTION
The accurate decoding of the genetic code depends critically on the ability of the ribosome
to select the aminoacyl tRNA (aa-tRNA) that matches the mRNA in its A site. During this process
of tRNA selection, the ribosome employs multiple strategies to maintain the low error frequency
of 10-4-10-3 per one amino-acid-incorporation event (1-4). The aa-tRNA is delivered to the
ribosome in a ternary complex with elongation factor thermal unstable (EF-Tu) and GTP. The
hydrolysis of GTP by EF-Tu essentially divides the tRNA selection processes into two stages:
initial selection and proofreading (5). Dividing the selection process gives the ribosome two
opportunities to reject the incorrect aa-tRNA. This mechanism of kinetic proofreading (6, 7)
utilizes both thermodynamic differences as well as induced fit to accelerate the dissociation rates
of incorrect aa-tRNAs and forward rates for correct aa-tRNAs (8-10). In particular, during the
initial selection phase, near cognate ternary complexes rapidly fall off the ribosome, whereas GTP
is rapidly hydrolyzed for cognate ternary complexes. Similarly, during the proofreading phase
following the dissociation of EF-Tu, near-cognate aa-tRNAs are readily rejected, whereas cognate
aa-tRNAs are readily accommodated into the active site to participate in peptidyl transfer (PT) (8).
More than half a century of biochemical studies on the ribosome have defined many of the
molecular elements responsible for the observed accuracy during protein synthesis (reviewed in)
(11). The ribosome itself plays a critical role in dictating the overall fidelity of this process (12,
13). Indeed, some of the first error-prone and hyperaccurate mutations to be identified mapped to
ribosomal proteins. For instance, many mutations in the ribosomal proteins genes rpsD and rpsE
have long been documented to confer a ribosome ambiguity phenotype (ram) (14-19). On the other
hand, mutations in the rpsL gene result in a restrictive phenotype. Most of these mutations also
confer resistance to, and in some cases dependence on, the error-inducing antibiotic streptomycin
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(20, 21). In contrast to ribosomal proteins, mutations to the ribosomal RNA (rRNA) rarely appear
naturally, due to incomplete penetrance of these mutations, as rRNA genes are typically found in
numerous copies in the genome. Nonetheless, screens using high copy plasmids carrying the rrn
operon of E. coli have been used to isolate rRNA variants that alter the decoding properties of the
ribosome (22, 23). More recent studies using orthogonal ribosomes have also been successful in
isolating mutants that otherwise would be dominant negative. Interestingly, most of these
mutations appear to map to functionally important parts of the ribosome such as the decoding
center or intersubunit bridges (24).
In addition to the ribosome, translation factors play a critical role in maintaining the fidelity
of protein synthesis. For example, mutations in elongation and release factors (RFs) have been
found to increase the error frequency during translation (25, 26). In addition, tRNAs arguably play
one of the most important roles in the decoding process during both the aminoacylation reaction
as well as the tRNA selection process. This is best exemplified by suppressor tRNAs that decode
stop codons and result in missense suppression. While the miscoding properties of most of these
RNAs can be easily rationalized by alteration to the anticodon, which allows them to base pair
with the incorrect codon, some, I which mutations far from the anticodon appear to be responsible
for their phenotype, are more complex. For instance, the Hirsch tRNATrp suppressor tRNA (CCA
anticodon) harbors a G24A mutation in the D arm enabling it to decode the tryptophan UGG and
UGA stop codons (27). Biochemical studies of this tRNA showed that this variant tRNA
accelerates forward rates of tRNA selection even in the presence of mismatched codon-anticodon
interaction, underlining the critical role of the tRNA during the selection process (28).
Emerging from recent structural studies of ribosomal complexes are some key hints about
the molecular mechanics of the decoding process and how perturbation to the translation
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machinery disrupts it (29, 30). In particular, during the tRNA selection process, the decoding
center of the ribosome undergoes local conformational changes that in turn drive larger changes
within the small ribosomal subunit (31, 32). This so-called “domain closure” of the small subunit
is also accompanied by changes to the A-site tRNA that are manifested by a large conformational
change in its structure. This structural change is likely responsible for relaying a signal to the
GTPase activation center of the large ribosomal subunit, leading to the subsequent accommodation
of the tRNA into the peptidyl-transferase center (33, 34). These structures also provided some
important mechanistic clues about how classical mutations in the ribosome perturb decoding. They
appear to alter the thermodynamics of the interchangeability between the “open” and “closed”
state of the ribosome (32). The rpsD and rpsE mutations of error-prone ribosomes disrupt
interactions that are necessary to maintain the open conformation, whereas the rpsL mutations of
hyperaccurate ribosomes disrupt interactions necessary for the closed conformation. In addition to
the ribosome, the accompanying conformational changes in the tRNA as it moves into the A site
play an integral role during protein synthesis (33, 35). Structural studies of the Hirsch suppressor
tRNA revealed tRNA distortion was critical for decoding (36). This increased flexibility of the
tRNA allows increased GTPase activation of EF-Tu even in the presence of a near-cognate tRNA
(28).
What is clear from the abundance of biochemical and structural studies on the ribosome is
that decoding is an intricate process that takes cues from almost every single factor of the
translation machinery. What has been less understood is the extent to which the structure of the
mRNA itself is important for this process. Nonetheless, biochemical studies on the role of the
ribose backbone during decoding showed the substitutions of the 2’-OH groups of the A-site
mRNA residue by deoxy or fluoro groups to have only modest effect on tRNA selection (37). This
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is in contrast to structural studies, which showed the hydroxyl groups to be important for A-minor
interactions with the decoding center nucleotides (31, 32).
Equivalent studies of the role of the phosphodiester backbone of the mRNA on ribosome
function are lacking. Interestingly, crystal structures of the ribosome revealed the mRNA adopts a
kink-like structure between the P and A sites (38, 39). A magnesium ion stabilizes this structure
through electrostatic interactions with the non-bridging oxygens of the phosphodiester backbone
of the mRNA (39). While the kink has been speculated to be critical for frame maintenance by
preventing slippage (39), this has not been directly tested. Whether the structure contributes to
tRNA selection is yet unknown. Here, we perturbed the mRNA structure by introducing
stereospecific phosphorothioate substitutions in the mRNA at the interface of the P and A site and
assessed their effect on decoding using a well-defined in vitro system. We found that substitution
of either of the nonbridging oxygens results in a hyperaccurate phenotype; however, substitution
of the pro-Sp oxygen, one of the oxygens involved in coordinating the divalent metal, with sulfur
has a more drastic effect. In the presence of the Rp-phosphorothioate, PT rates for near-cognate
aa-tRNAs were reduced by about 10-fold relative to the native mRNA. In contrast, the same rates
were more than 100-fold slower for the Sp-phosphorothioate. Peptide release on near-stop codons
was similarly affected, suggesting that the kink is critical for the process by which A-site ligands
interact with the ribosome. In an effort to determine whether the substitutions affect both phases
of tRNA selection, we measured the rates of GTP hydrolysis by near-cognate ternary complexes
in the presence of the modifications. Either substitution resulted in a modest two- to threefold
reduction in the observed rate, suggesting that magnesium coordination by the mRNA is important
only for the proofreading phase of the selection process. Interestingly, while both substitutions
appear to have no effect on most cognate aa-tRNA selection, the Sp-phosphorothioate substitution
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significantly reduced the PT rate for a difficult-to-decode cognate codon. In particular, PT for the
AUA codon, which is decoded by the anticodon-modified Ile-tRNAIle(k2CAU), is approximately
fivefold slower in the presence of Sp-modified mRNA relative to the unmodified or the Rpmodified mRNAs. Finally, to expand on the potential role of the mRNA backbone on tRNA
selection, we investigated the effect of the deoxy substitutions on peptide-bond formation for
cognate and near-cognate ternary complexes. Similar to previous observations (37), substitution
of any of the three 2’-OH of the A-site codon by a deoxy does not alter peptide-bond formation in
the presence of cognate aa-tRNA. However, peptide-bond formation was drastically inhibited for
these modified mRNAs in the presence of a near-cognate aa-tRNA. Collectively our findings
provide some of the first hints at the integral role of the mRNA structure in decoding and how its
perturbation could have profound consequences on the speed of protein synthesis.
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RESULTS
Experimental approach
To investigate the role of the mRNA-kink structure in tRNA selection, we decided to
destabilize magnesium-binding at the interface of the P and A site of the small subunit. The
divalent metal ion is held in place by a network of electrostatic interactions that include three nonbridging oxygen atoms of the mRNA phosphodiester backbone (Fig. 1A). As a starting point, we
chose to introduce sulfur substitutions right between the initiation codon and the second codon of
a model mRNA. Namely, we sought to substitute the pro-Sp oxygen of the phosphodiester linkage
between the third nucleotide of the P-site codon and the first nucleotide of the A-site codon (Fig.
1A). However, since the smallest model mRNA (~25 nt) is too long to efficiently separate the
resulting two diastereomers from chemical synthesis, we chose to generate the mRNAs from two
pieces. This allowed us to synthesize the phosphorothioate-containing RNA as a 9-mer, which is
readily separated into the Rp and Sp diastereomers using reverse-phase HPLC methods (Fig. 1B).
Subsequent near quantitative ligation using T4 RNA ligase 2 to an upstream RNA oligonucleotide
containing the necessary Shine-Dalgarno sequence gave us the full-length model mRNA (Fig. 1C).
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Fig. 4.1 Structure of the mRNA on the ribosome and preparation of phosphorothioatemodified mRNAs. A) Overview of the mRNA structure (PDB 2J00) highlighting the kink
structure dividing the P and A sites of the ribosome. The non-briding oxygen atoms (red)
coordinating a magnesium ion (green) are shown. B) A representative HPLC chromatogram
showing the separation of the two phosphorothioate diastereoisomers of the downstream RNA
sequence. C) Schematic of the procedure used to synthesize the full-length modified mRNA.
Sequence of the two pieces is shown annealed to a DNA splint. The bottom panel shows a
representative denaturing PAGE used to follow the ligation reaction using a radio-labeled
downstream sequence.
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The modified mRNA was then used in our in vitro reconstituted system (40) to make
initiation complexes. Ribosomes were incubated with initiation factors (IFs) 1, 2 and 3, f-[35S]Met-tRNAfMet, and GTP in the presence of native or modified mRNAs. The initiation complexes
were then purified away from the IFs and unbound mRNA through ultracentrifugation over a
sucrose cushion. The first set of initiation complexes displayed the Glu GAA codon. Peptide-bond
formation was commenced by incubating initiation complexes with ternary complexes comprised
of aa-tRNA, EF-Tu, and GTP. Following quenching and hydrolysis of the ester linkage between
the peptide and the tRNA with KOH, dipeptides were resolved from unreacted fMet using
electrophoretic TLC and were visualized by phosphorimaging.

Phosphorothioate substitutions at the interface of the P and A site result in stringent tRNA
selection.
For our initial studies we conducted a surveying approach (41) in an effort to gain an
unbiased view of the modifications’ effects on the decoding process. Three initiation complexes
programmed with the native mRNA or with Rp- or Sp-phosphorothioate modified mRNAs were
reacted with the 20 canonical aa-tRNA isoacceptors for 30 seconds (Fig. 2). As expected, all three
complexes, which displayed the GAA codon in the A site, reacted efficiently with the cognate GlutRNAGlu ternary complex. In contrast, replacement of either of the non-bridging oxygen atoms by
sulfur had a profound effect on the reactivity of near-cognate ternary complexes. In particular,
whereas dipeptide formation was observed for a number of near-cognate aa-tRNAs (including but
not limited to Asp-tRNAAsp and Lys-tRNALys) in the presence of the native complex (O),
significantly less dipeptide was observed in the presence of the Rp complex, and it was nearly
undetectable for the Sp complex (Fig. 2). These observations suggested that the structure of the
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mRNA backbone, particularly at the interface of the A and P sites of the ribosome, plays an
important role during tRNA selection.
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Fig. 4.2 Phosphorothioate mRNAs suppress the incorporation of near-cognate amino acids.
Phosophorimager scans of electrophoretic TLCs showing the reactivity profile of the initiation
complexes –programmed with the indicated native and phosphorothioate-modified mRNAs– with
the 20 aa-tRNA isoacceptors. A schematic of the initiation complex is shown at the top with fMettRNAfMet occupying the P site and the Glu GAA codon occupying the A site. Differential
reactivities with near-cognate aa-tRNA are marked by asterisks. Note that for this particular
reactivity survey the formylation of fMet was incomplete and as a result residual Met is observed.
This does not affect the analysis because of differences in migration on the TLC between fMet and
Met as well as the corresponding dipeptides.

Although the endpoint of the dipeptide survey reactivities provided some important clues
about the effect of the substitutions on the accuracy of peptide-bond formation, these assays fail
to provide more quantitative information about the extent to which fidelity is improved. As a result,
we resorted to a pre-steady-state kinetics approach to measure the rate of peptidyl transfer (PT) for
the cognate Glu-tRNAGlu ternary complex as well as for the near-cognate Lys-tRNALys and AsptRNAAsp ternary complexes. Consistent with our end-point analysis in Fig. 2, the modifications
appear to have little effect on the PT rates for the cognate aa-tRNA (Fig. 3A). More specifically,
we measure a rate of ~20 s-1 for the O mRNA and ~ 15 s-1 for the Rp- and Sp-phosphorothioate
mRNAs. In contrast to the cognate reaction, both substitutions had strong effects on the nearcognate PT rates, with the Sp-phosphorthioate having the most drastic effect. In the presence of
Lys-tRNALys, PT rates for the O, Rp- and Sp-phosphorothioate mRNA-containing complexes were
0.10 s-1, 0.0093 s-1, and 0.0055 s-1, respectively. In addition, the Sp-phosphorothioate complex
displayed a drastic endpoint defect, for which the fraction of fMet that converted to fMet-Lys
dipeptide was 27% (Fig. 3B). Conversely, the same reactions with the unmodified and Rpphosphorothioate went to near completion (~86%). These effects of the phosphorothioate
substitutions on near-cognate Lys-tRNALys selection were, by and large, similar to those measured
for Asp-tRNAAsp selection. We measured PT rates of 0.056 s-1, 0.0089 s-1, and 0.017 s-1 for the
unmodified, Rp- and Sp-phosphorothioate complexes, respectively (Fig. 3C). In addition, similar
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to the Lys-tRNALys reaction, the modifications appear to significantly improve proofreading by
the ribosome as evidenced by the reduced end points. The Sp-phosphorothioate complex displayed
an even better rejection of the Asp-tRNAAsp, for which we measure an end point of 0.035. In
comparison, the end points for the O and Rp-phosphorothioate complexes were 0.33 and 0.11,
respectively (Fig. 3C). Collectively these observations suggest that disruption of interactions
between the phosphodiester backbone of the mRNA and divalent metals induces a hyperaccurate
phenotype.

Fig. 4.3 The Sp-phosphorothioate substitution of the kink oxygen results in a severe
hyperaccurate phenotype. A) Representative time courses for PT reactions between the indicated
complexes and the cognate Glu-tRNAGlu ternary complex. B) Representative time course for PT
reactions between the indicated complexes and the near-cognate Lys-tRNALys ternary complex. C)
Representative time courses for PT reactions between the indicated complexes and the nearcognate Asp-tRNAAsp ternary complex. D) Bar graph showing the observed rate of GTP hydrolysis
for modified, Rp- and Sp- complexes with the near-cognate Lys-tRNALys ternary complex. Unlike
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PT reactions, which were all conducted at 37C, these reactions were conducted at 20C. Shown
are the means of three independent time courses with the error bar representing the standard
deviation from the mean. E) Representative time courses for RF2-mediated hydrolysis on the
indicated complexes. F) Representative time courses for RF1-mediated hydrolysis reaction on the
indicated complexes.

The accuracy of the initial phase of tRNA selection is not significantly impacted by the
phosphorothioate substitutions.

As our peptide-formation assays report on the overall process of tRNA selection, the
observed effects of substitutions could, in principle, be the result of defects in the initial phase or
proofreading phase of the process. GTP hydrolysis by EF-Tu reports on the GTPase activation of
the factor, which in turn reports on the accuracy of the overall initial phase. We measured the rate
for GTP hydrolysis for the native and Rp- and Sp-phosphorothioate complexes in the presence of
the near-cognate Lys-tRNALys ternary complex. In contrast to our observations for peptide-bond
formation, the substitution had only a modest effect on the observed rate of GTP hydrolysis (Fig.
3D). For the Rp-modified complex, the observed rate is merely twofold slower relative to the native
complex. Similarly, the observed rate for the Sp-modified complex was threefold slower (Fig. 3D).
Hence, it appears that the kink structure of the mRNA plays little to no role during the initial phase
of the selection process. Instead, given that we measured rates for peptide-bond formation that are
almost two order of magnitude slower under the same conditions, the kink structure is likely to
play an important role during the proofreading phase. Disruption of this structure appears to reduce
the accommodation rates and increases the rejection rates of near-cognate aa-tRNAs.

Phosphorothioate substitutions increase the fidelity of RFs
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Next, we sought to explore the effects of phosphorothioate substitutions on the accuracy of
peptide release by RFs. In particular, we were interested in examining whether the kink structure
affects protein-mRNA interaction during peptide release misrecognition of sense codons. The
GAA codon displayed in the A site of our complexes is a near-stop for both RF1 and RF2, as both
recognize the UAA codon. As a result, we could address the effect of the substitutions on the
accuracy of both factors. Although the modifications appear to affect both RF1- and RF2-mediated
hydrolysis (Fig. 3E and F), the extent of these effects was much smaller than those observed for
PT, and on average they were two- to threefold slower relative to the native mRNA. We measured
rates of hydrolysis for RF2 of 0.012 s-1, 0.0045 s-1, and 0.0041 s-1 for the unmodified and Rp- and
Sp-phosphorothioate complexes, respectively (Fig. 3E). Similarly, in the presence of RF1, we
measured hydrolysis rates of 0.012 s-1, 0.0030 s-1, and 0.0044 s-1 for the unmodified and Rp- and
Sp-phosphorothioate complexes, respectively (Fig. 3F). Interestingly, and in contrast to tRNA
selection, peptide release on the Sp complex was faster (ableit only slightly) than its Rp
counterpart. These observations are consistent with data from our group and others that show the
process of RF selection to be different than its tRNA selection counterpart (42, 43). For instance,
whereas certain base modifications appear to be detrimental for peptide-bond formation, they have
little effect on peptide release (44, 45). Nevertheless, the observation that phosphorothioate
substitutions affect peptide release (with little distinction between the two diastereomers)
highlights the importance of the mRNA backbone structure during the recognition of A-site ligands
regardless of their identity.

The effects of the phosphorothioate substitutions are not dependent on the A-site codon
identity
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Our analysis, so far, has focused on one particular mRNA sequence, so our next logical
step was to expand our analysis to assess whether the effects of the substitutions we observed are
specific or general in nature. Our analysis on the GAA mRNA revealed that both the Rp- and Spphosphorothioate substitutions appear to severely reduce the observed PT rates for near-cognate
aa-tRNAs (Fig.3). To simplify our approach, in the next set of experiments we chose to synthesize
the modified mRNA in one piece and generate mixed complexes with a racemic mixture of the
mRNA. The new complexes displayed the CAA Gln codon in the A site. Again, we started our
analysis by carrying out a survey for all aa-tRNA-isoacceptors reactivities (Fig. S1A). The
reactivity profile for the new complexes was nearly identical to the one observed for the previous
complexes (compare Fig. 3A to S1A). The native and phosphorothioate-modified complexes
reacted efficiently with the cognate Gln-tRNAGln ternary complex. In contrast, the native complex
reacted much better with the near-cognate Asp-tRNAAsp and His-tRNAHis ternary complexes
relative to the modified one (Fig. S1A). Furthermore, both RFs 1 and 2 appear to recognize the
native complex better than the modified one, for which we observe significant fMet release from
fMet-tRNAfMet only for the native complex. Therefore, our survey analysis suggests that effect of
the phosphorothioate substitution on A-site-ligand binding is general in nature.
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Fig. 4.S1 Reactions with a different mRNA yield similar results. A) Reactivity profile of the
depicted complex, which displays the Gln CAA codon in the A site, with the indicated aa-tRNAs
and RF. Products were separated on electrophoretic TLCs and visualized using phosphorimaging.
Differential reactivities are marked by asterisks. B) Representative time courses of PT reactions
between the indicated complexes (programmed with a native mRNA or racemic mixture of
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phosphorothioate mRNAs) and the cognate Gln-tRNAGln. C) Representative time courses of PT
reactions between the indicated complexes and the near-cognate His-tRNAHis. D) Representative
time courses for RF2-mediated hydrolysis reaction on the indicated complexes.

To gain a more quantitative understanding of the effects on decoding, we measured the PT
rates for the cognate and a near-cognate tRNA as well as the release rate for RF2. Similar to our
observations for the previous complexes, the modification had almost no effect on the PT rate for
the cognate Gln-tRNAGln complex. We measured rates of 17 s-1 and 15 s-1 for the unmodified and
modified mRNAs, respectively (Fig. S1B). Also in agreement with our surveying analysis, the
modification had a drastic effect on the His-tRNAHis near-cognate reaction. Although the PT rate
appears to be unaffected (in fact slightly increased from 0.0037 s-1 to 0.0069 s-1), the end point of
the reaction was dramatically reduced from ~0.6 to ~0.05 (Fig. S1C). These findings suggest that
the modification is likely to increase the rate of aa-tRNA rejection during the proofreading phase
of tRNA selection. Finally, and as expected the modification reduced the rate of RF2-mediated
peptide release by almost one order of magnitude (Fig. S1D). The observation that modification
of two independent mRNA sequences has near-identical effects on peptide-bond formation and
peptide release greatly suggests that the effect of the phosphorothioate substitution is independent
of the mRNA sequence. This in turn adds more support for the hypothesis that the mRNA-kink
structure plays a key role in ribosome function.

Phosphorothioate modification reduces peptide-bond formation for a subset of cognate aatRNAs
To this point, our analysis revealed that perturbation of the mRNA structure results in
aggressive proofreading by the ribosome with little to no effect on cognate tRNA selection. This
in turn begs the question as to why the mRNA evolved to adopt this conformation on the ribosome.
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It is highly likely that the structure plays a role in frame maintenance, as has been suggested by
structural biologists (39). However, for our next experiments we were motivated by data on
ribosome variants that showed certain hyperaccurate rRNA variants to also significantly
compromise PT for a subset of cognate aa-tRNAs, in particular those that exploit unusual base
pairs at the wobble position (46). For example, to avoid mispairing with the AUG Met codon, the
AUA Ile codon in E. coli does not base pair with an anticodon using the typical A:U base pair at
the third position. Instead, the corresponding C in the anticodon is modified to lysidine (k2C).
Studies by Ortiz-Meoz and Green showed that mutations in helix 69 of the large subunit, while
having no effect on most cognate tRNAs, significantly slow down the PT rate for tRNA Ile(k2C)
(46). As a result, we wondered whether the mRNA-kink structure is similarly critical for decoding
the AUA codon by Ile-tRNAIle(k2C).
To explore this hypothesis, ribosomes were programmed with three mRNAs: native, Rpand Sp-phosphorothioate modified mRNAs, all displaying the AUA codon in the A site. In
agreement with our earlier observation, the observed PT rate for the Rp-phosphorothioateprogrammed complexes with the cognate Ile-tRNAIle was indistinguishable from that for the native
complexes (~ 10s-1, Fig. 4A). In contrast, the same rate for the Sp-modified complex was almost
an order of magnitude slower (Fig. 4A). These findings again suggest that the pro-S oxygen plays
a more important role in maintaining the mRNA structure. We note that, similar to what we
observed for the two previous complexes, the AUA complexes exhibited defects in their reactivity
similar to those in near-cognate aa-tRNAs. In the presence of Met-tRNAMet, we measure rates of
peptide-bond formation of 0.41 s-1, 0.022 s-1, and 0.0082 s-1 for the native and Rp- and Sp-modified
complexes, respectively (Fig. 4B). These observations suggest that the pro-S oxygen, and likely
its ability to coordinate magnesium, is critical for decoding under less-than-ideal conditions.
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Fig. 4.4 Substitution of the pro-S oxygen reduces the rate of peptide-bond formation in the
presence of atypical tRNA-mRNA interactions. A) Bar graph showing the PT rate for
unmodified, Rp- and Sp- complexes, all displaying the Ile AUA codon in the A site (depicted
above), with the cognate Ile-tRNAIle. The corresponding Ile-tRNA harbors the lysidine (k2C)
modification at the wobble position. B) Observed PT rates for the near-cognate Met-tRNAMet in
the presence of the indicated complexes. Graphs show the means of three independent time
courses; error bars represent the SD from the mean.

Peptide release is not impacted by phosphorothioate modification of the mRNA
Our analysis thus far has suggested the kink structure to be likely important for decoding a
subset of sense codons. As a result, the next logical step was to assess its effects on canonical
peptide release. As before, we prepared unmodified- and phosphorothioate-mRNA-containing
initiation complexes that displayed the UAA stop codon in the A site. Similar to our observations
for PT, the rates of peptide release were found to be unaffected by the presence of the
phosphorothioate modification at the interface of the P and the A site of the mRNA. For RF1 we
measured rates of 0.35 s-1 and 0.49 s-1 for the native and modified mRNA, respectively (Fig. 5A).
Likewise, for RF2, we measured rates of 0.76 s-1 and 0.93 s-1 for the same set of mRNAs (Fig. 5B).
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These observations are in agreement with our model that the kink structure is not important for
decoding (sense and missense codons) under optimal conditions.

Fig. 4.5 Peptide release is not impacted by phosphorothioate modification at interface of the
P-site and A-site codons. A) and B) Representative time courses for peptide release between the
indicated initiation complexes (programmed with either a native mRNA or racemic mixture of
phosphorothioate mRNAs) and RF1 and RF2, respectively.

Phosphorothioate substitutions between the first and second nucleotide of the A-site codon
also result in a hyperaccurate phenotype
In addition to the pro-S oxygen between the P and A site, the kink-stabilizing magnesium
ion also appears to be coordinated by the pro-R oxygen between the first and second position of
the A-site codon (39). Consequently, substitution of this oxygen is very likely to perturb the mRNA
structure and, in turn, produce a phenotype similar to the one we saw with substitutions at the P/A
interface. We used the same strategy as before to generate native as well as modified complexes
and assessed the effect of the sulfur substitution on PT rate for cognate and near-cognate aa-tRNAs.
Consistent with earlier observations, both Rp- and Sp-phosphorothioate substitutions at the
second position of the A site have minimal effect on peptide-bond formation for the cognate aa141

tRNA (Fig. 6A). Furthermore, the same substitutions significantly reduced the PT rates for the two
tested near-cognate ternary complexes, Lys-tRNALys and Asp-tRNAAsp (Fig. 6B and 6C).
However, whereas the pro-S oxygen at the P/A interface appears to have a larger effect on
decoding near-cognate aa-tRNAs, at this position in the A site the Rp-phosphorothioate
substitution had a much more pronounced effect on the selection of these very same aa-tRNAs. In
particular, PT rates for lys-tRNAlys were 0.080 s-1, 0.0039 s-1, and 0.011 s-1 for the native and Rpand Sp-phosphorothioate complexes, respectively. Similarly, PT rates for Asp-tRNAAsp were
0.035 s-1, 0.0049 s-1, and 0.0050 s-1 for the native, Rp- and Sp-phosphorothioate complexes,
respectively. Furthermore, the end points for the same reactions were 0.51, 0.11, and 0.21,
respectively, suggesting that the modification also increases the rejection rate for the near-cognate
aa-tRNAs during the proofreading phase of the selection. Interestingly, at this position, the
substitution does not appear to affect peptide-release by RF1 (Fig. 6D) and only slightly for that
by RF2 (Fig. 6E). These observations again highlight the distinction between tRNA and RF
selections, with the latter being more robust to perturbations. Nevertheless, taken together, our
data suggests that coordination of the magnesium ion by the phosphodiester backbone of the
mRNA, and likely the resulting mRNA structure, plays a significant role during decoding.
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Fig. 4.6 Phosphorothioate modification at the second position of the A-site codon results in a
hyperaccurate phenotype. A) Representative time courses of peptide-bond formation between
the depicted unmodified or modified complexes with the cognate Glu-tRNAGlu. The
phosphorothioate modification is between the G and A of the A-site GAA codon (as shown above).
B) and C) Time courses of PT reactions with the near-cognate Lys-tRNALys and Asp-tRNAAsp
ternary complexes, respectively. D) and E) Time courses for RF1- and RF2-mediated hydrolysis
reactions, respectively.

Phosphorothioate substitutions between the second and third nucleotide of the A-site codon
has little effect on the accuracy of tRNA selection
Unlike that of the P/A interface and the first position of A-site codon, the phosphate of the
second position of the A-site codon does not appear to coordinate a divalent metal (Fig. 1A).
Therefore, phosphorothioate substitution at this position should serve as a nice control for effects
resulting from mere sulfur introduction into the backbone of the mRNA versus magnesium143

structural stabilization effects. We used the same GAA-codon-containing mRNA but introduced
the sulfur substitution between the last two nucleotides (GA-Sp-A) to generate modified initiation
complexes. As expected, the substitution had no effect on the observed rate of peptide-bond
formation by the cognate Glu-tRNAGlu ternary complex (Fig. 7A). In the presence of the nearcognate Lys-tRNALys ternary complex, we observed a modest threefold decrease for the modified
complex (Fig. 7B). In comparison, we saw a twentyfold decrease in the observed rate for the same
mRNA when it was modified at the first position (Fig. 6B), which was also accompanied by a
fourfold reduction in the end point of the reaction. These observations suggest that while the
introduction of sulfur on its own has some effects on the accuracy of peptide-bond formation,
magnesium coordination by the nonbridging oxygen atoms of the mRNA backbone and hence its
structure plays a far more important role in decoding accuracy.

Fig. 4.7 Phosphorothioate substitution between the second and third nucleotide of the A-site
codon does not significantly impact peptidyl transfer. A) and B) Representative time courses
for PT between the indicated initiation complexes and the cognate Glu-tRNAGlu and near-cognate
Lys-tRNALys, respectively. The phosphorothioate modification is between the second and third
nucleotide of the A-site codon (as shown above).
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The presence of a deoxyribose sugar between the A and P-site codons results in a
hyperaccurate phenotype
Thus far, our studies have focused on the role of the phosphodiester backbone on the
accuracy of tRNA selection and suggests an important role for its structure during tRNA selection.
As a logical next step, we sought to examine the role of the ribose backbone in the accuracy of
decoding. Initial structural studies of the small subunit highlighted the potential role for the
chemical structure of ribose in decoding. These studies suggested that the A-site 2’-OH groups to
be important for distinguishing between cognate and near-cognate tRNAs (31, 32). In particular,
rRNA residues G530, A1492, and A1493 were shown to monitor the minor groove of the cognate
codon-anticodon helix by forming hydrogen bonds with the 2’-OH groups. However, recent
structural studies from a different group suggested that the hydrogen bonding was identical for
both cognate and near-cognate codons (38) and that accuracy originates from energetic penalties
associated with base pair mismatches being forced to adopt a Watson-Crick base-pair geometry.
Previous biochemical studies by Simpson and colleagues explicitly addressed the role of the 2’OH groups of the A site in decoding (37). Interestingly, single substitution of any of the 2’-OH
groups by a deoxy only marginally affected peptide-bond formation. Multiple deoxy substitutions,
on the other hand, severely inhibited tRNA selection parameters. In contrast, 2’-Fluro substitutions
of all three hydroxyl groups of the A site has little to no effect on tRNA selection. These findings
suggested that hydrogen bonds with the ribose backbone are not important for decoding; instead
shape complementarity of the bases and their partners appears to be paramount. We note that, these
studies looked at the role of the 2’-OH groups on the accuracy of the decoding process through
competition assays. These assays suggested that individual substitutions to have no effect on
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fidelity. However, their effect on peptide-bond formation in the presence of near-cognate aatRNAs was not directly measured.
Motivated by these earlier findings, we next explored the role of the 2’OH groups of the
ribose backbone in discriminating against near-cognate tRNAs. As in the phosphorothioate assays,
we prepared initiation complexes that displayed the Glu GAA in the A site. In addition to the native
complex, we generated four more that harbored one deoxy substitution at the third position of the
P-site codon or at the first, second, or third position of the A-site codon. As had been seen earlier,
these substitutions had a negligible effect on the rate of peptide-bond formation in the presence of
the cognate aa-tRNA (Fig. 8A). In contrast, the substitutions had drastic effects on peptidyl transfer
in the presence of the near-cognate Lys-tRNALys, with the substitutions of the A-site codon having
the most profound effect (Fig. 8B). More specifically, introducing the deoxy modification to the
third position of the P-site codon resulted in a tenfold decrease observed rate of peptidyl transfer,
with no appreciable effect on the end point (Fig. 8B). In contrast, although the observed rates for
A-site-substituted complexes does not vary much from the unmodified one, the end points for these
reactions were severely diminished (1-2% of the initiation complexes reacted with the ternary
complex) (Fig. 8B). Hence, substitution of the hydroxyl groups of the A-site codon appears to
result in aggressive proofreading by the ribosome.
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Fig. 4.8 Deoxyribose substitutions in the A-site codon result in a severe hyperaccurate
phenotype. A) Representative time courses for PT reactions between the initiation complexes
programmed with the indicated native and deoxyribose-modified mRNAs and the cognate GlutRNAGlu ternary complex. B) Representative time course for PT between complexes displaying
the native AUA codon or the deoxy-modified one at the third position of the codon (AUdA) and
the cognate Ile-tRNAIle ternary complex. The corresponding Ile-tRNA harbors the lysidine (k2C)
modification at the wobble position.
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DISCUSSION
Decades of biochemical and structural studies on translation have shown almost every
component of the translational machinery, including the ribosomal RNA and proteins, tRNAs, and
translation factors, to be important for faithful and rapid decoding (11, 29). In contrast, the role of
the mRNA substrate itself during the process has been largely overlooked. Beyond its primary role
in interrogating the incoming tRNA to ensure matched codon-anticodon interactions are
maintained, the mRNA is arguably perceived as a mere onlooker during elongation. It is worth
noting that the tRNA substrate was also viewed similarly until structural and biochemical data
provided compelling evidence to the contrary (28, 36). For instance, the tRNA is very dynamic
during the selection process, adopting distinct conformations as it moves into the A site and
eventually participating in peptidyl transfer (47, 48). Perturbance to this conformational flexibility
has significant consequences on the fidelity of protein synthesis, allowing tRNAs to read the
incorrect codon (49). In addition to its role in decoding, the tRNA plays an important role in the
chemistry of peptide-bond formation and peptide release (50-54). The hydroxyl group of the
terminal ribose (A76) of the tRNA and its ability to form a hydrogen-bonding network is important
for PT (54) and appears to be absolutely required for peptide release (55, 56). Similar to the
findings of studies on the functional importance of the tRNA structure, it is highly likely that the
mRNA structure plays an extensive role in many aspects of protein synthesis.
Early structural studies of the decoding process revealed a central role for the ribose
backbone of the mRNA in maintaining codon-anticodon interactions (31). These include A-minor
interactions between the mRNA and decoding center rRNA nucleotides. In addition to interacting
with O2 and N4 of the respective purine and pyrimidine bases of the codon/anticodon, the rRNA
residues also hydrogen bond with the 2’-OH groups of the mRNA (31). Disruption of these
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interactions by substituting the ribose groups by 2’-deoxy ribose or 2’-fluoro, as expected, results
in increased dissociation of the A-site tRNAs (57). However, these substitutions also result in
increased translocation rates (57) suggesting that disruption of the interactions between the mRNA
and tRNAs are required to remodel the mRNA during translocation. In contrast to their role in
translocation, the 2’-OH groups of the A-site codon appear to be dispensable for tRNA selection
(37); instead, shape complementarity appears to be the driving force for decoding. While these
limited studies have highlighted the importance of the ribose backbone of mRNA during
translation, the importance of the phosphodiester backbone has not been explored. In functional
RNAs, the phosphodiester backbone plays an important role in coordinating divalent metals (58),
which are important for maintaining the overall structure of the molecule; in certain cases, the
metal is directly responsible for the function of the RNA (59, 60). In the case of the ribosome,
atomic-resolution structures have revealed a number of locations where metals appear to play an
important role (39). However, the contribution of most of these sites to the function of the ribosome
has not been directly tested. Naturally, the main limitation to carrying out such studies is the
difficulty of conducting atomic mutagenesis on the rRNA and, in particular, substitutions of
nonbridging oxygen atoms to interfere with metal binding. In contrast to the ribosome, these types
of phosphorothioate substitutions approaches have been instrumental in working out mechanisms
of ribozymes (61).
In addition to rRNA, structural studies have shown the mRNA backbone to be directly
involved in coordinating at least one divalent metal at the interface of the P/A sites of the small
subunit (38, 39). More important, the metal appears to play a critical role in maintaining an unusual
structure of the mRNA characterized by a kink. This in turn allows rRNA nucleobases of the small
subunit to sandwich themselves (through base stacking) between the P and the A site and in the
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process divide the two sites (38, 39). These initial studies speculated that this structure is important
for preventing slippage and hence frameshifting during translocation (39). In contrast to its
supposed role in frame maintenance, the role of the kink in decoding has not been considered
previously. By disrupting the interaction between the mRNA and the divalent metal (and very
possibly the kink structure) through phosphorothioate substitutions we were able to show the
structure to be likely important for uniform decoding. In particular, whereas the substitutions
appear to have little to no effect on PT for cognate tRNAs that utilize typical Watson-Crick as well
as G-U wobble base pairs, they dramatically reduced PT for an aa-tRNA that uses atypical base
pairing at the third position. Substitution of the pro-S oxygen at the kink (one of the atoms involved
in coordinating the crucial divalent metal) reduced the PT rate for Ile-tRNAIle(k2C) by more than
fivefold (Fig. 4A). Consistent with its role in boosting tRNA selection under compromised
conditions, altering the kink structure also resulted in a severe hyperaccurate phenotype (Figs. 3,
4 and S1). As a case in point, the rate of the peptide bond reaction and the endpoint for the nearcognate Lys-tRNALys on the Sp-GAA codon is ~twenty fold slower and approximately fourfold
lower than that for the unmodified mRNA (Figs. 3B and 3C). We note that these observed effects
of the phosphorothioate substitutions on the tRNA selection, through which the effective accuracy
is improved by almost two orders of magnitude, are much more dramatic than those observed in
the hyperaccurate-variant ribosomes. Restrictive mutations in the ribosomal protein S12, for
instance, have been documented to improve accuracy by less than 10-fold (62). Similarly,
mutations in H69 have been shown to improve accuracy by only threefold (46). These observations
argue that, beyond its requirement to base pair with the tRNA, the mRNA structure is at least as
equally critical for tRNA selection as are the rRNA and ribosomal proteins.
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Arguably one of the key questions that came out of this study is how the kink structure
might be affecting the interaction between the mRNA and the incoming tRNA. While our data
alone do not answer this question, one could take advantage of the available structural and
biochemical information to come up with scenarios to explain our findings. Disruption of the kink
structure appears to affect later steps of tRNA selection more severely than early steps (Fig. 3). In
particular, in the presence of the Sp-phosphorothioate modification, PT reactions with nearcognates exhibited drastic end-point defects (Fig. 3B and C), but a modest decrease in observed
rate of GTP hydrolysis (Fig. 3D). Hence, interfering with magnesium binding at the P/A interface
appears to increase the rate of near-cognate tRNA rejection. It is plausible that the kink structure
serves to rigidify the mRNA in the A site; as a result, the mRNA is more dynamic in its absence.
Consequently, the dissociation rate of the tRNA is likely to increase during the proofreading phase.
For typical cognate aa-tRNAs, the proceeding step of accommodation is so rapid that the increase
in the dissociation rate is not realized to an extent that would affect the overall selection process.
For near-cognate aa-tRNAs, accommodation is much slower; as a result, the effects of the kink
disruption on codon recognition are felt, reducing the overall rate of peptide-bond formation. These
ideas are corroborated by the observations that disruption of potential hydrogen bonds with the 2’OH of the A-site codon has modest effect on cognate tRNA selection, but drastically diminishes
peptide-bond formation in the presence of near-cognate aa-tRNAs (Fig. 8).
In an alternative scenario, the kink structure could play a role relaying signals between the
P and the A sites of the ribosome. This idea is motivated by earlier studies by our group showing
that mismatches in the P site severely compromise the fidelity of the next bout of tRNA selection
(63, 64). These earlier findings as well as the observations we report here are consistent with a
model in which the extended mRNA-tRNA interaction is important for decoding.
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Notwithstanding, whatever the mechanism by which the kink affects decoding may be, our
findings provide some new unappreciated insights into the role of the substrate mRNA in ensuring
protein synthesis proceeds uniformly. The observation that a mere atomic substitution of one of
the nonbridging oxygen atoms could drastically modify tRNA selection parameters argues that
decoding is an intricate process that evolved to take advantage of all available interactions for
optimal gene expression. In addition to this role in tRNA selection, the mRNA structure is highly
likely to be important for frame maintenance. Indeed, mutations and perturbations even farther
from the A site in the E site have been shown to increase frameshifting (64). It will be exciting to
directly probe the role of the kink in translocation and to explore whether phosphorothioate
substitutions affect frameshifting.

EXPERIMENTAL PROCEDURES
Materials and reagents.
Unmodified mRNAs were synthesized using in vitro runoff transcription by T7 RNA
polymerase (66). Double-stranded DNA templates were amplified from single-stranded
oligonucleotides that were purchased from IDT. The final DNA templates had the following
sequences:
AUG-GAA (Met-Glu):
TAATACGACTCACTATAGGGTTAACTTTAGAAGGAGGTATACTATGGAATAACTCGCA
TGCCCACTTGTCGATCACCGCCCTTGATTTGCCCTTCTGT
AUG-CAA (Met-Gln):
TAATACGACTCACTATAGGGTTAACTTTAGAAGGAGGTATACTATGCAATAACTCGCA
TGCCCACTTGTCGATCACCGCCCTTGATTTGCCCTTCTGT

152

AUG-AUA (Met-Ile):
TAATACGACTCACTATAGGGTTAACTTTAGAAGGAGGTATACTATGATATAACTCGCA
TGCCCACTTGTCGATCACCGCCCTTGATTTGCCCTTCTGT

The T7 promoter is italicized, the Shine-Dalgarno sequence is underlined, and the initiation codon
is in bold.
AUG-sCAA

(Met-Gln)-modified

mRNA

with

the

sequence

AAGGAGGTAAAAAAAATGsCAAAAGTAA (“s” indicates the site of the phosphorothioate
modification) was purchased from Dharmacon. AUG-sGAA, AUG-sAUA and AUG-GsAA
phosphorothioate-modified mRNAs were generated from two chemically synthetized ribooligonucleotides

that

were

purchased

from

IDT.

The

upstream

sequence

of

AAUAAGGAGGUAUACU was common to all of them. The downstream oligonucleotides had
the following sequences: AUGsGAAUUU, AUGsAUAUUU and AUGGsAAUUU, respectively.
Before generating the full-length mRNAs, the modified oligonucleotides were separated into the
Rp and Sp diastereoisomers using reverse phase chromatography as described earlier (66). In
particular, 10 nmoles of RNA was injected into an Agilent 1100 HPLC system equipped with a
C18 column (Zorbax ODS, 5 μm, 4.6 × 250 mm). The following conditions were used for the
purification: the column was equilibrated with 100 mM ammonium acetate buffer pH 7 containing
3% acetonitrile; 5 minutes following injection, acetonitrile concentration was linearly increased to
13% over a 15-minute period and kept there for an additional 5 minutes. During the purification,
the column was maintained at 45°C. The purified RNA was dried using a SpeedVac concentrator
at ambient temperature overnight. The purified oligonucleotides were resuspended in water and
then phosphorylated using polynucleotide kinase (NEB) in the presence of ATP. Prior to initiating
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the ligation reaction, the upstream and the phosphorylated purified modified oligonucleotides were
annealed to a DNA splint with final concentrations of 13 μM upstream RNA sequence, 10 μM
modified phosphorylated oligonucleotide and 11 μM DNA splint. The DNA splints had the
following sequence: AAATTCCATAGTATACCT for the AUG-sGAA and AUG-GsAA mRNAs
and AAATAT CATAGTATACCT for the AUG-sAUA mRNA. Ligation was carried out using T4
RNA ligase 2 (NEB) and incubation at 37°C for 2 hr. The ligated products were purified away
from the substrate RNA and DNA splint using denaturing PAGE.

Tight-coupled 70S ribosomes were purified using a double pelleting strategy as described
(68). Briefly clarified lysate was centrifuged at 107100 × g for 16 hr over a sucrose cushion at 4°C;
ribosome pellet was resuspended, and the centrifugation step was repeated. Ribosomes were stored
in polymix buffer (69) (95 mM KCl, 5 mM NH4Cl, 5 mM Mg(OAc)2, 0.5 mM CaCl2, 8 mM
putrescine, 1 mM spermidine, 5 mM potassium phosphate at pH 7.5, 1 mM DTT), aliquoted, flash
frozen and stored at -80°C. His-tagged IF1, IF3 (45) and IF2 (70) were purified over Ni-NTA resin
as described earlier (45). Purification of the His-tagged 20 aa-tRNA synthetases, RF1 and RF2
was carried out as described in (70). EF-Tu and EF-G were also purified over Ni-NTA resin;
following purification the His tag was removed using TEV protease (71). E. coli tRNAfMet,
RNAMet, RNAGlu, RNALys , RNAArg, RNAVal, RNAPhe and RNATyr was purchased from
ChemBlock.

tRNA aminoacylation
[35S]-fMet-tRNAfMet was prepared as described (72) using Met-tRNA synthetase and
Methionyl-tRNA formyltransferase in the presence of [35S]-Met (Perkin Elmer) and 10-
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formyltetrahydrofolate formyl donor at 37C. Purified tRNAs were aminoacylated as described
(41) by incubating them in the presence of the appropriate tRNA synthetase, the corresponding
amino acid and ATP. All other tRNAs were charged by incubating E. coli total tRNA (Roche)
with the applicable tRNA synthetase and the equivalent amino acid in the presence of ATP.

Ribosome complex formation
Initiation complex were generated as described previously (45) by mixing 2 µM 70S
ribosomes with 3 µM IF1, IF2, IF3, [35S]-fMet-tRNAfMet, 6 µM mRNA, and 2 mM GTP in polymix
buffer. Following incubation at 37°C for 2 minutes, the mixture was placed on ice before adding
MgCl2 to a final concentration of 10 mM. The complex was purified away from IFs, and unbound
tRNA and mRNA through centrifugation over a sucrose cushion (1.1 M sucrose, 20 mM Tris pH
7.5, 500 mM NH4Cl, 10 mM MgCl2, 0.5 mM EDTA) at 223424 × g in an MLA-130 rotor
(Beckman) for 2 hours at 4°C. The purified pelleted complexes were resuspended in polymix
buffer (using the original volume). Small aliquots were taken before and after centrifugation for
scintillation counting to estimate complex recovery and concentration.

Dipeptide-formation and release assays
Ternary complexes were generated by first incubating 30 μM EFTu with 2 µM GTP to
exchange bound GDP at 37°C for 15 minutes before adding the appropriate aa-tRNA to a final
concentration of 4 µM. The mixture was further incubated for an additional 15 minutes. Peptidebond formation was initiated by mixing equal volume of initiation complex and ternary complex
at 37C. For fast reactions, the mixing was done on an RQF-3 quench flow apparatus (KinTek) at
37C. The reactions were quenched by the addition of KOH to a final concentration of 1 M.
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Dipeptides were resolved from unreacted fMet using cellulose TLC plates electrophoresed in a
PyrAC buffer (3.48 M acetic acid, 62 mMpyridine) and Stoddard’s solvent at 1200 V (40). The
TLCs were dried and exposed to phosphoscreens before imaging on a Biorad personal imager
phosphorimager. The fractional reactivity corresponding to the dipeptide was quantified as a
function of time using Bio-Rad Quantity One software. The resulting data was fit to a singleexponential function using GraphPad prism software. All reactions were conducted at least in
duplicates.
Peptide release was carried out by mixing 2 µM initiation complex with 10 µM RF1 and
RF2 in polymix buffer at 37°C. Reactions were stopped through the addition of formic acid to a
final concentration of 5% or EDTA to a final concentration of 20 mM. Released fMet was resolved
from fMet-tRNAfMet using electrophoretic TLCs as described above.
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Chapter 5

Conclusions and Future Directions
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ABSTRACT
The focus of my thesis work has been on understanding how changes to mRNA structure
impact the accuracy and fidelity of translation, which is a vital step in the transmission of genetic
information. This was accomplished through several in vitro studies designed to understand the
precise effect each mRNA modification had on the speed and accuracy of decoding, as well as
changes in specific miscoding events. Through these studies, we uncover the base pairing
preference of the most common oxidative damage adduct of mRNA, 8-oxoguanosine, in the
context of the A-site of the ribosome. We confirm that the alkylative damage adduct, N(1)methyladenosine, stalls the ribosome and provide evidence to support that it severely distorts the
codon-anticodon helix. Additionally, we show that alkylative damage of RNA increases the
activity of trans-translation in bacteria, suggesting that it stalls ribosomes. In another project, we
show that the kink structure that the mRNA phosphodiester backbone assumes in the A site of
the ribosome is only important to decoding under non-optimal conditions. Overall, this work has
contributed to our understanding of the importance of mRNA structure during translation.
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The impact of N(1)-methyladenosine on peptidyl transfer in vitro
N(1)-methyladenosine (m1A) has recently emerged as a potential regulatory modification
of mRNA; however, no demethylases have been shown to exist specifically for removing m1A
from mRNA. Additionally, no “reader” proteins that recognize m1A have been identified (1). On
the contrary, one study shows that the presence of m1A in the coding region of mRNA
significantly increases ribosome stalling (2) and another study demonstrates that m1A increases
local duplex melting (3), suggesting that it is detrimental to decoding. To understand the
magnitude by which m1A decreases the rate of peptidyl transfer as well as to understand if it
impacts miscoding, in vitro peptide-bond formation assays were performed using our wellestablished reconstituted bacterial translation system (4).
We show that m1A in the second position of the codon significantly decreases the rate
and endpoint of peptide-bond formation, confirming its activity as a disruptive adduct of mRNA.
Furthermore, we demonstrate that the addition of the aminoglycoside antibiotic, paromomycin,
does not rescue the effect of m1A on peptidyl transfer. This suggests that m1A causes the codon
to behave more as a non-cognate than a near-cognate codon, because if m1A were only
disrupting its own ability to form base pairs, the reaction should have at least been partially
rescued by the addition of the antibiotic (5, 6). From these results, we predict that the positively
charged resonance structure introduced to adenosine by the addition of the methyl group to N1
disrupts its neighboring nucleotides from forming base pairs.
In order to understand the details of how m1A disrupts interactions between codons and
aa-tRNAs or release factors, structural studies will need to be performed. These studies will help
to confirm that m1A is disrupting the codon-anticodon helix and elucidate the details of how
neighboring hydrogen bonds might be disrupted by this lesion. Additionally, they will reveal
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how m1A is disrupting the interaction between the codon and release factor. Future kinetic and
structural studies using stop codons containing m1A may also reveal interesting changes to the
recognition of stop codons by release factors.
Several studies in which m1A-sequencing was performed revealed that it is enriched
around the start codon and 3’ of the first splice site in human cells (7, 8). If these studies are
accurate, it would be interesting to investigate if m1A has an intentional role to regulate
translation initiation. We predict that the presence of the adduct would prevent proper translation
initiation, and potentially cause the ribosome to continue scanning past the m1AUG and initiate at
a downstream start codon. However, a third study that performed m1A-sequencing showed that
the adduct is significantly rarer than the previous studies reported, detecting only nine modified
sites in cytosolic and mitochondrial mRNAs with no enrichment pattern (9). Much work remains
to be performed to resolve these discrepancies; however, our data supports the theory that m1A is
primarily a damage adduct that is highly disruptive to decoding.
Ribosome rescue from alkylated transcripts in bacteria
While several studies have been performed to investigate the impact of alkylative adducts
of mRNA on decoding in vitro, less is known about how this damage affects translation in vivo
(10). Previous work from our group showed that the most common oxidative damage adduct, 8oxoguanosine (8-oxoG), significantly reduces the rate of peptide-bond formation in vitro when it
is present in mRNA. Additionally, this study revealed that when the no-go decay quality control
pathway in eukaryotes is compromised, 8-oxoG accumulates to higher levels than in wild-type
cells, suggesting that no-go decay may have evolved to cope with damaged mRNA (11). The
cellular response to alkylative damage as well as mRNA damage in bacteria had not been
previously explored. We hypothesized that alkylative damage of mRNA stalls translation in vivo,
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and that the main bacterial ribosome rescue pathway, known as trans-translation, is responsible
for rescuing these stalled ribosomes. To address these hypotheses, we introduced alkylative
damage in vivo and visualized the resulting activity of the trans-translation pathway.
We first confirmed that two common alkylating agents, MMS and MNNG, caused
accumulation of damage adducts in E. coli and identified the specific adducts introduced by each
agent. Cells were treated with either alkylating agent and the resulting RNA adducts were
quantified via LC-MS/MS. We measured significant increases in several disruptive adducts,
including m1A and m3C after treatment with MMS or MNNG, and m6G after treatment with
MNNG. Our results support previous data demonstrating that mRNA is more susceptible to
alkylative damage than DNA, as the hydrogen-bonding interface between double-stranded DNA
impedes the accumulation of m1A and m3C (12, 13).
After demonstrating the accumulation of multiple disruptive RNA adducts after
alkylating agent treatment, we then sought to observe ribosome stalling in vivo. To accomplish
this, we utilized a previously modified-transfer-messenger RNA (tmRNA) that His6-tags
incomplete peptides from stalled ribosomes rather than tagging them for degradation by cellular
proteases (14). We then treated these cells with MMS or MNNG and observed significant
increases in His6 levels via Western blot, suggesting that trans-translation is being activated upon
nucleotide damage. To demonstrate that the observed increase in tmRNA activity was due to
RNA damage rather than the production of truncated transcripts from damaged DNA, we
performed a transcriptional runoff assay and treated cells with agents that exclusively introduce
damage to DNA. We then observed His6 levels in each of these samples and observed that while
double-stranded DNA breaks do increase His6 tagging, these levels significantly decrease after
transcriptional runoff. Additionally, His6 levels in the MMS and MNNG samples after
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transcriptional runoff do slightly decrease, but not to the same extent as the samples treated with
the DNA damaging agent. From these results, we conclude that while some His6 tagging in the
MMS and MNNG is due to the production of truncated transcripts from damaged DNA, most of
the activity is due to damaged mRNA, demonstrating that trans-translation is responsible for
rescuing ribosomes stalled by alkylative damage in vivo.
We also hypothesized that the trans-translation pathway is important for bacteria to
efficiently recover from alkylative damage. To test this, we treated both WT E. coli and those
lacking tmRNA (∆ssrA) with the alkylating agents and monitored their growth post-treatment.
While the growth curves of the untreated WT and ∆ssrA cells were indistinguishable, ∆ssrA cells
after treatment with either MMS or MNNG recovered approximately 1.5 hours after WT cells.
This demonstrates that a functional trans-translation system is required for efficient recovery
post-alkylative damage. We predict that the ∆ssrA cells are still able to recover post-alkylative
damage treatment because E. coli contain two additional ribosome rescue factors, ArfA and
ArfB. ArfA is known to function as a backup for trans-translation, as its expression increases
when tmRNA activity is limited. Future experiments can include performing qPCR in the WT
and ∆ssrA to observe if ArfA activity increases. ArfB does not appear to function solely as a
backup for tmRNA, so it would be interesting to investigate if it plays a role in rescuing
ribosomes from damaged transcripts.
Here, we provide the first evidence that alkylative damage causes ribosomal stalling in
vivo, and that trans-translation in bacteria is responsible for rescuing ribosomes stalled on
alkylated transcripts. Another type of mRNA damage that can cause ribosome stalling is
oxidative damage. To show that trans-translation is the pathway responsible for rescuing
ribosomes stalled by other types of nucleotide damage besides alkylative damage, future
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experiments will include repeating the tmRNA His6-tagging analyses after treatment with
oxidizing agents, such as hydrogen peroxide.
The mechanism through which tmRNA recognizes ribosomes stalled by alkylated
transcripts is not understood. Previous studies have shown that tmRNA requires that no more
than six nucleotides are present downstream of the P-site to rescue stalled ribosomes (15, 16). If
the alkylative adduct exists in the middle of the transcript, we predict that the stalled ribosome
triggers the cleavage of the mRNA at or within these six nucleotides. Previous reports have
suggested that the tmRNA-complex recruits RNase R to degrade the non-stop mRNA (17, 18);
however, RNase R is an exonuclease so it is not able to perform the initial endonucleolytic
cleavage necessary for tmRNA to act on a ribosome stalled by a damage adduct. A previous
report from our group shows that the collision of upstream ribosomes with the stalled ribosome
induces no-go decay in eukaryotes (19). This involves the cleavage of the mRNA between the
stalled and the colliding ribosome, and the endonuclease that performs this cleavage remains
unidentified. It is possible that a similar process exists in bacteria, where the colliding ribosomes
induces cleavage of mRNA so that the complex can become a target for trans-translation. To
identify this potential endonuclease, a genetic screen could be performed to identify mutants that
reduce His6-tagging by tmRNA after treatment with alkylative damaging agents.
Recent in vitro studies have shown that when mRNA damaged with MMS was treated
with AlkB, which is a hydroxylase in E. coli that has been shown to demethylate RNA and
single-stranded DNA (20), translation was enhanced (21). Additionally, the same study showed
that the treatment of tRNA with an alkylating agent inhibited aminoacylation, but that this
inhibition was substantially relieved upon treatment with AlkB. To show that AlkB has the same
effect in vivo, we can overexpress the protein in E. coli expressing tmRNA-His6 and observe
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differences in His6-levels after treatment with alkylating agents. If there is a reduction in His6levels in the cells overexpressing AlkB, this would support the in vitro study that AlkB
demethylates RNA and restores translation.
The treatment of E. coli with alkylating agents also revealed that activation of Ada
increases proportionally to tmRNA activity. Ada is a key player in the adaptive response in E.
coli, during which it serves as a suicide enzyme that transfers alkyl groups from O6- alkyl
guanine, O4-alkyl thymine, and the oxygen of the phosphodiester backbone of DNA to one of its
cysteine residues (22, 23). Once it is methylated, Ada serves as a transcriptional activator,
inducing the expression of itself and other genes involved in the adaptive response (24, 25). One
open question is whether Ada can transfer alkyl groups from damaged RNA, such as m6G,
resulting in the same activation of the adaptive response. One ongoing study in our group
involves damaging mRNA with MMS and subsequently transfecting the mRNA into E. coli and
observing if Ada is activated. If Ada activation is observed, this will provide evidence to support
the hypothesis that Ada responds to both DNA as well as mRNA damage.
The base pairing preference of 8-oxoguanosine on the ribosome
8-oxoguanosine (8-oxoG) is the most common oxidative damage adduct of DNA and
RNA (26, 27). Studies investigating 8-oxodG in DNA have shown that the lesion is mutagenic,
as it has dual-coding potential due to its ability to change from an anti to a syn conformation and
reveal an alternate hydrogen-bonding interface where is can form a Hoogsteen base pair with
adenosine (28). This change in conformation relieves the steric hindrance that the O8
experiences with the phosphate backbone when 8-oxoG is in the anti conformation. A previous
report by our group demonstrated that 8-oxoG in mRNA drastically reduced the rate of peptidyl
transfer in vitro in the presence of an 8-oxoG•C base pair while slightly increasing the rate of
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miscoding for 8-oxoG•A (11). However, the underlying mechanism for this disruption of tRNA
selection was unaddressed. Here, in vitro peptidyl transfer studies in the presence of error-prone
conditions demonstrate that 8-oxoG predominantly adopts a syn conformation in the A site.
We initially hypothesized that 8-oxoG is interfering with initial codon selection rather
than the steps further downstream in tRNA selection. The irreversible hydrolysis of GTP
separates initial codon selection and downstream reactions (29), so to test our initial hypothesis,
we performed GTP hydrolysis assays in the presence and absence of 8-oxoG at all three
positions of the codon. We observe a decrease in the rate of GTP hydrolysis that is similar to the
decrease we previously observed for the rate of peptidyl-transfer in the presence of 8-oxoG.
From this, we conclude that 8-oxoG is predominantly interfering with early-stage tRNA
selection, likely during initial codon selection.
We then set out to investigate the preferred base pairing conformation of 8-oxoG in both
the first and second position of the codon. To accomplish this, we took advantage of the ability
of aminoglycoside antibiotics to relax tRNA selection conditions (5, 6, 30, 31). We performed in
vitro peptidyl transfer reactions in the presence or absence of aminoglycoside antibiotics as well
as in the presence of the cognate and all possible near-cognate aa-tRNAs. We observed that the
average rate and endpoint of peptidyl transfer in the presence of 8-oxoG•A base pairs exceeded
that of 8-oxoG•C base pairs in both the first and second positions of the codon. We also
performed peptidyl transfer reactions in the presence of error prone ribosomes and observed
higher rate and endpoint values for 8-oxoG•A than 8-oxoG•C. These results support the
hypothesis that 8-oxoG primarily exists in the syn conformation on the ribosome, but that the 8oxoG•A base pair is recognized as a mismatch and rejected during tRNA selection under normal
conditions.
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The next steps of investigating the base pairing preference of 8-oxoG on the ribosome
include performing structural studies to investigate not only the changes that occur in the codonanticodon helix in the presence of 8-oxoG, but also how the hydrogen bonds of the rRNA
residues that are important for monitoring this interaction are altered by 8-oxoG in both the syn
and anti conformation. Structural studies of DNA polymerases with templates containing 8oxodG in the active site demonstrate that the fidelity of the polymerase determines how
frequently the adduct codes for dC or for dA. Lower fidelity polymerases can incorporate bulkier
base pairs, such as 8-oxodG•dC, in their active sites so they less frequently miscode for dA. On
the contrary, high fidelity polymerases have a smaller active site, and the 8-oxodG•A base pair
adopts a geometry that is very similar to that of a Watson Crick base pair, so these polymerases
are more likely to miscode in the presence of the adduct (32–35). Similar structural studies of 8oxoG in the A site of the ribosome will help to elucidate why this lesion generally causes stalling
rather than bypass under normal conditions.
Additionally, we hypothesized that E. coli containing error-prone ribosomes would be
better able to survive oxidative stress conditions due to their ability to bypass oxidative lesions
rather than stall protein synthesis. This would provide a selective advantage for organisms living
in highly oxidative environments, such as pathogens that deal with the reactive oxygen species
associated with immune responses. To test this, we treated either WT E. coli or cells expressing
error-prone ribosomes with hydrogen peroxide and observed recovery either by performing spot
assays or monitoring growth curves. No significant difference in ability to recovery postoxidative treatment was observed between the strains. Interestingly, one previous study did
observe a 30% - 70% decrease in survival rates during oxidative damage of WT E. coli
compared to those expressing error-prone ribosomes post-oxidative treatment (36), but the
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mutations to generate error-prone ribosomes in this study were in the same ribosomal protein but
at a different locus than the mutation we utilized. Overall, the results of this study were
inconclusive but do not support the conclusion that all error-prone ribosomes provide a selective
advantage for bacterial recovery following oxidative stress.
The importance of the phosphodiester backbone kink structure during decoding
While much is known about the importance of rRNA and tRNA structure with regards to
the decoding process, less is known about how mRNA structure impacts translation. Structural
studies have revealed that the mRNA adopts a kink-like structure in the context of the ribosome
between the P and A sites (37, 38). A magnesium ion stabilizes this structure through
electrostatic interactions with the non-bridging oxygens of the phosphodiester backbone of the
mRNA (38). Whether or not this structure contributes to tRNA selection remained unknown. To
address this question, we utilized our reconstituted in vitro translation system in combination
with an mRNA construct that contains stereospecific phosphorothioate substitutions to disrupt
this kink structure.
When we substituted either of the non-bridging oxygen atoms between the A- and P-site
codons with sulfur to disrupt the coordination of the magnesium ion, we observed that tRNA
selection became more stringent. The phosphorothioate-modified mRNAs were less reactive
with near-cognate tRNAs than the unmodified mRNA control. Interestingly, reactivity with
cognate aa-tRNAs remained unaffected. This suggested that the structure of the mRNA
backbone at the interface of the A and P sites plays an important role in tRNA selection. When
extended reactions were performed, both the Sp- and Rp- phosphorothioate substitutions reduced
the rate of peptide-bond formation in the presence of near-cognate aa-tRNAs, but the Sp
substitution resulted in a more severe endpoint defect, suggesting that the pro-S oxygen is more
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important for coordinating the kink structure than the pro-R oxygen. We also analyzed the rate of
peptide release for these constructs, and while there was a slight decrease in rate for the Sp and
Rp-phosphorothioate-modified mRNA compared to the control, it was not as significant as the
effects observed on tRNA selection.
To investigate the phase of tRNA selection impacted by the substitution, we performed
GTP hydrolysis assays and demonstrated that the initial phase of tRNA selection is not
significantly impacted by the substitutions. This suggests that the kink structure plays an
important role during the later proofreading phase. Additionally, we investigated the impact of
phosphorothioate substitutions between the first and second position as well as the second and
third positions of the A-site codon on tRNA selection. Structural studies show that the kinkstabilizing magnesium ion also appears to be coordinated by the pro-R oxygen between the first
and second position of the A-site codon, but not by oxygens in the backbone between the second
and third position of the A-site codon [38, 39]. For the phosphorothioate substitutions between
the first and second position but not the second and third position, we observed effects on tRNA
selection that were similar to those observed for the substitutions at the P/A interface. This
served as a control to show that the effects on tRNA selection were due to the disruption of
magnesium coordination which likely also disrupts the kink structure.
The results that the disruption of the kink structure decreases the rate of miscoding in the
presence of near-cognate aa-tRNAs while having no effect on the rate of the reaction in the
presence of the cognate aa-tRNA begs the question as to why the mRNA evolved to adopt this
kink structure if it makes decoding less accurate. We hypothesized that a subset of cognate aatRNAs that exploit unusual base pairs at the wobble position would be negatively impacted by
the loss of this kink structure, as the substitution might not provide promiscuous enough
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conditions to allow for tRNA selection to occur. To this end, we utilized the AUA Ile codon
which does not base pair with the anticodon in the typical A•U base pair at the third position.
Instead, the C in the anticodon is modified to lysidine (k2C) in order to avoid base pairing with
the AUG Met codon (39). When we perform the peptidyl transfer reactions with unmodified or
Rp- phosphorothioate-programmed complexes in the presence of the cognate Ile-tRNAIle, the
rates were indistinguishable. However, the rate for the Sp-modified complex was about an order
of magnitude slower. This supports the hypotheses that the kink structure is critical for decoding
under less-than-ideal conditions and that the pro-S oxygen is more important for coordinating the
kink structure than the pro-R oxygen.
While our study shows that the kink structure is important for tRNA selection, previous
studies speculated that this structure is important for preventing slippage during translocation
(40). This slippage of the mRNA template causes frameshifting, which can lead to the improper
decoding of the template. It is possible that the structure also plays a role in frame maintenance.
Future studies can focus on measuring the rates of frameshifting in the presence of the
phosphorothioate-substituted templates.
Conclusions of the thesis
The overall goal of my dissertation was to expand on the understanding of how mRNA
structure impacts tRNA selection. For my research, I focused on understanding the effects of
chemical damage of mRNA on tRNA selection, as well as elucidating a role for the structure of
the phosphodiester backbone of mRNA during decoding. In addition to refining and redefining
what is known about mRNA structure during decoding, these findings demonstrate that chemical
damage of mRNA can stall ribosomes in vivo and elicit cellular responses. The studies
performed in this thesis demonstrate that mRNA is more than just a passive template during
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decoding, and I believe future studies will continue to demonstrate the important role mRNA
structure plays throughout the various steps in translation.
To further understand the importance of mRNA structure during translation, we explored
how both oxidative as well as alkylative damage alters the way in which nucleotides are
decoded. Additionally, we explored the previously underappreciated role of the mRNA
phosphodiester backbone during tRNA selection. We also provide the first evidence that the
trans-translation ribosome rescue pathway in bacteria is responsible for rescuing ribosomes
stalled by RNA damage. As the field progresses, this data will be integral to our understanding of
how cells deal with structural alterations to mRNA.
Moving forward, there are still many questions remaining as to how organisms tolerate
mRNA damage as well as how mRNA might be specifically modified to regulate cellular
processes. Our studies support the idea that the preservation of mRNA structure is important to
maintaining the speed and fidelity of decoding and elude to the possibility that mRNA structure
can be intentionally regulated to modulate this process. I am confident that, over time, additional
alterations to mRNA structure will identify further roles for mRNA in the regulation as well as
the maintenance of translation.
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Chapter 2 Rate and Endpoint Data
Table 1: m1A Glu Rate and Endpoint Data
Glu Codon: GAA
m1AGlu Codon: Gm1AA
Codon

tRNA/RF Treatment

Rate

Endpoint

Glu

Glu

65.89

0.807

49.22

0.8614

0.1347

0.126

0.1618

0.07675

0.1624

0.1726

0.243

0.04352

0.01676

0.06504

0.01988

0.06279

0.04841

0.01304

0.06531

0.01988

m1A

m1A

Glu

m1A

Glu

Glu

Glu

Lys

Lys

RF1

NT

NT

Paromo

NT

NT

NT

0.001309 0.6147
0.001525 0.9687

m1A

Glu

m1A

RF1

RF2

RF2

NT

NT

NT

0.1047

0.001309

0.1099

0.001785

0.003196 0.03785
0.03537

0.01446

0.3265

0.000638

0.4124

0.00071
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Chapter 3 Rate and Endpoint Data
Table 2: 8-oxoG Val Rate and Endpoint Data
Val Codon: GUU
8oxoVal Codon: 8oxoGUU
Codon

tRNA

Treatment Rate

8oxoG

Val

NT

8oxoG

Val

Strep

8oxoG

Val

Paromo

G

Ile

NT

G

Ile

Strep

G

Ile

Paromo

8oxoG

Ile

NT

8oxoG

Ile

Strep

8oxoG

Ile

Paromo

8oxoG

Phe

NT

8oxoG

Phe

Strep

8oxoG

Phe

Paromo

G

Phe

NT

G

Phe

Strep

G

Phe

Paromo

8oxoG

Leu

NT

8oxoG

Leu

Strep

0.0474
0.03998
0.08455
0.07638
0.2025
0.179
0.08125
0.0186
0.08165
0.07477
0.07731
0.06805
0.0816
0.08085
0.01849
0.01207
0.02389
0.02086
0.01956
0.01675
0.3361
0.2468
0.2534
0.188
0.1872
0.1867
0.1504
0.1075
0.2108
0.1634
0.07894
0.06641
0.05692
0.05201

Endpoint Average
Rate
0.3011
0.04369
0.3154
0.5521
0.080465
0.5806
0.609
0.19075
0.5772
0.02796 0.049925
0.2625
0.6934
0.07821
0.6723
0.6789
0.07268
0.6638
0.02899 0.081225
0.02665
0.06192 0.01528
0.1776
0.08755 0.022375
0.1396
0.1015
0.018155
0.1238
0.6393
0.29145
0.672
0.5937
0.2207
0.6138
0.01531 0.18695
0.01748
0.7181
0.12895
0.7264
0.6519
0.1871
0.6979
0.005643 0.072675
0.007032
0.01688 0.054465
0.01635
182

Average
Endpoint
0.30825
0.56635
0.5931
0.14523
0.68285
0.67135
0.02782
0.11976
0.113575
0.11265
0.65565
0.60375
0.016395
0.72225
0.6749
0.0063375
0.016615

8oxoG

Leu

Paromo

G

Leu

NT

G

Leu

Strep

G

Leu

Paromo

G

Val

NT

G

Val

Strep

G

Val

Paromo

0.1048
0.05585
0.1318
0.0573
0.02859
0.02448
0.05557
0.0483
31.39
26.51
26.77
20.81
31.76
25.36

0.01161
0.01683
0.004502
0.005461
0.01089
0.01109
0.01259
0.01015
0.6868
0.7712
0.8663
0.7237
0.925
0.7317
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0.080325

0.01422

0.09455

0.0049815

0.026535

0.01099

0.051935

0.01137

28.95

0.729

23.79

0.795

28.56

0.82835

Table 3: 8-oxoG Arg Rate and Endpoint Data
Arg: CGC
8oxoVal Codon: C8oxoGC
Codon
8oxoGArg
8oxoGArg
8oxoGArg
8oxoGArg

tRNA
Leu

Leu

Leu

His

Treatment
NT

Rate
0.02064

Endpoint
0.3555

Average Rate
0.015645

Average Endpoint
0.47645

Strep

0.01065
0.03287

0.5974
0.7419

0.030825

0.6412

Paromo

0.02878
0.08754

0.5405
0.6805

0.074255

0.66565

NT

0.06097
0.02932

0.6508
0.009227 0.02801

0.010874

0.01252
0.02029

0.036867

0.073995

0.0182

0.20316

8oxoGArg

His

Strep

0.0267
0.07271

8oxoGArg

His

Paromo

0.001023 0.1277
0.03536 0.04542

NT

0.001039 0.3609
0.1513
0.001144 0.09327

0.002369

Strep

0.03524
0.01943

0.003593
0.003755 0.014225

0.004578

0.0054
0.002805 0.04913

0.003337

0.003868
0.02483 0.009748

0.027685

8oxoGArg
8oxoGArg

Pro

Pro

8oxoGArg

Pro

Paromo

0.00902
0.07701

8oxoGArg

Arg

NT

0.02125
0.018

Strep

0.001495 0.03054
0.03647 0.4865

0.022026

0.37025

Paromo

0.007582 0.254
0.08517 0.5697

0.04868

0.5221

8oxoGArg
8oxoGArg

Arg

Arg

G

Leu

NT

G

Leu

Strep

0.01219
0.115
0.03295
0.03705

0.4745
0.03705 0.073975
0.003407
0.003785 0.020832
184

0.020229
0.008468

G

Leu

Paromo

G

His

NT

G

His

Strep

G

His

Paromo

G

Pro

NT

G

Pro

Strep

G

Pro

Paromo

G

Arg

NT

G

Arg

Strep

G

Arg

Paromo

0.004614
0.02586
0.02381
0.0181
0.003349
0.2457
0.1135
0.9127
0.7397
0.138
0.08037
0.02478
0.005687
0.02645
0.02184
33.47
11.26
44.39
29.77
46.59
13.34

0.01315
0.07102
0.01912
0.06442
0.2971
0.1624
0.8246
0.5836
0.5869
0.000745
0.002626
0.01144
0.06771
0.03292
0.01746
0.7557
0.5227
0.8139
0.8313
0.8675
0.3911

185

0.024835

0.04507

0.010725

0.18076

0.1796

0.4935

0.8262

0.58525

0.109185

0.001686

0.015234

0.039575

0.024145

0.02519

22.365

0.6392

37.08

0.8226

29.965

0.6293

Table 4: 8-oxoG Arg Ribosomal Mutant Rate and Endpoint Data
8oxoVal Codon: C8oxoGC
tRNA

Ribosome Rate

Arg

WT
HA
EP

Leu

WT
HA
EP

Endpoint Average
Rate
0.001625
0.3788
0.001171
0.0007169 0.06412
0.00000044 0.07934 0.00028
0.00056
NA
0.01313
0.3776
0.007773
0.002415
0.1355
0.01526
0.5514
0.014385
0.01351
0.6078
0.0008105 0.4841
0.00159
0.002369
0.3835
0.0706
0.6504
0.07353
0.07646
0.6614
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Average
Endpoint
0.22146
0.07934
0.25655
0.5796
0.4338
0.6559
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Specifications for Mass Spectrometry
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Table 1: Specifications for Mass Spectrometry

A
C
G
U

precursor
mass
268.1
244.1
284.2
245.2

product
ion
136
112
152
152.1

retention
time
1.92
0.48
2.4
1

collision
energy
18
14
16
14

extinction
coefficient
15600
9000
13700
10000

EC
Wavelength
259
271
252
262

m1A
m6A

282.2
282

150.1
150

0.9
4.08

16
16

14600
15567

258
265

m3C

258.2

126

0.8

8

7008

254

m7G
m1G
m6G
8oxoG

298.2
298
298
300

166
166
166
168.1

1.5
4.623
4.84
2.956

10
4.143
4.84
2.956

9056
12948
7100
7868

260
254
280
296
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